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Oxidative stress has been associated with numerous degenerative diseases and disorders, as 
well as cancer and the process of ageing. In higher animals, the response to oxidative stress is 
largely regulated by the master transcription factor Nrf2, which controls the transcription of 
cytoprotective genes, and its inhibitor Keap1 which functions as a “sensor” of oxidative stress. 
Keap1-Nrf2 pathway is known to be conserved across vertebrates and certain invertebrates, but 
its evolution is yet to be described and it is currently unknown if microbes such as yeasts and 
bacteria possess this pathway. This thesis examines microbial genomes for evidence of Keap1-
Nrf2 pathway, investigates the evolution of this pathway over geological time, and assesses the 
potential for activation of Nrf2-controlled cytoprotection by microbially produced small 
compounds.  
The novel software for identification of distant homologs was developed and utilized to study 
the homologs of Keap1 and Nrf2 proteins in genomes of animals and microorganisms. The 
evolution of Keap1-Nrf2 pathway was reconstructed by phylogenetic studies, and the time-
frame of evolution was calibrated using the fossil record. The existence of Keap1-Nrf2 pathway 
in fungi was also examined empirically by utilizing high-throughput proteomics to quantify the 
stress response mechanisms of an UV-tolerant yeast model. Structure based virtual screening 
was employed to identify microbial natural products with potential to activate human Nrf2 
pathway by inhibiting the Keap1-Nrf2 binding, and the prospective in-silico activators of Nrf2 
were tested in vitro by fluorescence polarisation and thermal shift assays to detect competitive 
inhibition of human Keap1-Nrf2 binding.  
In-silico analyses identified that the Keap1-Nrf2 pathway exists in all major eukaryotic phyla, 
ranging from fungi to mammals, and that Nrf2 evolved under a selective pressure incurred by 
the rise of oxygen levels over geological time. The in-silico virtual screen identified the 
potential for competitive inhibition of Keap1-Nrf2 binding by mycosporine-like amino acids 
(MAAs), small compound UV-protective and antioxidant metabolites of marine 
microorganisms. This activity of MAAs was tested empirically, and the MAAs shinorine and 
porphyra-334 were confirmed to competitively inhibit the human Keap1-Nrf2 interaction in 
vitro. The results presented herein indicate that natural products of microorganisms, such as 
MAAs, are the prospective compound leads for the design of novel therapeutics to target 
activation of the human Keap1-Nrf2 pathway for treating degenerative diseases of oxidative 
stress, whilst avoiding the off-target effects of currently utilized Nrf2 activators. 
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Chapter 1: Introduction 
 
1.1 Foreword to Chapter 1 
This chapter introduces the basic terminology of redox biology and the computational and 
empirical approaches used in this work. The concept of oxidative stress and basic terminology 
of redox biology are introduced in section 1.2, and the principal stress response pathway in 
animals is described in the section 1.3. The section 1.4 introduces a class of natural compounds 
which were identified as potential activators of animal stress response using the in-silico 
methods described in section 1.5. The section 1.6 describes the empirical approach used to 
evaluate the stress response mechanisms of in-vivo model to validate the in-silico studies of 
animal stress response pathway, while the sections 1.7 and 1.8 give a brief summary of the 
introduction and present the research hypotheses and goals of this project. 
1.2 Oxidative stress 
The concept of oxidative stress was introduced in 1985 by Helmut Seis as “a disturbance of the 
prooxidant – antioxidant balance in favour of the former.” (1). The Seis’ work and “oxidative 
stress” hypothesis was largely inspired by the discovery of free radicals in biological tissues 
(2), the discovery of superoxide dismutase proteins (3) and the inception of Harman’s Free 
radical theory of ageing (4), which postulated that the process of ageing is caused by ROS-
induced damage. Further studies, at a turn of the twentieth century, led to the realization that 
oxidative cellular damage is associated with innumerable diseases and disorders, including, but 
not limited to, carcinogenesis, inflammation, neurodegeneration and ageing (1,5,6). Since the 
eighties, the field of redox biology and medicine has seen an enormous expansion; for 
illustration, a PubMed database (7) search for “oxidative stress” lists over 150,000 articles 
published until the end of 2016, with over 70,000 published in the period 2011 – 2016. 
It should be noted, however, that Harman and Seis’s work was not without its critics. For 
example Hallywell and Gutteridge  argued that an association between ROS and disease does 
not imply a causal relationship (8,9). It was also recognized at that time that redox processes 
and ROS are not necessary deleterious for biological systems, and are vital for immune 
response as well as parts of cellular metabolism such as production of derivatives of fatty acids 
and deoxyribonucleotides (5,10). Indeed, despite the decades of research and tens of thousands 
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of published studies in redox biology, the role of ROS in health, disease and ageing is still an 
active field of research with a number of controversies; these are briefly reviewed in Section 
1.2.8.  
1.2.1 Oxidative stress, terminology  
The extreme levels of oxidants, such as hydrogen peroxide (H2O2) or pure oxygen (O2), are 
toxic (6) and the disruption of critical cellular redox signalling mechanisms, e.g. mutation of 
superoxide dismutase (SOD) encoding gene, cause severe pathologies in model organisms (11). 
Defining oxidative stress, however, is not as simple as stating that ROS cause cellular damage 
leading to damage and number of pathologies unless kept in check by cellular antioxidant 
mechanisms. Plenty of evidence exists for the role of ROS, especially H2O2, in cellular 
signalling, functioning of the immune system and the control of cell cycle (12–14). In addition, 
it has been demonstrated that removal of ROS from healthy biological systems can be 
deleterious (15,16). Finally, terms such as ROS and antioxidant lack clear definition, and the 
recent recommendation by the journal Free Radicals in Biology and Medicine is to avoid use of 
these terms in favour of those more specific (17). Acknowledging these issues, here follows a 
brief introduction to the basic redox biology terms used in this thesis.  
Free radical: Free radical is a chemical species with unpaired electron; free radicals common 
in biological systems include superoxide anion radicals (O2
-•), highly active hydroxyl radicals 
(OH•), and diverse biomolecule radicals and peroxyls, for example lipid radicals and peroxyls 
formed during the lipid peroxidation process (R•, ROO•); this term also includes radicals not 
derived from oxygen such as nitric oxide radical (NO•) (5,18). 
Reactive oxygen species (ROS): ROS are (reactive) products of molecular oxygen (O2); these 
include free radicals such as hydroxyl (OH•), and non-radical species such as hydrogen 
peroxide (H2O2), hydroxide anion (OH
-
) and peroxides of proteins, lipids, nucleic acids and 
other macromolecules (ROOH). Notably, terms ROS and free radicals are sometimes used 
interchangeably, despite the fact that some of the oxygen-derived species, e.g. H2O2 and OH
-
, 
are not radicals. In addition, this term is sometimes used also to refer to nitrogen derived 
reactive species (RNS) such as NO•, NO2 and ONOO (see (19–22) for examples). To add to the 
confusion, ROS is sometimes used as an abbreviation for reactive oxidizing species or reactive 
oxidant species (which would imply non-oxygen chemical species such as NO2 and is arguably 
a more correct, albeit less often used, term for chemical sources of oxidative stress).  
In order to avoid the confusion, terms free radicals and ROS are not used in this work in favour 
of the more generic term reactive chemical species (RS).  
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Reactive (chemical) species (RS): Unless the chemical entity involved is known, this work uses 
the term reactive species (RS) to refer to free radicals and other reactive, oxidizing, chemical 
species (such as ROS and RNS) involved in redox signalling networks and in the oxidative 
damage to biological systems, i.e. oxidative stress.  
Oxidative stress: Originally defined by Sies as “a disturbance of the prooxidant – antioxidant 
balance in favour of the former” (1), the definition of oxidative stress has since been recast as 
“an imbalance between oxidants and antioxidants, potentially leading to molecular damage” 
(23) to acknowledge the difference between oxidative damage and physiological levels of RS 
involved in cellular redox-signalling networks (12). Recent years have seen major criticism of 
this term as unspecific and unclear (17). For example, oxidative stress is usually used in the 
context of oxidative damage leading to disease, but the imbalance between the oxidants and 
antioxidants is a natural occurrence in the cell cycle (24). Furthermore, a low level of oxidative 
stress can be beneficial for the cell, e.g. by inducing the cytoprotection via Nrf2 pathway (25). 
These realizations prompted the introduction of the term oxidative eustress to describe 
“positive” stress leading to the activation of cellular defences, as seen for example during 
aerobic exercise (24); in addition, it was suggested that oxidative stress should instead be 
defined as “a disruption of redox signalling and control”, to account for redox signalling and to 
acknowledge the fact that oxidation and reduction reactions are not necessary in the balance in 
biological systems (25).  
To make this distinction clear, the term “oxidative stress” is herein used to refer specifically to 
the disruptive stress, i.e., disruption of physiological redox signalling and control by aberrantly 
high levels of RS, potentially leading to molecular damage.  
Antioxidant: This work uses the definition of Halliwell and Gutteridge and refers to an 
antioxidant as “a substance that, when present at low concentrations compared with those of an 
oxidiseable substrate, significantly delays or prevents oxidation of that substrate” (26). As 
follows from this definition, an antioxidant activity of a compound depends on an assay or the 
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1.2.2 Nature and causes of oxidative stress 
Reactive chemical species (RS) are unavoidable by-products of the oxidizing atmosphere of 
contemporary Earth, environmental toxins and pollutants, and the aerobic life-style of 
eukaryotic organisms (see Figure 1.1 for examples of RS sources). Within the cell, the 
mitochondria are a major producer of RS, primarily due to release of superoxide from 
complexes I and III of the electron transfer chain (27,28). Furthermore, mitochondrial enzymes 
involved in the citric acid cycle have also been associated with RS production (27,29). Aside 
from the mitochondria, a number of cytosolic protein families such as NADPH oxidases (NOX 
enzymes), xanthine oxidase, nitric oxide synthase, cyclooxygenases, cytochrome P450 
enzymes, and lipoxygenases potentially produce RS, although these effects likely vary between 
cell and tissue types (29,30).  
Numerous external sources have been associated with the production of RS in living systems. 
These include ionizing radiation, UV light and a wide range of chemicals often encountered as 
pollutants. For example, paraquat reacts to form peroxides or ozone; nitroaromatics, quinones 
and herbicides related to paraquat promote formation of superoxide; phenols, aminophenols 
and other chemicals are metabolized to radicals; iron and copper releasing compounds increase 
concentration of free metals in the cell, potentially causing formation of highly reactive 
hydroxyl radicals by Fenton reactions of H2O2 (19,31,32). Induction of oxidative stress is also 
observed as a result of exposure to heavy metals and various xenobiotics such as chlorinated 
compounds, radiation, metal ions and different pharmaceutical drugs, e.g. barbiturates and 
antitumor drugs cisplatin and doxorubicin (32,33). 
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Figure 1.1 Sources of oxidative stress 
External sources of RS include UV radiation, toxins, xenobiotics and various chemical stressors 
encountered in the environment. Internal sources of RS include mitochondrial respiratory chain, 
peroxisomal oxidation of long chain fatty acids (LCFA), endoplasmic reticulum (ER) stress caused 
by misfolded proteins and numerous enzymatic systems endogenous to the cell. Nucleus and ER 
are illustrated in blue, peroxisome in purple and mitochondrion in red; processes leading to 
formation of RS are depicted with orange arrows and RS are denoted with orange circles. 
1.2.2.1 UV radiation and oxidative stress 
Solar UV radiation (UVR) is a major exogenous hazard to the terrestrial and marine organisms 
on Earth. UVR inflicts direct damage to cellular macromolecules, e.g. DNA, and indirect, 
oxidative, damage by generating reactive chemical species (RS) in the cell (34). UVR is 
customarily divided into UV-A, UV-B and UV-C radiation based on wavelength, absorption by 
the atmosphere, and biological effects (35). While Earth’s atmosphere and the ozone layer 
block short length UV-C radiation (with wavelength λ = 100 – 280 nm), they provide less 
protection against longer wavelength UV-B (λ = 280-315 nm) and virtually no defence against 
UV-A (λ = 315 – 400 nm) radiation. Ground level UVR thus comprises ~95% UV-A and ~5% 
UV-B, with negligible UV-C levels (36).  
Therefore, while highly energetic, UV-C is of little biological significance in the natural 
environment as it does not reach ground level. While UV-B is a minor part of ground-level 
UVR (~5%), it is absorbed by DNA and causes formation of pyrimidine dimers and DNA 
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breaks (37). It is also absorbed by amino acid residues (mainly Trp, Tyr and Phe) and inflicts 
protein damage via photo-oxidation reactions (38). In addition, UV-B was also associated with 
induction RS and the oxidative stress (39). UV-B is the part of UV spectrum responsible for 
sunburn as well as sun-induced melanin production, and is the cause of direct tissue damage, 
mutagenic and carcinogenic effects (40). UV-A is less energetic then UV-B (due to higher 
wavelength) but penetrates deeper into skin tissue and has been associated with indirect damage 
via generation of RS and induction of oxidative stress (40).  
Observational human studies and experimental studies with animal models led to the inference 
of a causal link between UV exposure and numerous disorders including sunburn (40), 
immuno-suppression (41), skin cancer (42,43) and eye diseases (44). In addition, UVR was 
shown also to cause degenerative changes in skin collagen, leading to accelerated ageing (45). 
While UV-B induced DNA damage is strongly associated with multiple variants of skin cancer, 
such as basal cell and squamous cell cancers, it is shown that malignant melanoma lack 
mutations specific to UV-B irradiation, and are likely caused by indirect effects of UV-induced 
oxidative stress (46,47).  
1.2.3 Deleterious effects of oxidative stress 
While in low concentrations, reactive chemical species (RS) are a part of cellular metabolism 
and signalling (13), and are kept in check by antioxidant and detoxifying mechanisms (48). 
Imbalance between formation and cleansing of RS however leads to elevated RS concentration 
and potential for cell damage – a state called oxidative stress (1). When oxidative stress occurs, 
RS cause cellular damage by interacting with nucleic acids, lipids and proteins (49), but also 
induce redox signalling that leads to upregulation of cellular protective systems to purge 
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excessive RS (
 
Figure 1.2).  
Chapter 1: Introduction  
Page 8 of 230 
 
Figure 1.2 Sources and consequences of oxidative stress 
Schematic shows common sources of RS (red arrows), antioxidant mechanisms (green arrows), 
typical RS and their effects on the cell. Endogenous sources of RS include mitochondria (primary 
source of RS), peroxisomes and various enzyme systems, while exogenous sources include 
pollutants/toxins, xenobiotics and ionizing/UV radiation. RS are counterbalanced by enzymatic 
antioxidant systems and non-enzymatic antioxidants, keeping the cellular homeostasis. Oxidative 
stress arises when defensive mechanics are overwhelmed by the RS, leading to cellular damage 
and induction of redox signalling (such as Keap1-Nrf2 pathway) which upregulates defensive 
mechanisms. Prolonged stress leads to cell death and pathology and is associated with ageing. On 
the other end of the spectrum, aberrantly low RS levels impede redox signalling and certain cellular 
functions (such as proliferation or immune system). Adapted from (50).  
Notably, while RS are often generalized, it is important to take into account that different RS 
have very different chemistries. For example, the hydroxyl radical (OH•) reacts with all 
biological macromolecules at diffusion rate (half-life approximately 10
-9
 sec) and is thus highly 
reactive and unlikely to be intercepted by antioxidants, but also highly localized in its activity. 
On the contrast, the peroxyl radical (ROO•) has a half-life in seconds and is therefore much less 
reactive (51). Interestingly, while not considered RS, transition metals, i.e. iron (Fe) and to a 
lesser extent copper (Cu), play a critical role in the biochemistry of oxidative stress by 
mediating Fenton chemistry reactions (conversion of H2O2 into OH•) (51). Therefore, control 
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over free metal content in the cell, e.g. by iron chelating proteins such as ferritin and 
transferrin, is a critical part of cellular defences against oxidative stress (52). A brief summary 
of biochemistry of oxidative stress given here, and the reader is referred to (5,6) for further 
detail. 
Oxidative damage to nucleic acids 
Reactive chemical species damage nucleic acids by induction of single and double stranded 
breaks, base modifications and cross-linkage with proteins (5). This leads to genetic damage via 
point mutations and DNA deletions. While single-stranded DNA breaks are well-tolerated by 
the cell, double-stranded breaks potentially lead to cell death, and mutations in coding DNA or 
promoter regions impede cell functions (49). Notably, physiological levels of superoxide anion 
(O2-•), hydrogen peroxide (H2O2) and nitric oxide (NO•) have not been associated with direct 
DNA damage, and the majority of RS-induced genotoxicity is likely caused by hydroxyl radical 
(OH•), including hydroxyl produced from H2O2 in presence of DNA associated iron and copper 
(i.e. via Fenton reactions) (53). Genotoxic effects of RS have been linked to various diseases 
such as cancer and accelerated ageing (54). 
Lipid peroxidation 
Lipid damage by RS is caused by lipid peroxidation, chain reaction initiated by free radicals 
such as hydroxyl radical (OH•), superoxide anion (O2
-
•) or peroxyl radical (ROO•) in the 
presence of oxygen and metal ions. Reaction of free radical and fatty acid produces lipid 
peroxide which in turn can react with another lipid (55). As this reaction chain can cause 
significant lipid disruption even with low levels of free RS molecules, it poses a considerable 
threat to the cell. Lipid disruption due to peroxidation leads to changes in lipid bilayers, alters 
membrane permeability and has the potential to inactivate membrane bound receptors and 
enzymes (54,56). Lipid peroxidation products have been used as markers of oxidative stress in 
degenerative conditions such as chronic obstructive pulmonary disease (54) and 
neurodegeneration (57).  
Protein damage by reactive oxidative species 
Proteins are subject to oxidative damage by oxidation of amino acid residues, potentially 
causing a change of conformation (for example by breakage of disulfide bonds) or loss of 
activity by altering critical residues. Free radicals can also cause protein fragmentation and alter 
protein conformation, cause changes in hydrophobicity and protein aggregation (5,54). These 
effects lead to loss of protein function and precipitation (58). Protein damage can affect 
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numerous biochemical pathways in the cell; for example, it can impair the function of redox 
sensors (such as Keap1) or transcription factors (such as Nrf2), causing dysregulation of protein 
biosynthesis and response to oxidative stress. Oxidative damage to DNA repair mechanisms 
can decrease these activities and aggravate the genotoxic effects of RS. Damage to metal 
chelating proteins can release free metals and enhance RS toxicity due to increased OH• 
production (53). Products of protein oxidation have been associated with autoimmune diseases, 
atherosclerosis, neurodegenerative diseases and ageing (53,57). 
1.2.4 Radical-free oxidative stress and redox code 
Oxidative stress is commonly associated with free radicals and direct damage to cellular 
macromolecules, e.g. lipid peroxidation and DNA damage (5). Recent research, however, 
supports the notion that oxidative stress is, at least in part, caused by non-radical species such 
as H2O2, and does not necessarily involve damage to cellular components (59). For example, it 
has been shown that elevated H2O2 levels can lead to cell death by inducing apoptosis via 
cellular signalling systems without causing direct oxidative damage to the cell (60). The “redox 
hypothesis” and recently formulated “redox code” model state that: 1) Redox elements, e.g. 
cysteine residues, play a critical role in cellular signalling; 2) Activity of these elements is 
regulated by common “control nodes”, e.g. GSH and thioredoxin; 3) Redox elements form 
kinetically and spatially separated circuits; and 4) These form the cellular redox signalling 
network. According to this model, oxidative stress is the product of disruption of “redox code”, 
the cellular signalling network, and cannot be explained only by an imbalance between 
antioxidants and pro-oxidants. (59,61) 
According to the “redox hypothesis” model, oxidative stress has two distinct mechanisms 
(Figure 1.3). Free radicals (e.g. superoxide and hydroxyl radicals) are mainly responsible for 
direct damage to cellular components (e.g. lipid peroxidation, DNA breakage and protein 
oxidation), while non-radical species (e.g. H2O2) cause indirect oxidative stress through 
disruption of cellular signalling (e.g. by oxidation of critical thiols of transcription factors or 
related proteins leading to pathological gene expression or apoptosis). In addition, free radicals 
are likely to be a minor part of the RS produced by cellular metabolism, as exemplified by 
experiments with xanthine oxidase (59), suggesting that non-radicals form the majority of 
chemical species responsible for oxidative stress. Therefore, if non-radical species (e.g. H2O2) 
are the major causes of oxidative stress related pathologies via indirect damage, i.e. disruption 
to cellular signalling, the pathology can correlate to markers of macromolecular damage (e.g. 
lipid peroxidation) and be relatively insensitive to free radical scavengers (59,61).  
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Figure 1.3 Redox hypothesis model, two mechanisms of oxidative stress 
Pro-oxidant / antioxidant imbalance leads to production of free radical (e.g. •O2
-
) and non-radical 
oxidants (e.g. H2O2), and the majority of RS are of non-radical type. Free radicals, responsible for 
direct damage to cellular macromolecules (left side), are further converted into non-radical species 
(e.g. •O2
- 
to H2O2 by superoxide dismutase); therefore, chemical species produced during oxidative 
stress conditions are mainly non-radical (right) and generate oxidative stress by disruption of cellular 
signalling (e.g. leading into apoptosis). Schematic is based on (59,61). 
1.2.5 Responses to oxidative stress 
The Earth’s oxidizing environment is by its very nature damaging to biological systems 
composed of oxidation-prone macromolecules such as proteins, lipid membranes and nucleic 
acids (5,6). Thus the change from anaerobic to aerobic environment on Earth, roughly 2.5 
billion years ago (62), led to a selective pressure to evolve protection against the toxic effects of 
oxygen and other reactive (oxidative) species. As a result, current forms of life, with the 
exception of anaerobic bacteria and certain obligatory anaerobic fungi, flagellates and amoebae 
(63) possess a number of adaptations to oxidative stress. These can be roughly divided into 
mechanisms for prevention of oxidative stress, scavenging/interception of RS, and repair of 
oxidative damage (5).  
Prevention of oxidative stress 
The first line of defence includes prevention of oxidative stress by avoiding generation of RS 
from exogenous sources such as UV radiation and endogenous sources such as oxidative 
phosphorylation on mitochondrial membranes. UV avoidance and resistance are common 
adaptations, examples including movement away from sunlight and production of UV-
absorbing pigments such as melatonin in mammals and mycosporine-like amino acids in algae 
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and some fungi (52,64). Organisms living in high environments exposed to high levels of solar 
UVR have also evolved photo-dependent DNA repair mechanisms (65).  
Free metal ions, e.g. iron and copper, increase reactivity of RS by catalysing Fenton reactions 
of hydrogen peroxide to hydroxyl radical. Thus, metal chelation by enzymes such as ferritin 
and transferrin play a critical part in prevention of oxidative stress (66). Another strategy of 
prevention of oxidative damage is “prevention by diversion”, i.e. by providing alternative 
targets for RS to minimize the damage to critical cellular components. The packaging of DNA 
into chromatin, where nucleic acid is shielded by histone proteins, is considered to be a form of 
this type of protection against oxidative attack; on the organism level, examples include tissues 
such as intestinal mucosal cells which serve as a protective layer that is rapidly replaced (52). 
Scavenging and interception of RS 
In order to cope with RS production and the threat of oxidative stress, cells have evolved an 
array of enzymatic and non-enzymatic mechanisms for scavenging and interception of RS, i.e. 
conversion of reactive species such as superoxide radical (O2
-
•) into chemically inert species, 
for example water. Common scavenging mechanisms are illustrated in Figure 1.4.  
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Figure 1.4 Antioxidant mechanisms 
Various exogenous and endogenous mechanisms generate RS (ROS and RNS). Enzymatic and 
non-enzymatic antioxidants reduce these reactive chemical species and are in turn oxidized. Major 
small molecule antioxidants include uric and ascorbic acids, ubiquinol (CoQ) and glutathione (GSH). 
Major enzymatic systems include superoxide dismutase (SOD), catalase (Cat), thioredoxin (Trx), 
glutaredoxin (Grx) and glutathione peroxidase (Gpx); recycling enzymatic systems such as 
glutathione reductase (Gsr) and NAD(P)H quinone (oxido)reductase (NQR) turn oxidized 
antioxidants back into their reduced, functional forms. Red arrows show routes of oxidation, while 
blue arrows show reduction reactions.  Figure is based on (67). 
Antioxidants can be classified into non-enzymatic / small molecule antioxidants (examples are 
listed in Table 1.1) and macromolecular / enzymatic antioxidants (Table 1.2); Cellular 
localization and compound solubility also play important roles as lipid soluble compounds such 
as α-tocopherol protect biological membranes, while water-soluble compounds such as ascorbic 
acid are active in the cytosol (5).  
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Table 1.1 Major non-enzymatic antioxidants 
Table lists examples of non-enzymatic antioxidants. Lipid soluble antioxidants protect cell 
membranes against RS, while water soluble antioxidants scavenge RS in the cytosol. The list is 
compiled from (5,6). 
Antioxidant scavenger Other names Solubility 
Ubiquinol CoQ (CoQ10, CoQ-H2) Lipids 
α-tocopherol Vitamin E Lipids 
β-carotene  Lipids 
Retinol Vitamin A Lipids 
Uric acid  Water 
Glutathione GSH Water 
Ascorbic acid Vitamin C Water 
 
Enzymatic antioxidants include enzymes that catalyse the multi-step conversion of RS to water, 
as well as enzymatic systems for recycling of non-enzymatic and enzymatic antioxidants (67). 
Examples are shown in Table 1.2. 
Table 1.2 Major antioxidant enzymes 
Table lists some of major antioxidant enzyme families, common acronyms and catalysed reactions. 
Most of those enzymes exist in many variants with similar structure and many are also capable of 
catalysing reactions not listed in the table. *: It should also be noted that acronyms and names of 
these enzymes are not consistent through the literature. The list is compiled from (54,68).  
Antioxidant scavenger Acronym* Reaction 
Superoxide dismutase SOD O2
-•  O2;  O2
-• + 2H+ H2O2 
Superoxide reductase SOR O2
-• + 2H+ H2O2 
Catalase Cat 2 H2O2 2 H2O + O2 
Glutathione reductase Gsr, GTRx GSSG + NADPH + H
+
  2 GSH + NADP+ 
Glutathione peroxidase Gpx, GPx ROOH + 2GSH  ROH + GSSG + H2O 
Thioredoxin Trx, TRX Reduces oxidized protein-S2 / Prxox 
Thioredoxin reductase TR, TrxR Trxox + NAD(P)H + H
+
  Trxred + NAD(P)
+
 
Glutaredoxin Grx Reduces oxidized protein-S2 / Prxox 
NADPH quinone (oxido)reductase NQR CoQ  CoQ-H2 
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1.2.6 Pathology of oxidative stress 
Numerous diseases have been associated with oxidative stress, including neurodegenerative 
diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis 
(69); cardiovascular diseases, e.g. atherosclerosis, coronary artery disease and hypertension 
(70); diabetes and related complications such as vascular and kidney damage (71); and various 
types of cancer caused by RS-induced mutagenesis such as hepatocellular carcinoma and lung 
cancer (72).  
In addition, oxidative stress is also regarded as one of the causes of age-related degeneration 
(4). These disorders tend to co-occur with increase in markers of oxidative stress in tissue 
samples of afflicted patients, as compared to healthy tissues. For example, most of the diseases 
are associated with an increase in the products of lipid peroxidation by free radicals, a depletion 
of reduced glutathione, an increase in the levels of oxidized nucleotides and markers of 
oxidative damage to proteins (57). In addition, experiments with in-vivo mouse models with 
deficient responses to oxidative stress, e.g. due to Nrf2 knockout, show increased sensitivity to 
neurodegenerative diseases (73), damage by external stressors such as cigarette smoke (74), 
and increased carcinogenesis when exposed to genotoxic agents (75). Although the presence of 
markers of oxidative damage in a large number of pathologies is well-supported, it should be 
noted that co-occurrence of oxidative damage and disease does not necessarily imply causality, 
i.e. markers of oxidative damage in disease tissue does not by itself prove that oxidative stress 
causes the pathology; this subject is discussed further in 1.2.8. 
1.2.7 Oxidative stress and ageing 
Among the definitions of ageing, a commonly used one states that ageing is “a collection of 
time dependent, universal, intrinsic, progressive and deleterious changes in cells and tissues of 
an organism, eventually leading to degeneration and death” (76). While the phenomenon of 
ageing has been of considerable interest to people since the dawn of human history, with 
written sources describing ageing dating to early antiquity (77), modern study of ageing dates 
to the late 19th century (77). Although dozens (by some sources hundreds (76)) of theories of 
ageing have been postulated, a prominent theory directly linked to redox biology research is the 
free radical theory of ageing (FRTA) (76,78,79). Influenced by the discovery of free radicals in 
biological tissues in 1954 (2), Harman proposed the FRTA in 1958, hypothesizing that ageing 
is caused by accumulation of cellular damage inflicted by free radicals (4). The theory evolved 
over time and its current incarnation is the mitochondrial free radical theory of ageing 
(MFRTA). Based on the fact that oxidative phosphorylation on the mitochondrial membranes is 
a major source of RS in aerobic metabolism (80), MFRTA states that RS produced by the 
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respiratory chain causes damage to the mitochondria; in turn, this causes cellular degeneration 
followed by tissue damage that leads to the degenerative changes associated with ageing (81). 
According to this theory, ageing can be considered a degenerative disorder caused by oxidative 
stress and is potentially treatable by prevention or alleviation of the stress.  
1.2.8 Controversies and difficulties in redox biology 
Since the discovery of free radicals in biological systems, of oxidative damage to cellular 
components, and of enzymatic antioxidant systems, research in the field is now referred to as 
redox biology and has been largely driven by the notion that free radicals are deleterious and 
cause a number of diseases and disorders unless properly countered by antioxidants. Thus, 
oxidative stress has been connected to a variety of diseases, as well as cancer and ageing, and 
major efforts have been undertaken to identify and classify antioxidants for, presumably 
beneficial, dietary supplementation.  
While these views were never without critics, recent years have seen a slow shift of paradigm 
away from the classical “RS are damaging, antioxidants are beneficial” view (1,4) to the “redox 
code” hypothesis which emphasizes the balance of redox signalling as a central theme (13,61). 
In addition, a number of commonly used methods for assessing antioxidants and oxidative 
stress have been put into doubt, resulting in a call for greater standardization of the vocabulary, 
models and methods used in research of oxidants and antioxidants (17,82).  
In light of these ongoing changes, here follows a short review of controversies of redox 
biology, focusing on concepts, e.g. oxidative stress and antioxidants, as well as recent results 
obtained from clinical trials of antioxidant therapies. This review is not indented to be 
comprehensive, to criticize individual research, or to answer these controversies; it is instead 
intended to draw attention to, and to illustrate the difficulties of redox biology, which will 
undoubtedly be avenues for future research.  
1.2.8.1 What is oxidative stress? 
The term oxidative stress, originally introduced by Sies as an imbalance between oxidants and 
antioxidants is one of the basic concepts of redox biology. Yet it is an unfortunate term as it 
implies stress caused by oxidizing chemical species but does not postulate a clear hypothesis. 
Indeed, in his recent review, Sies himself stated that an oxidative stress hypothesis has not been 
formulated up to now and he discouraged the unselective use of this term (83).   
Recent research identified that the RS in the cell are not always harmful and that removal of RS 
might be deleterious to the organism. For example, moderate increase in RS levels during 
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aerobic exercise has been shown to be beneficial in mouse models (84), while direct 
antioxidants have been found to inhibit human killer cell activity (10) and prevent the health-
promoting effects of physical exercise in humans (15). Furthermore, as discussed in section 
1.2.8.4, clinical trials of antioxidant therapy have failed to demonstrate benefits to human 
health, and instead suggested that certain antioxidants are deleterious to humans (85). The role 
of RS in neurodegeneration (86) and in ageing has also been put into doubt (87,88). Altogether, 
these studies suggested that the original definition of oxidative stress might be outdated. 
Should the term “oxidative stress” be abolished? Several suggestions have been made in recent 
years. For example, it might be appropriate to abolish the term altogether and instead focus on 
specific processes and (bio)chemistry (83). Another option would be to replace the term 
“oxidative stress” with the “redox code” hypothesis that serves the same role, but is more in 
line with recent models of redox biology that attribute the RS-caused pathology to the 
dysregulation of redox signalling rather than by oxidative burden (61). Another suggestion has 
been to classify the oxidative stress into “stress levels” according to biological effects, e.g. 
mild, physiological stress that triggers antioxidant defences as opposed to high level, toxic, 
stress that damages the cell (89). Finally, there has been a proposal to split oxidative stress into 
positive stress, “oxidative eustress”, that upregulates cellular defences, e.g. by Nrf2 activation, 
and “oxidative distress” that inflicts cellular damage by disruption of cellular signalling and 
oxidation of cellular components (13). 
Notably, none of these suggestions currently has a significant following in the scientific 
community, as evident from the vast majority (above 99.9%) of recently published research 
articles that used the term “oxidative stress” [data is based on web of science term analysis of 
articles published in the 2007-2017 period, results are not displayed]. Thus, whilst arguably 
outdated, the term “oxidative stress” seems to be entrenched and is likely to stay in use, at least 
in the near future.  
1.2.8.2 What is an in-vivo antioxidant? 
Similar to oxidative stress, antioxidant is a very vague term and recently published guidelines 
discourage its use (17), yet just like the term oxidative stress, it seems unlikely to be abolished 
in the near future. Halliwell and Gutteridge defined an antioxidant as “a substance that, when 
present at low concentrations compared with those of an oxidisable substrate, significantly 
delays or prevents oxidation of that substrate” (26). The problem with this term is that most 
chemical species can be labelled as antioxidants by choice of appropriate chemical assay (26).  
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Nonetheless, defining antioxidant in vitro is reasonably straightforward, as long as definition 
includes the assay or test; for example, the definition in the food industry could be “a substance 
which slows down the natural oxidation and decay of food”. Thus, the term “antioxidant” is 
clearly measurable and has a significant utility in an in vitro environment.  
Compounds with in vitro antioxidant activity, however, are not necessarily active in vivo. That 
is because the oxidation in biological systems is a result of multiple chemical species and the 
chemistry of RS is in no way uniform, e.g. half-lives of peroxyl radical (ROO•) and hydroxyl 
radical differ by ~10 orders of magnitude (51). In addition, biological systems possess a 
number of highly active “antioxidant” systems including enzymatic systems and endogenously 
produced small-molecule antioxidants, e.g. glutathione, α-tocopherol and ascorbic acid 
(52,53,90). Therefore, compounds with activity lower than endogenous in-vivo antioxidants are 
unlikely to significantly reduce oxidative stress (16,53). Recent studies of antioxidant therapies 
failed to demonstrate health benefit in humans (91), suggesting that tested direct antioxidants 
such as ascorbic acid and α-tocopherol do not have significant in-vivo activity, when introduced 
in the diet. 
By contrast, “indirect antioxidants” - compounds that activate the biosynthesis of endogenous 
RS neutralizing enzymes - are known to protect cells against oxidative stress in vivo. For 
example, indirect antioxidant sulforaphane (SFN) protects mouse fibroblasts from UV-A 
induced oxidative stress (92), and resveratrol protects human lung epithelial cells from cigarette 
smoke (93). These compounds are not chemical antioxidants and protect cells by induction of 
the Nrf2 pathway. Despite being called “antioxidants”, these compounds are, in fact, oxidizing 
chemical species and activate redox signalling in the cell by oxidising cysteine residues of 
sensor proteins such as Keap1 (94–96). This implies that RS, in general, are “indirect 
antioxidants”, which is contrary to the very definition of an antioxidant. In addition, it is also 
unclear whether compounds that prevent oxidative damage by other mechanisms, e.g. metal 
chelation or blocking of UV radiation, should be termed indirect antioxidants as antioxidants do 
prevent RS mediated damage, but do not conform to the above definition. 
1.2.8.3 Does oxidative stress cause disease and/or ageing? 
As discussed in 1.2.5, biomarkers of oxidative cell damage, such as the products of lipid 
peroxidation, have been found in a large number of diseases, including neurodegenerative 
diseases and various cancerous tumours (57). Co-occurrence of oxidative damage, however 
does not provide proof that oxidative stress causes a disease, because confounding factors can 
cause both the oxidative damage and the disease (86). 
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Similar criticism can be raised for genetically-modified animal models: co-occurrence of a 
certain mutation or phenotype and markers of oxidative stress does not prove causality. For 
example, genetic mutation might be introducing a phenotype that causes the tissue damage (e.g. 
by dysregulation of cell signalling leading to apoptosis or necrosis), and the tissue damage 
causes oxidative stress; thus, the observed effects would be symptoms of disease and markers 
of oxidative stress, but the main cause of disease is not the oxidative stress (53).  
Therefore, unless the biochemical pathways to a disease are known (which is not the case for 
most diseases), a proof that oxidative stress causes the disease would require an experiment 
where introduced oxidative stress can be correlated to increased incidence of the disorder 
compared to the control. Alternative proof, if less strict, is to provide strong evidence that 
reduction of oxidative stress, e.g. by antioxidant therapy, alleviates the disease. These 
arguments were raised by Halliwell and Gutteridge as early as 1984 (8) and their subsequent 
work added a large amount of evidence to back their argument (16,53,97–99). A strong 
argument against causal link between oxidative stress and (most) diseases is that cell death 
causes oxidative stress. The ruptured cell releases metal ions and hydrogen peroxide into 
surrounding tissue and induces an immune response, all of which elevates RS concentration. As 
tissue damage is an integral part of any degenerative disease and tissue damage causes 
oxidative stress, markers of oxidative damage will thus always be present in disease-affected 
tissues, even if tissue damage is caused by stress-independent pathology, e.g. dysregulation of 
metabolic pathways leading to necrotic cell death (86,99,100). The schematic of this model is 
shown in Figure 1.5. 
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Figure 1.5 Oxidative stress and tissue damage 
Schematic illustrates relations between tissue injury, oxidative stress and diseases. Processes 
leading to the oxidative stress are coloured orange; mechanisms by which oxidative stress causes a 
disease are coloured in red, and mechanisms by which stress alleviates the pathology are denoted 
in green. Schematic is based on (16,53,99). 
1.2.8.4 Failure of antioxidant based therapies 
Multiple studies based on addition of direct antioxidants such as ascorbic acid and α-tocopherol  
to cell culture or to mouse diet demonstrated that antioxidant therapy has a potential to prevent 
cancer (101–104). However, when translated to double-blinded clinical trials with human 
subjects, these therapies failed to demonstrate a benefit in treatment of degenerative diseases or 
in cancer prevention. For example, a recently concluded trial of Coenzyme Q10 for alleviation 
of early Parkinson’s disease (105) demonstrated no benefit; a combination of antioxidants for 
treatment of Alzheimer’s disease fared no better, failing to influence progression of the disease 
(106). Multiple studies have been conducted to demonstrate the cancer-preventive effects of 
antioxidants including β-carotene, vitamin E, vitamin C, selenium, retinol, zinc, riboflavin, and 
molybdenum, and none were shown to provide significant protection against cancer (107). 
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Finally, recent meta-analyses of 78 trials involving a total of ~300,000 participants determined 
that there is no evidence to support the use of antioxidant supplements for prevention or 
treatment of human diseases (85,91). In addition, authors of these meta-studies concluded that 
increased intake of vitamin E, beta-carotene and vitamin A increased the mortality rate of study 
participants (85,91). While the causes of the observed increase in mortality rate have not been 
determined in these studies, it is possible that increase intake of chemical, direct, antioxidants 
reduces the endogenous, Nrf2-mediated, cytoprotection leading to increased susceptibility to 
oxidative stress. Antioxidant therapy has been previously found to inhibit the beneficial effects 
of aerobic exercise in men, presumably by inhibiting endogenous activation of cytoprotection 
(15).  
While these meta-studies and failures of clinical trials provide strong evidence against 
antioxidant therapies for treatment of human diseases, there is a number of arguments to take 
into account: 1) Dietary antioxidants rarely cause much change in biomarkers of oxidative 
damage in humans (98,108); 2) The majority of trials used a synthetic form of vitamin E and 
used much lower doses compared to cell-based and mouse model studies (109,110); 3) these 
trials did not investigate indirect antioxidants such as SFN which were demonstrated to have an 
effect in vivo (111); 4) the chemistry of RS is in no way uniform and scavenging of RS by non-
enzymatic systems is unlikely to be a main mechanisms of prevention of RS-induced oxidative 
stress in vivo (51,52,90); and 5) multiple antioxidant-based drugs have successfully passed 
clinical trials and are currently in use, e.g. Edaravone for the treatment of ischemic shock and 
n-aceylcysteine for paracetamol overdose (108). 
In summary, while oxidative stress has been implicated in a large number of diseases, 
antioxidant therapies have so far been unsuccessful in alleviating these disorders in humans. 
These failures are likely due to the overly optimistic approach based on the free radical 
scavenging by “direct antioxidants” (110). While this approach is attractive due to its 
simplicity, it is unlikely that all diseases associated with biomarkers of oxidative damage are in 
fact caused by oxidative stress (86). Thus, it is not unexpected that the “one-size fits all” 
approach has failed to provide a universal treatment to the vast array of biochemically very 
different diseases and disorders in humans. A better understanding of biological processes 
involved in these disorders and the recently postulated “redox code hypothesis” (see 1.2.4) 
might be of considerable utility in explaining mechanisms of diseases associated with oxidative 
stress. Finally, a more tailored approach, perhaps by targeting cellular response networks such 
as the Keap1-Nrf2 pathway (see 1.3) by “indirect antioxidants” may offer the potential to 
succeed where general antioxidants have failed (16,53). 
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1.3 Nrf2-mediated response to oxidative stress 
Cells are constantly challenged by electrophiles endogenously generated as by-products of 
oxidative metabolism, and by the UVR, environmental oxidants and pollutants. In animal cells, 
one of the master regulators of redox metabolism is transcription factor Nrf2 which lies at the 
centre of an intricate signalling system composed of the transcription factor Nrf2, its repressor 
Keap1, the transcription enhancer ARE and a number of other components. This system was 
discovered at the turn of the 20
th
 century and has since attracted considerable attention in redox 
biology and medicine (112,113).  
1.3.1 Discovery of Nrf2/ARE/Keap1 pathway 
A common promotor of stress response genes was first described by Picket et al. in 1990 as the 
β-NF responsive element, an upstream enhancer of the rat glutathione-S-transferase (GST) 
gene, which responds to beta-naphthoflavone (β-NF) (114). The DNA sequence of the β-NF 
responsive element was analysed by mutagenesis and selective deletions and the sequence was 
identified as 5'-RTGACNNNGC-3' (where R denotes A or G, and N denotes any nucleotide). 
The same study recognized that this enhancer responded to H2O2 and phenolic antioxidants that 
undergo redox cycling, prompting the renaming of the β-NF responsive element to the 
antioxidant response element (ARE) (115). Whilst the acronym ARE is widely used (and will 
be used in throughout this thesis), the electrophile response element (EpRE) has also been 
suggested as a more appropriate name as most ARE inducers are, in fact, electrophiles or 
function by generating H2O2 (116).  
Bioinformatics analysis of putative ARE sequences by Nerland (2007) (117) and mutagenesis 
experiments by Hayes et al. (2003) identified a number of differences in ARE sequences of 
mouse, rat and human genes and the authors argued that one universal ARE sequence is 
unlikely (118). The study suggests rather that AREs show significant variation between the 
species, even for closely related organisms such as mouse and rat (118). Notably, the 
evolutionary history and relationships of AREs are currently unknown and worthy of future 
investigation. 
1.3.1.1 Nrf2, discovery and function 
Nuclear factor erythroid-2-related factor 2 (Nrf2) was first described by Moi et al. in 1994 as 
the transcription activator of β-globin protein expression in human immortalised myelogenous 
leukemia cell-line K562. The study also identified that this protein was expressed in-vivo in 
mice and in nonerythroid cell lines HeLa and Raji (119). Based on its homology to Drosophila 
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melanogaster Cap-n-Collar (CNC) proteins, the Nrf2 was classified as a member of the “Cap-
n-Collar” (CNC) subfamily of basic leucine zipper (bZIP) transcription factors (119). In 1995, a 
study with chicken erythroid cells, progenitor cells of megakaryocytes and erythrocytes, 
determined that the chicken homolog of the mouse CNC transcription factor p45 NF-E2 (mouse 
Nrf2), likely plays a role in avian erythropoiesis. This protein was named erythroid cell-derived 





genotype) found no visible phenotype, leading to the conclusion that Nrf2 gene function is not 
necessary for mouse development, growth, or fertility (121). However, this study was based on 
the assumption that Nrf2 plays a role in hematopoiesis in mice and effects of external factors 
such as oxidative stress, UV radiation or mutagens were not tested on these Nrf2 knockout 
animals. 
The Nrf2 function as a promotor of cellular defences was postulated based upon the similarity 
of the ARE (5’-TGACNNNGC-3’) to Nrf2 binding site (5’-RTGASTCAGCA-3’; R denotes A 
or G, while S denotes C or G) and prompted another venture into Nrf2 knockout mice 
experiments by Yamamoto et al. (122). The study, published in 1997, was based on induction 
of phase-2 detoxifying enzymes glutathione-S-transferase (GST) and NAD(P)H:quinone 
oxidoreductase (NQO1) by the phenolic antioxidant butylated hydroxyanisole (BHA), 
previously found to induce activity of antioxidant enzymes in mice tissues (122). Results 
demonstrated that BHA does not upregulate GST or NQO1 production in Nrf2 knockout mice, 




) and wild type (Nrf2
+/+
) mice where these enzymes were 
upregulated when exposed to BHA. Notably, this experiment also demonstrated that other CNC 
proteins, such as Nrf1 and Nrf3, do not share Nrf2’s function. Furthermore, the study used an 
electrophoretic mobility shift assay (EMSA) to demonstrate that Nrf2-ARE binding required 
heterodimerization of Nrf2 with a small Maf (sMaf) protein. While the study used a MafK 
protein, the authors suggested that other sMaf proteins might also heterodimerize with Nrf2 
(122), which was later confirmed from studies of sMaf knockout mice, where sMafs were 
found to be essential for embryonal development and for upregulation of ARE-controlled genes 
(123). Since then, research based on gene knockout mice models (122,124–126) and high-
throughput –omics experiments such as microarrays, proteomics and ChIP-seq (125,127–130) 
have identified Nrf2 as a regulator of biosynthesis of over two hundred genes. Many of these 
genes are involved in a response to oxidative stress, drug transport, phase-2 detoxification or 
drug metabolism, strongly implying that Nrf2 is a master regulator of mammalian stress 
response networks. 
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1.3.1.2 Discovery of inhibitors of Nrf2 
Initial studies of the regulation of Nrf2 were performed by Yamamoto et al. (1999). Functional 
characterization of Nrf2 by sequence similarity comparison uncovered 6 domains conserved 
between the human Nrf2 protein and chicken homolog. These domains were named Neh1 – 
Neh6, where Neh stands for Nrf2-ECH homology (131). Of these, domain Neh1 was identified 
as a DNA-binding domain based on homology to the DNA-binding domains of other CNC-
bZip proteins (131). The Neh2 domain was found to be critical for inhibition of Nrf2 activity, 
as demonstrated by enhanced ARE binding of Nrf2 protein when the Neh2 domain was deleted, 
and prompted search for Neh2 binding inhibitors of Nrf2 (131). Subsequent yeast 2-hybrid 
studies with Neh2 as bait identified that Neh2 binds to yeast protein with similarity to a 
previously uncharacterized human protein designated KIAA0132. This protein was named the 
Kelch-like ECH-associated protein 1 (Keap1) (131). Further research characterized the 
structure of Keap1, while immunoprecipitation and cellular localization studies with fluorescent 
constructs (Nrf2-GFP and Keap1-GFP) verified its role as the inhibitor of Nrf2. These studies 
concluded that Keap1 binds to Nrf2, through the Neh2 domain, and sequesters Nrf2 in the 
cytoplasm, thereby preventing migration of Nrf2 to the nucleus and Nrf2-DNA binding. Two 
years later, it was demonstrated that electrophiles such as diethylmaleate (DEM) and catechol 
cause release of Nrf2 from Keap1 (131,132). Finally, in 2003 and 2004, Yamamoto’s group 
performed studies of Keap1-Nrf2 and identified that the mechanism of Nrf2 inhibition also 
includes degradation of Nrf2. Keap1 was recognized as mediator of the 
ubiquitination/degradation process, functioning as an adaptor for the cullin-3 RING ubiquitin 
ligase (CRL) complex (133,134). Further research identified that the Neh2 domain of Nrf2 
contains high affinity ETGE and low affinity DLG motifs that bind the Keap1 dimer (135). 
This led to a proposal called the “hinge and latch” model of Keap1-Nrf2 interaction; according 
to this model, Keap1-Nrf2 binding is a two-step process, where ETGE binding creates an 
“open” Keap1-Nrf2 conformation and is followed by DLG binding resulting in a “closed” 
complex required for CRL-mediated ubiquitination (135). A current model of Keap1-Nrf2 
interaction, called the “cyclic sequential attachment and regeneration model of Keap1-mediated 
degradation of Nrf2”, was suggested based on live-cell imaging studies (136) and explains the 
interaction as a four-step process, with the Nrf2 ubiquitination step and Nrf2 release with the 
subsequent degradation step following the two-step “hinge and latch” model (136,137).  
In addition to Keap1-based regulation of Nrf2, a number of other mechanisms have been 
suggested to control Nrf2 activity, indicating that this transcription factor is under much more 
complex regulation than originally postulated. As of 2016, proteins including chromo-
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ATPase/helicase DNA-binding protein (CHD) (138), cAMP response element-binding protein 
(CREB)-binding protein (CBP) (139), β-transducin repeat-containing protein (β-TrCP) (140) 
and retinoid X receptor (RXR)α (141) have all been suggested to play a role in Nrf2 regulation, 
alongside other mechanisms such as micro-RNAs (142), phosphorylation (143,144), Notch 
signalling (145), endoplasmic reticulum stress (146) and unfolded protein stress (147). These 
mechanisms are briefly reviewed below. 
1.3.2 Components and regulation of Nrf2-Keap1-ARE pathway 
Discovery of Keap1-based inhibition of transcription factor Nrf2 led to the naming of the 
Nrf2/ARE/Keap1 pathway. Later research, however, discovered that a multitude of other 
components are involved in the regulation of Nrf2. Here follows the brief review of the current 
model describing other components involved in Nrf2 regulation, with emphasis on canonical 
(i.e. Keap1 dependent) regulation of Nrf2 activity.  
1.3.2.1 Nuclear factor erythroid-2-related factor 2 (Nrf2) 
Nrf2 is the major regulator of mammalian redox signalling, implicated in the control of a large 
number of genes involved in various cellular functions, mainly associated with cellular 
defences and detoxification (see 1.3.3).  
Structurally, Nrf2 is a modular protein consisting of Nrf2-ECH homology (Neh) domains 1 to 7 
(Figure 1.6). The Neh1 domain of Nrf2 forms the “cap-n-collar” basic leucine zipper (CNC-
bZip) structural motif and is responsible for dimerization with small Maf proteins and DNA 
binding (128). The Neh2 is responsible for canonical, Keap1-mediated, negative regulation of 
Nrf2 activity. Neh2 is composed of DLG and ETGE motifs responsible for recruitment of 
Keap1, which leads to Cullin (Cul)3–RING (really interesting new gene)-box protein (Rbx)1 




mediated ubiquitination and degradation of Nrf2 (131). 
The C-terminal of the Neh3 domain recruits the chromo-ATPase/helicase DNA-binding protein 
(CHD)6, and upregulates Nrf2 activity (138). Both Neh4 and Neh5 are transactivation domains 
responsible for binding of CBP and/or RAC (139). The Neh6 domain binds the dimeric β-
transducin repeat-containing protein (β-TrCP) via the DSGIS and DSAPGS motifs. Neh6 is 
responsible for an alternative pathway for ubiquitination and degradation of Nrf2, mediated by 
the S-phase kinase-associated protein 1 (Skp1)–Cul1–Rbx1 core E3 complex (SCFb-TrCP) 
(140). Finally, the Neh7 domain downregulates Nrf2 activity by recruiting retinoid X receptor 
(RXR)α (141).   
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Figure 1.6 Structure of Nuclear factor erythroid-2-related factor 2 (Nrf2).  
Schematic displays functional domains and conserved motif, with amino acid numbering based on 
human Nrf2 protein. Domains involved in activation of Nrf2 are coloured green, while domains 
involved in its inhibition are coloured orange. Nrf2 binds to its inhibitor Keap1 via Neh2 motifs DLG 
and ETGE; domains Neh4 and Neh5 represent transactivation domains that recruit receptor-
associated coactivator (RAC)3 and/or cAMP response element-binding protein (CREB)-binding 
protein (CBP); domain Neh7 inhibits Nrf2 activity by physical association with the retinoid X receptor 
(RXR)α; Neh6 domain is involved in Nrf2 degradation mediated by dimeric β-transducin repeat-
containing protein β-TrCP; Neh1 is DNA binding and small Maf co-factor binding domain and C-
terminal Neh3 domain is transactivation domain involved in recruitment of chromo-ATPase/helicase 
DNA-binding protein (CHD). Schematic is based on (96). 
1.3.2.2 Kelch-like ECH-associated protein 1 (Keap1) 
The Keap1 (Figure 1.7) protein is a Broad complex, Tramtrack and Bric-a-Brac (BTB)-Kelch 
protein that forms a homodimer under normal cell conditions (148). Keap1 contains a BTB 
domain responsible for Keap1:Keap1 dimerization and for binding of Cullin protein (148), and 
an intervening (IVR) domain and six Kelch/double glycine (DG) repeats. These form a six 
bladed beta-propeller tertiary structure (149) which binds to the Neh2 domain of Nrf2 (131). 
Keap1 contains a number of “electrophile sensing” cysteine residues that modulate its Nrf2 
inhibition activity (i.e. electrophile attack on Cys151, Cys226/Cys613, Cys-273/Cys-288 and 
Cys-434 residues causes conformational changes of Keap1 and prevents degradation of Nrf2 by 
the CRL
Keap1
 complex) (96).  
The view that Keap1 is the primary inhibitor of Nrf2 activity has been questioned and multiple 
“non-canonical” Nrf2 regulation mechanisms, described briefly in 1.3.2.4, have also been 
identified (150). The role of Keap1 is firmly supported, however, because disruption of Keap1 
is sufficient for a major increase in cellular Nrf2 activity (151,152). In addition, somatic 
mutations of Keap1 characteristic for certain cancers (153,154) result in upregulation of Nrf2, 
as does inactivation of Keap1 by micro RNAs (142) or hypermethylation of the Keap1 
promotor (155). 
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Figure 1.7 Structure of Keap1 
Figure displays the schematic of Keap1 protein. The Broad complex, Tramtrack and Bric-a-Brac 
(BTB) domain, coloured orange, is responsible for formation of Keap1 dimer and Nrf2 binding; 
Kelch-repeat domain, also referred to as double glycin (DG) repeat domain, forms six-bladed β-
propeller structure and binds DLG and ETGE motifs of Neh2 domain of Nrf2. Intervening (IVR) 
domain is comprised of residues between BTB and Kelch repeats. Cysteine residues that function 
as electrophile sensors are denoted above the schematic. 
1.3.2.3 Keap1 based regulation of Nrf2 activity 
While the cell is not under oxidative stress, Nrf2 is subject to constitutive proteasomal 
degradation in a step-wise CRL
Keap1
-dependent manner; accordingly, Nrf2 has a short half-life 
and very low basal activity in unstressed cells (134). Specifically, the Neh2 domain of Nrf2 
contains an ETGE motif which binds a β-propeller subunit of the Keap1 dimer with high 
affinity, and a DLG motif with low Keap1-binding affinity. Nrf2 binding and degradation is a 
four step process (see Figure 1.8), with Nrf2-ETGE binding to a β-propeller subunit of the 
Keap1 dimer to form an “open” conformation, followed by Nrf2-DLG binding to the other 
Keap1 β-propeller subunit to “close” the Keap1-Nrf2 complex. This complex enables 
recruitment of Cul3-Rbx1 and the ubiquitination of Nrf2. Ubiquitinated Nrf2 is released from 
the Keap1 dimer and degraded in the proteasome, freeing the Keap1 dimer to bind another 
molecule of Nrf2 (136,137). This model of Keap1-mediated inhibition of Nrf2 is supported by 
live cell imaging experiments (136,137) and is an extension of previously postulated “hinge 
and latch” two-step model Keap1-Nrf2 interaction via the ETGE and DLG domains of Nrf2 
(135).  
Oxidative stress, i.e. increased concentration of RS in the cell, leads to conformational changes 
of Keap1 which block the degradation cycle by preventing ubiquitination of Nrf2 and 
subsequent release from Keap1; this in turn results in saturation of free Keap1 in the cell and 
allows for nuclear translocation of newly synthesized Nrf2. Specifically, Keap1 contains a 
number of “RS-sensing” cysteine residues (Cys151, Cys226, Cys273, Cys288, Cys434 and 
Cys613) which are prone to modification by electrophiles (e.g. cysteine -SH group oxidation 
that leads to formation of disulphide bridges between the Keap1 cysteine residues). These 
changes do not prevent Keap1-Nrf2 binding, but disrupt the binding of the “closed” Keap1-
Nrf2 complex to the CRL ubiquitination complex, thus stopping the degradation of Nrf2. 
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Interestingly, recent studies suggest that Keap1 is not reactivated after conformational changes 
by electrophiles and is instead degraded (136). Electrophile activators of Nrf2, such as tert-
butylhydroquinone (tBHQ), sulforaphane (SFN), Bardoxolone, dimethyl fumarate (DMF) and 
the majority of other known Nrf2 inducers, also function by this mechanism by targeting 
critical Cys residues of Keap1 (156,157). Thus, these compounds, while sometimes referred to 
as “indirect antioxidants” or “Nrf2-activating antioxidants”, are in fact, pro-oxidants. These 
compounds oxidize biological macromolecules and have chemical properties similar to RS 
rather than conventional direct antioxidants such as α-tocopherol or ascorbic acid. 
Non-electrophile activators of Nrf2, e.g. small-peptides developed by Wells et al. (158,159) and 
recently developed small-molecule Nrf2 activators (160), function by competitive inhibition of 
Keap1-Nrf2 binding. These compounds inhibit the complexation of Keap1-Nrf2 by binding to 
the Keap1 β-propeller structure responsible for DLG and ETGE binding. While less studied 
than electrophile-based Nrf2 activation, targeting of the Keap1-Nrf2 binding site by small 
compounds or peptides has potential to upregulate Nrf2 without the danger of “off-target” 
effects, as these compounds and peptides do not depend on electrophile modification of 
cysteine residues, which is non-selective and likely to affect a multitude of cysteine-containing 
proteins of other cellular signalling networks (157). 
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Figure 1.8 Model of Keap1 mediated regulation of Nrf2 
Figure displays “cyclic sequential attachment and regeneration model of Keap1-mediated 
degradation of Nrf2" (A-D) and a model of Nrf2 induction by stress and non-stress inducers (E-G). A 
single unit of Keap1-Keap dimer binds ETGE motif of Nrf2 Neh2 domain with high affinity, forming 
“open” conformation (B); this is followed by low-affinity binding of second Keap1 unit to Nrf2 Neh2 
DLG motif and results in “closed” conformation; (C) the “closed” conformation interacts with Cul3 
and Rbx1 to form protein complex which ubiquitinates Nrf2 (D); ubiquitinated Nrf2 is released from 
Keap1 and degraded, freeing Keap1 dimer to bind next Nrf2 molecule (A). Stress (e.g. presence of 
electrophiles such as H2O2) causes the oxidation of critical Cys residues of Keap1 which leads to 
change in conformation, preventing the ubiquitination of Nrf2 by Cul3 (E); this leads to saturation of 
free Keap1 in the cytosol, allowing the newly synthesized Nrf2 to translocate to the nucleus (G). 
Alternatively, non-electrophile induces of Nrf2 can bind to one of DC beta propellers of Keap1-dimer 
to prevent the “closing” of the Keap1-Nrf2 complex (F) which again leads to conformation unsuitable 
for binding of Cul3 to Keap1, saturation of Keap1 and translocation of Nrf2 to the nucleus (G). Keap1 
dimer is shown in blue, with DC (DLG repeat and C-terminal domain structure) representing β-
propeller structure of Keap1 responsible for Keap1-Nrf2 binding; Nrf2 is shown in green and Rbx1 
and Cul3 proteins are shown in red and orange. Schematic is based on (135,136,157). 
1.3.2.4 Non-canonical regulation of Nrf2 activity  
The Keap1-Nrf2 system has been studied in great detail over the last decade and a large number 
of Keap1-independent mechanisms of Nrf2 regulation have been suggested. These mechanisms 
are described in-depth in recent general reviews of Nrf2 regulation (96,156,161) as well as 
specialized reviews of Nrf2/Notch signalling (162), Nrf2/NF-κB signalling (163), epigenetic 
regulation of Nrf2 (155), the role of β-TrCP (164) and the role of nuclear receptors such as 
RXRα (165). The work presented here is primarily based on the “canonical”, Keap1-mediated 
regulation of Nrf2. Thus, the “non-canonical” mechanisms of Nrf2 control are not considered 
critical for the results presented in Chapters 2 to 5 and are reviewed here only briefly. 
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Keap1 independent degradation of Nrf2 
While Keap1-mediated degradation of Nrf2 is considered to be the primary mechanism of Nrf2 
degradation, Nrf2 is also degraded at a slow rate in stressed cells, implying the existence of 
Keap1-independent mechanisms. Mutagenesis analysis of Nrf2 identified that the Neh6 domain 
is necessary for Nrf2 degradation under conditions of oxidative stress (166). Further studies 
showed that the Neh6 domain of Nrf2 contains DSGIS and DSAPGS motifs that bind the β-
TrCP protein (140,167). β-TrCP binds to Nrf2 via the β-propeller WD40 domain, forming the 
ubiquitination complex with SCF E3 ubiquitin ligase. This complex ubiquitinates Nrf2, 
resulting in proteosomal degradation of Nrf2 (140). Notably, a number of kinases, e.g. GSK-3 
and ‘priming’ kinases required for GSK-3 activity, have also been implicated in β-TrCP 
mediated degradation of Nrf2, indicating that phosphorylation plays a role in regulation of this 
process (167,168).  
In addition to Keap1 and β-TrCP, Hrd1 is an integral endoplasmic reticulum (ER) membrane 
E3 ubiquitin ligase, which has been found to downregulate Nrf2 levels during liver cirrhosis, as 
identified in tissue samples from liver cirrhosis patients and confirmed by in-vivo Hrd1 
knockout mouse models (146). This downregulation of Nrf2 is probably caused by ER stress, 
i.e. stress resulting from unfolded proteins in ER but has so far only been reported in liver 
cirrhosis (156).  
Transcriptional and epigenetic regulation of Nrf2 
The gene encoding Nrf2is designated the NFE2L2 gene and is considered constitutively 
expressed, but is under a number of regulatory mechanisms, as evident from differences in 
expression levels between tissues (169). For example, Nrf2 levels are considerably higher in 
mouse liver and kidney compared to muscles, lungs and brain (169). Analysis of the mouse 
NFE2L2 promotor identified a xenobiotic response element (XRE) and two sequences similar 
to XRE; these are enhancer sequences involved in upregulation of xenobiotic response genes, 
e.g. the CYP super family enzymes involved in phase I detoxification (170). In addition, the 
promotor region also includes two ARE elements, an NF-κB binding site and an a12-O-
tetradecanoylphorbol-13-acetate-response element that allows the transcriptional activation of 
NFE2L2 by oncogene KrasG12D via transcription factors c-Jun and c-Fos. Therefore, NFE2L2 
transcription is potentially regulated by Nrf2 itself, as well as xenobiotics, inflammation 
processes, and oncogenes (156). Furthermore, it has been shown that Nrf2 levels might be 
influenced by other stress signalling pathways, for example response to fasting (171).  
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In addition to promotor-level regulation, evidence exists for epigenetic regulation of NFE2L2 
transcription by DNA methylation and histone modification (155). For example, Nrf2 is 
repressed epigenetically during neuronal development in mice, resulting in negligent expression 
of an Nrf2-dependent antioxidant response in mature mouse neurons (172). Another example is 
hypermethylation of the NFE2L2 promotor that increases Nrf2 activity in tumorigenic cells, but 
not in non-tumorigenic cells in a transgenic adenocarcinoma of mouse prostate (TRAMP) 
model (173).  
Finally, microRNAs have been implicated in both positive and negative regulation of Nrf2 
levels (142). An example of negative regulation of Nrf2 is homozygous sickle cell anemia 
disease, where erythrocytes of patients with the disease have reduced tolerance to oxidative 
stress due to Nrf2 downregulation by the microRNA designated miR-144 (174). In contrast, 
Nrf2 is upregulated by microRNAs in some types of breast cancer by miR-200a mediated 
degradation of Keap1 (175).  
Regulation of Keap1-Nrf2 binding by competitive inhibition with endogenous proteins 
Human and mouse cells contain a number of proteins with affinity for the Nrf2 Neh2 domain 
and Keap1 beta-propeller structure. For example, the autophagy cargo receptor and signalling 
adaptor protein p62/SQSTM1 contains a STGE binding motif similar to the Neh2 motif ETGE 
responsible for binding Keap1. Keap1-p62 binding was demonstrated in vitro and in mouse cell 
lines, where an increase of p62 led to increased activity of Nrf2 (176). Similarly, the stress 
response cyclin-dependent kinase inhibitor p21
Cip1/WAF1 
interacts with Neh2 ETGE and DLG 
motifs and competes with Keap1 binding to prevent ubiquitination and degradation of Nrf2, 
leading to upregulation of Nrf2 controlled genes such as NQO1 and HO-1. This was 
demonstrated by a combination of cell-based assays and p21 knockout mouse models (177). A 
number of other ETGE motif-containing proteins, e.g. peptidase DPP3, kinase IKKβ, tumour 
suppressor gene BRCA associated protein PALB2 and phosphoglycerate mutase PGAM5, were 
reported also to interact with Keap1, but the importance of these interactions has yet to be 
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1.3.3 Role of Nrf2 in cellular functions and disease 
At the cellular level, Nrf2 has been associated with the upregulation of a large number of genes 
implicated in a variety of processes including detoxification (phase I, II and III), biosynthesis of 
antioxidants such as glutathione (GSH) and thioredoxin (TRX), lipid metabolism, carbohydrate 
metabolism, iron metabolism (96) and mitochondrial function (178). Examples of genes under 
Nrf2 control are listed in Table 1.3. The commonly quoted number for Nrf2 controlled genes is 
“hundreds” (157), presumably based on ChIP-sequencing and microarray studies (125,129). 
Malhotra et al. (2010) used ChIP-sequencing and microarrays to identify 244 genes under Nrf2 
control in mouse embryonic fibroblasts (125), while Chorlie et al. (2012) detected 242 Nrf2 
bound genomic regions in human lymphoblastoid cells (129).It should be noted, however, that 
other studies have reported numbers of genes under Nrf2 transcriptional regulation ranging 
from as high as 700 (128), to as low as 23 (179). For example, Chip-Seq experiments by 
Hirotsu et al. (2012) found 702 genomic regions co-occupied by Nrf2 and MafG (but of these, 
only 66 genes were upregulated by pro-oxidant diethyl maleate in a Hepa1 cell line, as detected 
by microarrays (128)); Chorlie et al. (2012) identified 242 Nrf2 bound genomic regions, yet the 
authors noted that the expression of about two-thirds of the candidate genes  were likely to be 
Nrf2-dependent, putting the final number closer to ~150 (129). Yet another study based on 
quantitative proteomics of Nrf2 knockout mouse livers, found widely different numbers of Nrf2 
regulated proteins (38 and 108 in two repeats of the experiment) (180).  
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Table 1.3 Examples of genes positively regulated by Nrf2 in mice and humans 
Table lists examples of Nrf2 upregulated genes associated with various cellular functions. Genes 
supported by multiple independent studies are marked by *. Table is based on (96) and references 
therein. 
General function Symbol Description 
Detoxication 
Phase I 
(Drug oxidation,  
reduction and  
hydrolysis) 
ADH7* alcohol dehydrogenase class 4 mu/sigma chain 
AKR1B1* aldo-keto reductase family 1, member B1 (and 1B8 and 1B10) 
AKR1C1* aldo-keto reductase family 1, member C1 (and 1C2 and 1C3) 
ALDH1A1* aldehyde dehydrogenase 1 family, member A1 
ALDH3A1* aldehyde dehydrogenase 3 family, member A1 (and 3A2) 
ALDH7A1 aldehyde dehydrogenase 7 family, member A1 
CBR1 carbonyl reductase 1 (and 3) 
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 
CYP2B9 cytochrome P450, family 2, subfamily B, polypeptide 9 (and 10) 
EPHX1* epoxide hydrolase 1, microsomal 
PTGR1* prostaglandin reductase 1 (also called LTB4DH) 




GSTA1* glutathione S-transferase class Alpha 1 (and A2, A3 and A4) 
GSTM1* glutathione S-transferase class Mu 1 (and M2, M3, M4, M6 and M7) 
GSTP1* glutathione S-transferase class Pi 1 (and P2) 
MGST1* microsomal glutathione S-transferase 1 (and 2) 
SULT1A1 sulfotransferase family, cytosolic, 1A, member 1 (2) 
UGT1A1 UDP glucuronosyltransferase 1 family, polypeptide A1 (and 1A6) 




ABCB6* ATP-binding cassette, subfamily B (MDR/TAP), member 6 
ABCC1* ATP-binding cassette, subfamily C (CFTR/MRP) member 1 
ABCC2* ATP-binding cassette, subfamily C (CFTR/MRP) member 2 
ABCC3* ATP-binding cassette, subfamily C (CFTR/MRP) member 3 
ABCC4* ATP-binding cassette, subfamily C (CFTR/MRP) member 4 
ABCC5 ATP-binding cassette, subfamily C (CFTR/MRP) member 5 
Antioxidant, 
GSH-based 
GCLC* glutamate-cysteine ligase, catalytic subunit 
GCLM* glutamate-cysteine ligase, modifier subunit 
GGT1 gamma-glutamyltransferase 1 
GLRX glutaredoxin 1 
GLS glutaminase 
GPX2 glutathione peroxidase 2 
GPX4 glutathione peroxidase 4 
GSR1* glutathione reductase 
SLC6A9 glycine transporter 
SLC7A11 cystine/glutamate transporter 
Antioxidant, 
TXN-based 
PRDX1* peroxiredoxin 1 
PRDX6* peroxiredoxin 6 
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SRXN1* sulfiredoxin-1 
TXN1* thioredoxin 





G6PD* glucose-6-phosphate 1-dehydrogenase 
HDK1 hexokinase domain containing 1 
IDH1* isocitrate dehydrogenase 1 
ME1* malic enzyme 1, NADP+-dependent, cytosolic 
PGD* 6-phosphogluconate dehydrogenase 
TALDO1* transaldolase 
TKT transketolase isoform 1 
UGDH UDP-glucose dehydrogenase 
Iron metabolism BLVRA biliverdin reductase A 
BLVRB biliverdin reductase B [flavin reductase (NADPH)] 
FECH* ferrochelatase 
FTH1* ferritin, heavy polypeptide 1 
FTHL12* ferritin, heavy polypeptide-like 12 
FTHL17 ferritin, heavy polypeptide-like 17 
FTL1* ferritin, light polypeptide 
HMOX1 heme oxygenase (decycling) 1 
Transcription  
regulation 
AHR arylhydrocarbon receptor (AhR) 
CEBPB* CCAAT/enhancer-binding protein (C/EBP), β 
MAFG* MafG protein 
NFE2L2 nuclear factor-erythroid 2-like 2 
PPARG* peroxisome proliferator-activated receptor gamma (PPARγ) 
PPARGC1
B 
peroxisome proliferator-activated receptor gamma coactivator 1-beta 
RXRA* retinoid X receptor alpha (RXRα, or NR2B1) 
KEAP1 Kelch-like ECH-associated protein 1 
Lipid metabolism ACOT7 acetyl-CoA thioesterase 7 
 ACOT8 acetyl-CoA thioesterase 8 
 ACOX1 acetyl-CoA oxidase 1 
 ACOX2 acetyl-CoA oxidase 2, branched chain 
 AWAT1 acetyl-CoA wax alcohol acyltransferase 1 
 CES1G carboxylesterase 1G 
 CES1H carboxylesterase 1H 
 SCD2 stearoyl-CoA desaturase-2 
 LIPH lipase, member H 
 PLA2G7 phospholipase A2, group vii (platelet-activating factor acetylhydrolase) 
 PNPLA2 patatin-like phospholipase domain containing 2 
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1.3.3.1 Role of Nrf2 in drug metabolism and oxidative stress response 
Xenobiotic metabolism is a set of biochemical pathways for modification, detoxification and 
efflux of compounds foreign to an organism’s biochemistry, such as drugs and poisons. Often 
referred to as drug metabolism, these pathways are divided into three phases. Phase I includes 
oxidation and modification of xenobiotics by enzymes such as the cytochrome P450 oxidase 
(CYP) superfamily. Modified xenobiotics, which are often toxic, are conjugated to polar 
compounds, e.g. glutathione, in phase II reactions. These reactions are mediated by transferases 
such as glutathione S-transferases and UDP glucuronosyltransferases. Phase III drug 
metabolism includes further processing and efflux of xenobiotics by a variety of membrane 
transporters of the multidrug resistance protein (MRP) family (181,182). 
Numerous studies, based on high-throughput technology such as Chip-seq and microarrays 
(125,129) as well as more traditional molecular biology approaches (122,124–126), have 
identified that numerous genes involved in drug metabolism phases I – III and antioxidant 
systems are under control of an ARE promotor and directly induced by upregulation of Nrf2 
(see Table 1.3 for examples) (96). These roles were confirmed by multiple in-vivo mice 




) mice found to be more susceptible to oxidative 
stress-based diseases and drug-induced toxicity. Activation of Nrf2 by pharmacological (i.e. 
Nrf2 activating compounds such as sulforaphane) or genetic (i.e. knockdown of the Keap1 




mouse susceptibility to oxidative stress. For 
example, the phenolic antioxidant butylated hydroxyanisole (BHA) upregulates a number of 
phase-2 detoxification genes, such as GST, GCLC and NQ01, in wild-type mice, while 




 mice (122). Similarly, compared to wild type mice, Nrf2 knockout 
animals are sensitive to environmental pollutants such as diesel exhaust (183), carcinogens such 
as benzo[a]pyrene (184), and drug toxicity, e.g. acetaminophen (185). Whilst the majority of 
research in this area has been based on mouse models, human cell-line studies have confirmed 
animal model findings; for example, Nrf2 upregulation was found to protect human kidney 
cells against cytotoxicity of cisplatin (186), and to protect human epithelial cells against 
cigarette smoke (93). 
1.3.3.2 Role of Nrf2 in lipid and carbohydrate metabolism 
Multiple studies using microarray and proteomics analyses detected the upregulation of gene 
products involved in lipid and carbohydrate metabolism using cell cultures treated using Nrf2 
activators such as sulforaphane (SFN) (127,156). These results were confirmed in vivo using 
mice treated with sulforaphane (SFN) (187). In addition, Nrf2 knockout mice were found to 
downregulate genes encoding products controlling lipid and glucose metabolism (188). 
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Furthermore, different research groups reported that Nrf2 knockout mice are prone to fatty liver 
when placed on methionine- and choline- deficient diets, implying that Nrf2 is important for 
proper metabolism of lipids (156).  
A recent study by Brachs et al. (2016) (189) however found no evidence for Nrf2 regulation of 
glucose or lipid metabolism in adult mice, as measured in an in-vivo mouse model with a 
hepatic Keap1 knockdown performed using siRNAs. The authors explained these results by 
arguing that previously observed Nrf2 regulation of lipid and glucose metabolism was, in fact, 
the result of toxic effects from the use of Nrf2 activators such as CDDO-Im, CDDO-Me and 
Oltipraz (189). The study of Brachs et al. (2016) performed whole genome expression analysis 
using microarrays and targeted qPCR analysis of Nrf2, Keap1 and selected ARE regulated 
genes, and so experimental errors due to cross-hybridization and analogue nature of the 
microarray signal (190) were unlikely.  
1.3.3.3 Role of Nrf2 in degenerative diseases 
Since the discovery of the role of Nrf2 in protection against oxidative stress, the role of Nrf2 in 
disease has been subject to extensive study. The Nrf2 protein has been associated with 
protection from a number of diseases including neurodegenerative disorders (191), e.g. 
Alzheimer’s disease and Parkinson’s disease, various types of cancer (192), liver diseases (193) 
and kidney diseases (194). The role of Nrf2 in disease is reviewed in detail in (73,191,195), but 
briefly: 
Neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer disease (AD) and 
multiple sclerosis are associated with inflammation and oxidative stress, as evinced by markers 
of oxidative-stress induced damage found in affected tissues and blood plasma of patients (see 
(195), ref 3-31). A protective role of Nrf2 was studied in animal models of these diseases, and 
it was found that upregulation of Nrf2 alleviated the symptoms of these neurodegenerative 
conditions, while Nrf2 knockouts caused increased severity in symptoms (73).  
For example, Nrf2 knockout mouse models of PD show greater loss of dopaminergic neurons 
and more severe lysis of astrocytes and microglia cells in the brain, as opposed to wild type 
mouse disease models (196). Nrf2 overexpression in astrocytes was demonstrated to protect 
against development of PD. Similar protective effects were observed in wild type mice, but not 
Nrf2 knockout models, when Nrf2 levels were upregulated by a Keap1 knockdown, or by 
treatment with Nrf2 activators such as SFN (197). As with PD, Nrf2 knockout mice models of 
multiple sclerosis showed early onset and faster progression of the disease, when compared to 
wild type mice. (198). Nrf2 upregulation, e.g. by dimethyl fumarate (199) and CDDO-TFEA 
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(200), moderated the symptoms and markers of oxidative stress in wild type mouse models of 
MS, whilst having no clear effect on Nrf2 knockout mice (199).  
In addition to PD and MS, Nrf2 upregulation was found to afford protection in mouse models 
of other degenerative diseases, e.g. amyotrophic lateral sclerosis and Huntington’s disease, as 
well as acute neurological disorders such as stroke and traumatic brain injury (73). 
Interestingly, the role of Nrf2 in AD is less certain; while human AD patients and mouse AD 
models exhibit a drop in Nrf2 levels (201,202), it is not clear if the decrease in Nrf2 activity 
caused the pathology in AD or are the result of AD-induced neuron death. In addition, different 
studies have reported conflicting results showing Nrf2 upregulation, implying that the role of 
Nrf2 in AD might be dependent on the stage of disease (73,195). 
1.3.3.4 Role of Nrf2 in ageing 
The free radical mitochondrial theory of ageing (FRMTA, see 1.2.7) postulates that ageing is 
caused by oxidative damage to the cell, which would indicate that Nrf2 might also play a role 
in the ageing process. A number of studies were recently conducted to test this hypothesis; for 
example, Kubben et al. (2016) (203) used a human fibroblast cell-line model for Hutchinson-
Gilford Progeria Syndrome (HGPS), a premature ageing disorder, to test for activity of Nrf2 
regulated genes. High-throughput screen of siRNAs identified significant repression of a large 
number of genes under ARE regulation in the HGPS cell line, while constitutive expression of 
Nrf2 prevented the formation of the HGPS phenotype (203). Another recent study by Pan et al. 
(2016) studied SIRT6, a protein associated with longevity, in human mesenchymal stem cells. 
This study demonstrated that knock-out of SIRT6 encoding gene dysregulated redox 
metabolism and caused premature ageing and sensitivity to oxidative stress in the stem cells 
(204). This study also identified that SIRT6 forms a protein complex with Nrf2, and this 
complex is presumably required for Nrf2 transcription regulation of genes such as HO-1 (204).  
1.3.4 The “Dark-side” of Nrf2 
The foregoing discussions strongly suggest a role of Nrf2 in the control of cellular response to 
oxidative stress, and upregulation of Nrf2 as a potential therapy for oxidative stress related 
disorders such as cardiovascular and neurodegenerative diseases. Recent research, however, 
identified a correlation between Nrf2 upregulation and cancer proliferation and resistance to 
chemotherapeutic drugs, termed the “dark side of Nrf2”. This has led to the recognition that 
constitutive expression of Nrf2 has potential to cause deleterious changes at both the cell and 
organism levels (112,205). 
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1.3.4.1 Effects of constitutive Nrf2 upregulation in mice 
The first “dark side” effect of Nrf2 was observed during mice knockout experiments to 
generate Nrf2 and Keap1 deleted models. While Nrf2 deletion in mice was found to be of 
limited pathology, provided the mice were not exposed to excessive amounts of oxidative stress 
(121), Keap1 deletion was lethal and resulted in early postnatal mortality of mice due to 
hyperkeratosis of the oesophagus leading to problems with feeding (151). The pathology was 
caused by overexpression of Nrf2 rather than lack of Keap1 (151,206). A study of mice with a 
partial knockdown of Keap1 activity, generated using the Cre-loxP system for tissue specific 
gene knockdown (207), identified that long term overexpression of Nrf2 reduces the lifespan of 
mice (206). Interestingly, the same study also observed that an increase in Nrf2 levels conferred 
resistance to hepatic injury caused by acetoaminophen, but that the total inhibition of Keap1 in 
liver cells resulted in lower resistance compared to partial inhibition of Keap1 (206). In 
addition to identifying the importance of Nrf2 regulation in early mouse development, these 
studies demonstrated hormetic effects of Nrf2 upregulation in mice. The moderate increases in 
Nrf2 levels were beneficial, while higher and longer lasting upregulation had deleterious 
effects.  
1.3.4.2 Role of Nrf2 in cancer development and resistance to chemotherapy 
Nrf2 regulates transcription of numerous genes involved in cellular defences and has been 
associated with the prevention of oncogenesis (205,208), but the elevated Nrf2 levels have also 
been detected in various tumours (209–212) and associated with cancers resistant to 
chemotherapeutic drugs. This “dark side of Nrf2” was first identified in a study by Wang et al. 
(2008) who used human cell culture models to investigate Nrf2 levels in lung carcinoma, breast 
adenocarcinoma and neuroblastoma cancers. The authors determined that Nrf2 levels are 
increased in late-stage cancer cells, and that increase in concentration of Nrf2 enhances cell 
resistance to anti-cancer drugs. In addition, they demonstrated that Nrf2 knock-down by 
siRNAs sensitizes cells to chemotherapeutic agents (213).  
Furthermore, extensive mapping of somatic mutations in human tumours identified a high 
number of mutations clustered in the Nrf2 Neh2 domain, in the proximity of the DNA sequence 
encoding ETGE and DLG protein motifs (214,215). These studies provided strong evidence 
that Nrf2 was constitutively expressed in certain types of tumours (213). Analysis of different 
types of cancers associated with loss of function of Keap1 demonstrated increased tumour 
aggressiveness and enhanced resistance to irradiation and chemotherapeutic agents such as 
cisplatin, carboplatin and etoposide (216). Hence, cancers where Nrf2 is upregulated would 
appear difficult to treat, leading to poor clinical prognosis (217,218), while cancers where Nrf2 
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activity is down regulated appeared less resistant to chemotherapy and thus more successful to 
treat (219). Based on these lines of research, cancers can be classified depending on Nrf2 
activity levels, and measurement of Nrf2 levels has a potential to aid as a prognostic tool in 
cancer treatment (220).  
The discovery of the “dark side” of Nrf2 led to the model of dual roles of Nrf2 in cancer: 
increased transcription of genes regulated by Nrf2 prevents cancer development, but enhances 
proliferation and drug resistance of existing cancer cells (220). Multiple studies (154,192,208) 
support this model. For example, Taguchi et al. (2010) reported reduced lifespan, but not 
increased cancer incidence, in Keap1 knockdown mice (206); Satoh et al (2013) found that 
Nrf2 knockout mice exhibit higher rate of carcinogenesis when exposed to the carcinogen 
urethane, but tumours in these animals are less aggressive and proliferate at slower rate 
compared to cancers in wild-type mice (221). The role of Nrf2 in cancer is currently an active 
area of research and is further reviewed in (112,154,192,211).  
1.3.4.3 Role of Nrf2 upregulation in atherosclerosis and skin diseases 
In addition to the “dark side” of Nrf2 in cancer, recent research has suggested that Nrf2 exhibits 
both beneficial and adverse effects in atherosclerosis, with diverse results observed based on 
the particular mouse model and the stage of the disease (222).  
Increase in Nrf2 levels has been shown to protect against the early stage of atherosclerosis 
associated with oxidative damage. This was concluded from experiments with apolipoprotein E 
(ApoE) knockout mouse models and mouse models lacking the low density lipoprotein 
receptor. These animal models exhibited accelerated progression of early-stage atherosclerosis 
when transplanted with bone marrow cells of Nrf2 knockout mice (20,222). As discussed in 
1.3.3.2, Nrf2 regulates the transcription of certain genes that influence lipid metabolism and the 
control of inflammation, and increase in Nrf2 levels might be responsible for acceleration of the 
inflammation associated later stages of atherosclerosis. This is because the Nrf2 knockdown 
reduced the symptoms of the disease in the mouse model of late stage atherosclerosis 
(223,224). Thus, the role of Nrf2 in atherosclerosis is still unresolved and provides another 
example that therapeutic increase in concentration of Nrf2 should be approached with caution.  
The role of Nrf2 activation in skin diseases is currently controversial. While Nrf2 activators 
such as sulforaphane (SFN) and tert-butyl-hydroquinone (tBHQ) have been demonstrated to 
protect mouse and human skin in vivo (225,226) and in cell culture models (227), long term 
increase in concentration of Nrf2 was found to be deleterious in mouse animal models. For 
example, Schaefer et al. (2012) designed transgenic mice with constitutive expression of Nrf2 
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in keratinocytes and these mice developed severe skin pathology manifesting as epidermal 
thickening, hyperkeratosis and inflammation resembling lamellar ichthyosis (228). Their later 
research confirmed the effect for prolonged pharmacological activation of Nrf2 (by SFN and 
tBHQ) in wild type mice (229), suggesting that while short-term induction of Nrf2 protects the 
skin against oxidative damage, long term Nrf2 upregulation causes pathological alterations of 
the skin. 
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1.4 Mycosporine-like amino acids 
Numerous human diseases are associated with oxidative stress (1.2.6), but multiple clinical 
trials of direct antioxidants have failed to demonstrate benefits to human health (1.2.8.4). 
Indirect antioxidants which activate Nrf2 regulated cellular defences have, however, been 
proven to protect against oxidative stress in mouse animal models (1.3.3) and are currently in 
trials for human use (112). Different natural products have the potential to activate Nrf2 
regulated genes in vivo, and this work investigated a class of marine natural products called 
mycosporine-like amino acids (MAAs). MAAs are a class of UV-absorbing, low molecular 
mass (usually below 400 Da), natural compounds, associated with taxonomically diverse 
marine, freshwater and terrestrial organisms (64). MAAs are primarily UV-protective 
compounds, and are sometimes referred to as “microbial sunscreens” (230). These compounds 
have also been associated with stress-response, with evidence for antioxidant function and 
protection against osmotic, desiccation and thermal stresses (64,231–234).  
1.4.1 Structure and properties of MAAs  
Structurally, MAAs can be classified as mono-substituted MAAs (also referred to as oxo-
mycosporines) which consist of a mono-substituted amino-cyclohexenone ring (Figure 1.9/A), 
or as cyclohexenimine MAAs which have an amino-cyclohexenimine ring linked to an amino 
acid, amino alcohol or amino group (Figure 1.9/B). In addition to these structures, ester (235) 
and glycosylated (236,237) derivatives of MAAs have also been reported. MAA structures are 
reviewed in more detail in (231,232,238). 
Mycosporine-like amino acids are water-soluble compounds that are transparent to visible light 
and absorb light in UV-A and UV-B parts of the spectrum, with absorption maxima between 
260 and 370 nm. MAAs have high molar extinction coefficients (εmolar = 28 100 - 50 000 
depending on MAA, pH and solvent) and are photostable, harmlessly dissipating absorbed UV 
radiation as heat without being degraded (239,240). Due to these properties, MAAs were 
labelled as “The strongest UV-A absorbing compounds in nature” (241); in comparison, 
commercial synthetic sunscreen Avobenzone
®
 (butyl methoxydibenzoylmethane) has a molar 
extinction coefficient of 40 000, while Ecamsule
® 
(terephthalylidenedicamphor sulfonic acid) 
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-CH2-COOH -H 360 325.1763 Euthalothece-362 
(C14H22N2O7) 
  
-H 362 330.1427 
Figure 1.9 Chemical structures of MAAs 
Figure A) displays mono-substituted (oxo) mycosporines, while Fig B) displays multi-substituted (imino) mycosporines. For each MAA, figure lists base 
structure of MAA, substituents (-R, -R2, -R3), maximum of spectral absorbance (λmax, in nm) and molecular mass in Da, rounded at four decimal points.  
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1.4.1.1 Role of MAAs in protection against UVR 
The role of MAAs as UV protectants was established based on MAA absorbance profiles and 
high molar extinction coefficients (239). Studies with corals, where animals were kept at 
different depths underwater, found an inverse relationship between UV intensity/depth and 
MAA content in animal tissues (242,243). High concentration of MAAs found in UV-exposed 
tissues such as skin and ocular lenses of fish and other marine organisms (244) supports the 
UV-protective function of MAAs. In addition, research with human skin fibroblasts confirmed 
that the MAA porphyra-334 protects against UV-A induced photo-ageing (245) and the MAAs 
shinorine, porphyra-334 and mycosporine-glycine protect fibroblasts against lethal UV dose 
(246). Finally, a small scale human volunteer studies confirmed protection against photo-ageing 
using a mixture of porphyra-334 and shinorine (247). A similar MAA mixture was also 
observed to reduce UV-induced sunburn in an mouse animal model, as measured by clinical 
signs such as erythema, and biochemical parameters, such as expression of heat shock protein 
70 and antioxidant enzymes (248). Altogether, multiple lines of evidence firmly demonstrated 
that MAAs have a UV-protective function in vivo. 
1.4.1.2 Antioxidant functions of MAAs 
A considerable part of the UV induced damage (especially for UV-A, see 1.2.2.1) is caused by 
the photo-induction of RS in the cells of UV-exposed tissues (40). Thus, MAAs were 
hypothesized to provide protection against oxidative damage complementary to blocking of 
UVR (232). Numerous experiments were performed to elucidate potential antioxidant 
properties of MAAs, and these are covered in detail in a recent review by Wada et al. (232). 
The topic is briefly covered here, with focus on the MAAs investigated in this work. 
MAA precursors: Gadusol and 4-deoxygadusol (4-DG) were extensively tested for antioxidant 
activity and demonstrated to be strong antioxidants, with activity comparable to endogenous 
cellular antioxidants such as ascorbic acid and vitamin E. For example, gadusol was found to be 
a “stronger” antioxidant than Trolox (a water-soluble analogue of vitamin E), when measured 
by oxygen radical absorbance capacity (ORAC) assay (249); its activity is comparable to 
Trolox when measured for capacity to scavenge water-soluble stable radical ABTS (249). The 
MAA precursor 4-DG inhibited lipid peroxidation of phosphatidylcholine induced by AAPH 
(free radical generating compound) in vitro and has higher antioxidant activity than the MAAs 
shinorine and mycosporine-glycine (M-Gly) (64).  
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Mycosporine-glycine: M-Gly was found to inhibit lipid peroxidation with moderate activity 
(approximately 20-25% effect of ascorbic acid) (250), which was confirmed by a β-carotene 
bleaching method (251). Assays for free radical scavenging using the artificial stable radical 
DPPH and ABTS at pH 7.5 showed scavenging activity comparable to ascorbic acid (251,252).  
Shinorine: A lipid peroxidation study of the MAA shinorine, based on a phosphatidylcholine 
peroxidation assay of shinorine-containing extracts from the ascidian Lissoclinum patella, 
found no evidence for significant activity (244,250). Later research based on a β-carotene 
bleaching assays, demonstrated that shinorine is effective at preventing lipid peroxidation, with 
activity higher then M-Gly (251). Free radical quenching assays found no activity towards 
DPPH radicals, and low activity against ABTS radicals, as compared to ascorbic acid and M-
Gly (251,252). 
Palythine: Antioxidant activity of palythine has not been extensively investigated. Early studies 
by Dunlap et al. (1995) found no evidence for inhibition of lipid peroxidation by palythine, as 
measured using the phosphatidylcholine peroxidation assay (250), while later research by 
Rastogi et al. (2014) detected significant antioxidant activity from a mixture of MAAs 
including palythine. According to this research,  the antioxidant scavenging activity of this 
mixture was approximately 15 – 30% that of ascorbic acid as measured by DPPH, ferric-
reducing antioxidant power (FRAP) and superoxide radical scavenging activity (SRSA) assays 
(253,254). Since these studies were not performed with purified palythine, however, further 
research is required to elucidate the antioxidant capacity of this MAA. 
Porphyra-334: Investigation of an MAA mixture from algal extracts concluded that porphyra-
334 in the mixture had low antioxidant activity, as measured by ABTS and DPPH assays (251). 
The same study found moderate antioxidant activity, comparable to shinorine but lower then 
M-Gly, when measured by β-carotene bleaching and pyrogallol superoxide generating assays 
(251). Multiple studies based on inhibition of lipid peroxidation have indicated that porphyra-
334 protects lipids against AAPH induced peroxidation, but is less active then gadusol, 4-DG 
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1.5 Bioinformatics tools for biological discovery 
Over the last three decades, computational tools have played a considerable role in discovery 
and design of pharmaceutically active compounds, and computational approaches were recently 
utilized to predict small-peptide inhibitors of Keap1-Nrf2 binding (158). While extensive 
review of computer-aided drug design is beyond the scope of this thesis, here follows a brief 
introduction into methods relevant to work presented herein, with focus on approaches for 
reconstruction of molecular evolution (computational phylogeny) and virtual screening 
methods used for discovery of novel drug-like compounds. 
1.5.1 Computational phylogenetics 
Computational phylogenetics is a branch of bioinformatics dealing with the analysis of 
molecular evolution. Unlike classical phylogenetics which is based upon morphology and the 
study of fossil records, computational phylogeny uses nucleotide or protein sequences to infer 
evolutionary relationships based upon mathematical models of evolution. Results of 
phylogenetic analyses are commonly represented as phylogenetic (or evolutionary) trees, where 
edges (also called branches) represent taxonomical units, i.e. species or sequences, and nodes 
that connect these represent the hypothetical last common ancestors of connected taxa (257). 
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Figure 1.10 Phylogenetic tree of vertebrate Nrf2 neh2 domain 
Tree shows the phylogenetic reconstruction of vertebrate Nrf2 neh2 domains. The multiple 
alignment of vertebrate Nrf2 neh2 domains (Figure 1.11) was generated using the T-Coffee server, 
and phylogenetic reconstruction was conducted using the MEGA 6.0 software. The tree was 
reconstructed using the maximum likelihood method, with LG substitution matrix and complete 
deletion of gaps. The substitution matrix was selected using the MEGA 6.0 model selection tool. 
Bootstrap numbers (expressed as percentage of 1000 bootstraps) are listed for each taxonomical 
split. The tree is colour coded, with sequences from birds coloured blue, amphibians green, fishes 
purple, mammals black, and polyphyletic nodes coloured red. 
The phylogenetic reconstruction generates an evolutionary tree from a measure of homology, 
i.e. evolutionary relatedness, and mathematical model of an evolutionary process. A measure of 
homology is a starting point for phylogenetic reconstruction and is supplied via multiple 
sequence alignment (MSA) of nucleic acid or protein sequences (258). 
1.5.1.1 Sequence alignment and multiple sequence alignment 
A two sequence, or pair-wise, sequence alignment is a way of arranging two biological, i.e. 
protein, DNA or RNA sequences, defined as a list of letters (string), to identify similarities. The 
alignment matches identical and evolutionarily-related amino acids or nucleic acids while 
placing gaps in positions corresponding to likely deletion or insertion events. The multiple 
sequence alignment (MSA) is an extension of pair-wise sequence alignment to more than two 
sequences. It is typically represented as a matrix where each row is one sequence and columns 
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represent aligned amino-acids or nucleic acid nitrogenous bases (see Figure 1.11 for example) 
(259). Unlike the pair-wise alignment which was solved in the early days of bioinformatics 
(260,261), the optimal MSA algorithm is still an unsolved problem of bioinformatics. That is, 
none of currently existing MSA algorithms can generate an “optimal” alignment of many 
sequences, not in the least because the biologically-relevant, optimal, alignment is still to be 
defined (262,263). 
 
Figure 1.11 Multiple sequence alignment of Nrf2 Neh2 domains 
Figure shows the example of multiple sequence alignment of vertebrate Nrf2 Neh2 domain 
sequences, calculated using the T-Coffee server. Alignment columns are coloured according to 
conservation from “bad” (blue) to “good” (pink); fully conserved columns are marked by star (*), while 
partially conserved columns are marked with dot (.) or colon (:). Keap1 binding motifs DLG and 
ETGE are marked with blue lines. 
Phylogenetic study is based on the assumption that amino acids in each column of the multiple 
sequence alignment (MSA) are homologous (have evolved from the same position of a 
common ancestral sequence). Thus, MSA can be used to infer the evolution of a protein as well 
as structure and function (257). Active sites and other critical motifs in the protein tend to be 
evolutionarily conserved, as seen for example for DLG and ETGE motifs from Nrf2 in Figure 
1.11. This assumption, however, only holds if the MSA represents a meaningful biological 
relationship; that is, phylogenetic reconstruction is only as good as the MSA used for the 
analysis (257). While there is no universal measure of the quality of multiple alignments, MSA 
quality control tools such as ProbCons (264) have been developed to assess various accuracy 
metrics of the MSA. In addition, consensus alignment tools such as M-Coffee allow for 
combinations of different algorithms to minimize the potential bias of an MSA algorithm (265), 
and visual inspection using tools such as JalView (266) and MEGA (267) can identify 
conservation and consistency of the MSA.  
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1.5.1.2 Methods and models for phylogenetic reconstruction 
Multiple methods can be used to build a phylogenetic tree from a multiple sequence alignment; 
these are usually divided into distance matrix methods (e.g. UPGMA and neighbour-joining) 
and discrete data methods, also called tree searching methods, such as maximum likelihood, 
parsimony and Bayesian methods.  
Distance matrix methods build a phylogenetic tree using distances between aligned sequences. 
These methods are based on the premise that quantification of sequence differences can be 
expressed as a number that provides a good model of biological/evolutionary distance. These 
methods calculate distance, using a method-dependent metric, for each sequence pair and 
assemble these into a distance matrix. The matrix is used to generate a tree in a step-wise 
fashion, by grouping the two closest sequences to form a tree node, recalculating the distance 
matrix, and then repeating until the tree is assembled. Different algorithms calculate the 
distance between sequences using different metrics, while sharing the iterative approach and 
the idea of quantifying evolution by a single metric. These methods are computationally fast 
and relatively simple to implement, but assume that evolutionary rate is identical for all amino 
acids in the protein (257,268). 
The discrete data methods (e.g. maximum parsimony and maximum likelihood) examine each 
column of the multiple sequence alignment and search the tree space, i.e. all possible trees that 
could be composed from the input dataset, for a tree that best satisfies the criteria of the model 
of evolution. For example, maximum parsimony searches for the tree with least mutations that 
can explain the data, while maximum likelihood (ML) searches for a tree which optimizes the 
likelihood function. These methods can model unequal evolution rates across the protein to 
account for regulatory sites or critical amino-acid residues, and arguably provide more 
biologically relevant trees when compared to distance-based methods. These methods are, 
however, computationally expensive and are dependent on the choice of the model of 
evolution. For example, a model which assumes equal rates of evolution for all columns in the 
alignment can bias the results of phylogenetic reconstruction of enzyme-encoding DNA 
sequences, where the certain parts of sequence encode the amino acid resides that compose 
enzyme active sites, and evolve slower than the rest of the gene (269). As the size of tree space 
scales exponentially with the number of input sequences and thus, tree search methods use 
heuristic approaches to calculate a ‘good enough’ solution rather than the best tree (257,268). 
Finally, a relatively recent approach to phylogeny includes Bayesian methods; these are not 
unlike maximum likelihood approaches, but are based on Bayesian, as opposed to classical, 
statistics (268).  
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Models of evolution 
Aside from the reconstruction method which specifies a way of treating the input MSA, 
phylogenetic reconstruction requires the model of evolution (also called substitution model), the 
mathematical description on how to apply a method. For example, the simplest way to describe 
evolution mathematically is to assume that all DNA mutations (AT, AG, AC, CG, 
TG and reverse mutations) are equally likely; this model was introduced in 1969 by Jukes 
and Cantor and is known as Jukes and Cantor or JC69 substitution model (270). Since then, a 
large number of other models have been published. Detailed descriptions of various substitution 
models are given in (269), but briefly: 
Time-reversible models such as JC69 describe the evolution by assigning a rate to nucleotide 
mutations and assume mutations are reversible (e.g. AT mutation rate is the same as TA); 
these can be generalized into a General Time Reversible model (GTR), which allows for a 
different mutation rate for each mutation (271). 
Protein sequence phylogeny models are designed to explain the evolution of proteins rather 
than DNA sequences. Unlike DNA evolution models, these are based on observation instead of 
attempting to model the process of evolution, and use empirically derived substitution matrices 
not unlike the ones used for protein MSA. Examples include the Dayhoff model (272) and 
Jones-Taylor-Thornton (JTT) model (273). 
Different substitution models have vastly different numbers of parameters and interestingly, the 
most complex model of evolution does not necessary produce the most biologically relevant 
phylogenetic tree (269). Hence, there is a need to select the model that is complex enough to 
explain the data, while not using too many parameters. Several statistical measures have been 
invented to aid in this task; for example, a common method for model selection in phylogeny is 
to compare Akaike’s information criterion (AIC) between the models and then to select the 
model with the “best” (lowest) AIC value. The AIC is a measure of how well the model fits the 
data, taking into account the number of parameters in the model (269).  
Molecular clocks and dated trees 
A phylogenetic tree describes a process of evolution, but usually does not provide a correct 
time-frame to evolutionary events. That is, it explains ancestry of each studied taxa by virtue of 
taxonomical splits, but does not necessarily model when these splits occurred. While 
phylogenetic trees do calculate branch lengths, these distances are simplified metrics and are 
typically an inadequate representation of evolutionary history (274); also see 1.5.1.3.  
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Thus, reconstructing the time-frame of evolution requires application of an evolutionary or 
molecular clock, a hypothesis that the molecular evolution occurs at an approximately uniform 
rate over time (275). The “clock” is then calibrated using fossil records to assign a time-frame 
to one (or multiple) taxonomical splits, to generate the time-frame for the tree. This procedure 
is complicated by unequal rates of evolution, imperfection of fossil records (if available) and 
complications in the models, due to the extra parameters and computational difficulties incurred 
by the introduction of molecular clock (274,276); see 1.5.1.3 for more details. 
1.5.1.3 Challenges and difficulties in molecular phylogeny 
As described in section 1.5.1.2, phylogenetic reconstruction is a complex process that involves 
data selection, multiple sequence alignment, choice of a model of evolution and choice of a tree 
reconstruction method. Producing a time-calibrated tree also requires the molecular clock 
model and calibration of the tree. Here follows a brief review of common issues encountered in 
phylogenetic reconstruction. These issues have no single, universal solution and the Discussion 
chapter of this thesis will present the author’s approaches to addressing these problems 
encountered during this research. 
Multiple sequence alignment 
Phylogenetic reconstruction is highly dependent upon the multiple alignment used to build it, 
and it has been shown that the choice of alignment algorithm is as important as the evolutionary 
model or the reconstruction method (277). A large number of MSA algorithms have been 
published, and whilst many share similarity in approach and can be loosely grouped into 
progressive or iterative aligners, different algorithms do not produce identical alignments. By 
illustration, a recent review lists more than 25 “commonly used” algorithms (278). Assessment 
of MSA algorithms is complicated as results tend to vary based on the benchmark used. For 
example, an algorithm optimized for short sequences might not perform well on very long 
sequences or sequences with large gaps. Similarly, algorithms that produce high quality 
alignments, such as Psi-Coffee, might lack the computational optimizations necessary to align 
many sequences in reasonable amount of time. Therefore, reviews of MSA tools, such as a 
recent benchmark by Pais et al. (2014) (279), use multiple benchmarks and rank the tools 
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Evolutionary model and tree-reconstruction method 
In addition to the choice of MSA algorithm, the choice of model and reconstruction method 
also form critical part of phylogenetic reconstruction (277). Selection of the model, however, is 
arguably a less difficult problem due to the existence of statistical frameworks for model 
selection. For example, AIC and Bayesian statistics equivalent (BIC) provide a measure of how 
well the model fits the data (269).  
Establishing an evolutionary time-frame 
Establishing the correct time-frame for a phylogenetic tree requires a molecular clock 
hypothesis, that is, an assumption that evolution progresses in predictable, clock-like, manner. 
This is, however, complicated by the fact that there is no universal molecular clock, because the 
different DNA sequences evolve at different rates (276). For example, most microorganisms 
have very short generation time and thus evolve faster than large animals with long generation 
time (280). Other factors, such as difference between sexual and asexual reproduction, impact 
of mutation to organism’s reproductive success, genetic drift, and metabolic rate of the studied 
organism have been associated with the rate of evolution (281). A non-constant molecular 
clock is not a major problem when phylogenetic analysis is performed for closely related 
species, similar genes, or short time periods, but it complicates the dating of phylogenetic trees 
which span long time intervals, include very diverse species or have to account for potential 
changes in a gene functions (276,282).  
Construction of the correct time frame for a phylogenetic tree also requires one (or more) 
calibration dates, usually obtained from ages of known fossils. The, fossil record is however 
biased towards organisms susceptible to fossilization (large organisms with hard skeletons 
resistant to decay), and the fossils of organisms that evolved before the Cambrian explosion and 
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1.5.2 Virtual screening for drug discovery 
Virtual screening (VS) uses algorithms and computer programs to evaluate how likely a small 
molecule is to bind to a drug target, typically an enzyme or receptor protein. Somewhat similar 
to in vitro high throughput screening, VS is an in-silico approach in early stage drug design and 
discovery, and can be used to evaluate a large number of chemical structures to identify 
candidate compounds for follow-up in vitro studies. VS approaches can be divided into two 
broad categories, ligand-based screening and structure-based screening (285,286). Figure 1.12 
illustrates common virtual screening approaches and illustrates the main differences between 
ligand- and structure- based screening. It should be noted, however, that while often treated as 
alternate approaches to in-silico prediction of novel leads, structure and ligand-based 
approaches are not mutually exclusive and have been utilized complementarily (287,288). 
 
Figure 1.12 Virtual screening 
Schematic illustrates common virtual screening approaches. Structure based screen (A) is based on 
known 3D structure of the target and involves computational docking of large number of ligands onto 
the target; ligands are typically filtered based on docking scores and predicted chemical properties, 
e.g. hydrogen bonds, and examined manually to select “best hits”. Ligand based screening (B) 
approaches are based on: 1) examination of known active ligands to produce a pharmacophore 
model, 2) machine learning models built from known active and inactive ligands, and 3) searching 
chemical databases to identify ligands similar to known active compounds. These models are used 
to predict candidate molecules which are then further filtered based on chemical properties or 
druglikeliness, e.g. by Lipinski's rule of five. Notably, these approaches can be combined to 
generate list of candidates for further study. Schematic based on (285,289) 
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1.5.2.1 Ligand-based screening 
A ligand-based approach uses the information extracted from the known target-binding ligands 
to predict novel chemical leads, with the aim to predict compounds with better affinity for the 
target or other desirable, “drug-like”, properties (290) such as lower molecular mass, or lower 
polarity. These variants of virtual screen can be conducted in a number of ways, depending on 
the available data; for example, knowledge about the binding-affinity of multiple ligands allows 
the construction and training of machine-learning based models of ligand-target interaction 
(291); alternatively, ligand structures and activities can be used to construct a pharmacophore 
or a quantitative structure-activity relationship (QSAR) model (292). If less information about 
ligand-target interactions is available, the knowledge of a few active ligands is enough to 
produce a less sophisticated pharmacophore, i.e. model of molecular recognition by ligands 
(293). Finally, the knowledge of at least one active ligand allows the search for similar 
chemical structures. These approaches are used individually or combined to predict novel 
compounds which are likely to bind to the target. Notably, none of these approaches require the 
3D structure, e.g. x-ray crystallographic model, of the target (285,286).  
1.5.2.2 Structure-based virtual screening 
In contrast to the ligand-based screening, structure-based approaches start with the 3D structure 
of the target, e.g. enzyme or receptor protein, and use computational docking simulations to 
determine the binding affinity of test compounds, calculated using a scoring function. Such 
screening is often performed with large libraries of compounds, and studies with hundreds of 
thousands of candidate compounds are not unusual (see (294–296) for few recent examples). 
The results of the screen are filtered in step-wise fashion, e.g. by docking score, followed by 
clustering to identify high-scoring scaffolds, drug-likeliness analysis, and finally manual 
examination of docking models. Numerous compound libraries and tools are available for 
docking analyses, and examples of free-for-academic-use tools and resources are listed in Table 
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Table 1.4 Commonly used ligand databases and docking tools 
Table lists examples of commonly used ligand libraries and docking tools for structure-based virtual 
screening. Listed tools are free for academic use, well documented and widely used in the 
academia.   
Ligand library Notes Resource 
ZINC database Over 100 million compounds, docking ready http://zinc15.docking.org/ 
PubCHEM Over 200 million compounds, also contains 
data collected from over a million bioassay 
experiments. 
https://pubchem.ncbi.nlm.nih.gov/ 
DrugBank ∽8200 drugs, ∽21000 drug-targets. Contains 








AutoDock 4.2 Supports flexible and rigid-body docking, 
extensive documentation and GUI integration 




Supports flexible and rigid-body docking, 
documentations, tutorials and GUI integration 
(Raccoon) are available. 
http://vina.scripps.edu/ 
UCSF DOCK Supports flexible and rigid-body docking, 
multiple scoring functions; USCF Chimera 
plugins allow limited graphical interface. 
http://dock.compbio.ucsf.edu 
 
1.5.2.3 Considerations and limitations of virtual screening 
Structure-based VS is considered more effective at finding new chemical scaffolds than the 
ligand-based approach (299), but  it requires a high-quality 3D structure of the target. These are 
usually a result of x-ray crystallography studies, which tend to be resource-intense and 
exceedingly specialized, and thus most virtual screens rely on structures deposited in the PDB 
database (300). The lack of structure can, in principle, be rectified by homology modelling, i.e. 
prediction of protein structure based on 3D structures of similar proteins (templates), but 
protein structure prediction is of little utility when templates for homology modelling are not 
available (301). De-novo protein modelling, i.e. prediction of 3D structure from protein amino-
acid sequence, is a potential solution when no templates are available, but it is a challenging 
endeavour unlikely to produce a high-resolution 3D structure, especially when applied to large 
proteins (302,303). In addition to the need for a high resolution model of the target, structure-
based screens are computationally expensive, and often employ specialized, high-performance 
computing, hardware and can produce different results depending on the tools and algorithms 
used (304).  
Finally, there is a matter of the accuracy and biological relevance of the VS approach. 
Structure-based screens use simple and crude approximations of biological systems, and while 
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different tools use varied approaches, in general these screens treat a target macromolecule as a 
rigid body and ligands as rigid or semi-flexible (304). Determination of docking pose is based 
on scoring functions, which are often empirically or knowledge derived. In addition, these 
methods treat the system as static, and the movement of target and ligands during the docking is 
not included in the model, and do not model chemical reactions. These approaches are 
necessary as full quantum-chemistry treatment of large systems such as proteins is not yet 
precise/feasible and even simpler, molecular-dynamics based, approaches require very high 
computation time and are therefore impractical for the testing of large number of ligands 
(304,305).  
Benchmarking the performance of VS and tools for screening is a difficult prospect, as 
definition of success is not straightforward. For example, a screen that successfully finds new 
interesting chemical scaffolds with low hit rate is arguably “more successful” than a screen 
which detects large numbers of ligands with known activities. In addition, benchmarks of VS 
are retrospective, i.e. based on a method’s performance in retrieving known active ligands, and 
thus cannot be considered a good measure of tool’s performance in finding new, chemically 
different, ligands (306–308). 
1.6 Multidimensional protein identification technology 
Multidimensional protein identification technology (MudPIT) is a technology for identification 
of the protein content in a biological sample. Also called shotgun proteomics, MudPIT is based 
on a combination of protein separation, digestion of the proteins by proteases, mass 
spectrometry, and bioinformatics for data analysis. Proteins are roughly separated into a 
number of fractions, usually by electrophoresis, and digested into small peptides, e.g. by 
trypsin. The resulting peptides are further separated using HPLC and introduced into the mass 
spectrometer using “soft-ionization” techniques such as ESI or MALDI to obtain mass spectra 
(MS) of peptide ions and tandem mass spectra of fragmented ions (MS/MS). The analysis 
produces a large number of mass spectra (typically in tens or hundreds of thousands) which are 
computationally processed and identified, commonly by database matching algorithms. 
Algorithms compare mass spectra to theoretical spectra generated by in-silico fragmentation of 
a database of proteins from the subject organism or closely related organisms (309–311). An 
example of MudPIT workflow is presented in Figure 1.13.  
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Figure 1.13 MudPIT workflow schematic 
Schematic illustrates an example of MudPIT proteomics experiment. Proteins are extracted from the 
sample (1), separated using gel electrophoresis (2) and digested into peptides, e.g. by using trypsin 
(3). The peptides extracted from the gel are separated via HPLC (4) and introduced into mass 
spectrometer by soft ionization technique such as ESI (5). Mass spectrometer measures mass 
spectrum of each peptide ion and tandem mass spectrum produced by peptide ion fragmentation 
(7). Finally, these spectra are matched to database of theoretical spectra (8) to produce list of 
detected proteins (9). Figure adapted from (312). 
1.6.1 Quantitative and qualitative proteomics 
While originally introduced as a qualitative method that identifies proteins but provides no 
information about expression levels (313), the shotgun proteomics workflow has since been 
enhanced to enable quantification of protein expression. The protein expression can be 
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1.6.1.1 Label-free quantification 
Label-free quantification methods compare the mass spectra (MS) generated from identical 
proteins in different samples to calculate the relative protein expression levels. Two approaches 
have been used in this type of quantification; the first approach calculates expression from 
peaks in the mass spectra, using peak areas or peak heights, and the other approach is based on 
counting the number of spectra identified for the same protein in different samples (314). While 
attractive as a concept, these methods are complicated by several issues that limit applicability 
in experimental settings. For example, peptide ion fragmentation is not consistent between 
different peptides or proteins, and different peptides present in the same concentration do not 
generate ion peaks of the same intensity (315). A recent study by Schweiki et al. (2017) 
benchmarked different label-free quantification methods on the proteome of the plant 
Arabidopsis thaliana (316). The authors identified that label-free methods are inaccurate when 
used to quantify short proteins and low concentration proteins which generate few peptides and 
mass spectra. The study also concluded that label-free methods lack the sensitivity required to 
correctly quantify proteins with expression fold-changes below 2.0 (316).  
Nonetheless, label-free methods have been employed successfully, and are a promising 
approach due to simplicity (no extra reagents are required for the experiment) and the ability to 
compare a large (theoretically unlimited) number of samples (314). For example, Patel et al. 
(2011) used label-free approach to compare protein expression of 55 tissue samples obtained 
from chronic hepatitis C patients (317). A review by Megger et al. (2013) identified 15 
different label-free proteomics studies published between the years 2011 and 2013, and 
illustrated that the label-free approach is well-utilized in clinical studies (318).  
1.6.1.2 Quantification by metabolic and chemical labelling  
Quantification by metabolic labelling, such as stable isotope labelling with amino acids in cell 
culture (SILAC), is based on the assumption that biochemical properties of proteins do not 
change if amino acids in the protein are replaced by “heavy” amino-acids such as Lys or Arg 




N. The cells cultivated in the medium with “heavy” amino 
acids incorporate these into proteins, and replace the majority of the proteome with “heavy” 
proteins over five generations. Labelled cells are then combined with unlabelled cells and 
processed according to the standard MudPIT workflow. The peptides from labelled cells have 
higher mass than corresponding “light” peptides that contain normal amino acids, and the shift 
in the mass can be calculated from the peptide sequence (for example, shift is 6 Da in the case 
of 
13
C6-Arg). The mixture of “light” and “heavy” peptides generates the mass spectra with two 
peaks – one from ionization of the “heavy” peptide and the other from “light” peptide ion. 
Chapter 1: Introduction  
Page 60 of 230 
Because the peptides are chemically identical, except for difference in mass, the ratio of ion 
peak intensities equals the ratio of the protein concentration in “heavy” sample versus the 
“light” sample. This enables the relative quantification of protein expression between the 
samples (314,319). An example of SILAC workflow is illustrated in Figure 1.14/A. 
 
Figure 1.14 Comparison of metabolic and chemical labelling 
Schematic displays workflows for metabolic labelling (A) and chemical-tag based labelling using 
TMT tags (B). Metabolic labelling, e.g. SILAC, is based on adding a “heavy”, i.e. 13C substituted, 
amino acids into growth media; these are incorporated into the cellular proteins metabolically and 
quantification is based on spectral shift in MS spectrum of resulting peptides. Chemical labelling by 
TMT is based on labelling of peptides after protein digestion, e.g. by trypsin; TMT “heavy” and “light” 
tags have identical masses and are not observed in MS spectrum of a peptide, but have different 
reporter region masses; tags fragment during MS ion fragmentation and reporter ions are used to 
quantify peptides from MS/MS spectrum.  
Chemical labelling for protein quantification is based on attachment of chemical “labels” or 
“tags” to proteins or peptides isolated from test and control samples. A large number of 
different chemical tags have been developed since the introduction of high-throughput 
proteomics, and these are described in detail in recent reviews (314,320,321). All chemical 
tagging methods use similar approaches which are described here, using tandem mass tags 
(TMT) labelling as an example, (322). Quantification, illustrated in Figure 1.14/B, is based on 
attachment of a TMT label to the peptide N-terminus. The label is composed of three parts: a 
reactive group that attaches to the peptide, a reporter ion that is registered in the mass spectrum 
generated by peptide-ion fragmentation (MS/MS), and a balance (or mass normalization 
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group). A TMT kit includes 2 to 10 (depending on the kit type) different chemical labels with 
identical total masses but different reporter ion masses (counterbalanced by mass normalization 
groups to achieve the identical total mass). These kits enable the relative quantification of 
proteins from up to 10 samples (323). The TMT label reporter ion group fragments during the 
secondary fragmentation of the peptide ion in the mass spectrometer, after peptide ion spectrum 
(MS) is recorded, but before the identification of MS/MS spectrum. Thus, the differentially 
labelled peptides have identical MS spectra, but generate reporter ions with different masses in 
MS/MS spectra. As intensities of reporter ions of peptides from different samples correspond to 
abundancies of these peptides, relative quantification is achieved by comparison of reporter ion 
intensities, while the peptides are identified, e.g. by database matching, based on the MS/MS 
spectrum generated from the labelled peptide (322).  
1.7 In summary 
The section 1.2 of this introduction briefly reviews the concept of oxidative stress, its causes 
and consequences, and presents some of the controversies of redox biology. The oxidative 
stress, introduced in section 1.2.1 and discussed in sections 1.2.2 - 1.2.7, is caused by the 
increase in cellular concentration of free radicals and other reactive chemical species (RS). This 
causes oxidative damage to the cell, and can lead to apoptotic or necrotic cell death. The 
sources of RS, described in 1.2.2, include the mitochondrial respiratory chain as the major 
source of RS within the cell, and external sources such as UV radiation, pollutants and 
environmental toxins. As reviewed in section 1.2.5, the RS are routinely neutralized by cellular 
enzymatic and non-enzymatic antioxidant systems, and the cell has a capacity to tolerate and 
repair RS-caused oxidation. RS overload, however, leads to oxidation of all major cellular 
components including DNA, proteins and lipids. The cellular damage caused by the oxidative 
stress has been associated with neurodegenerative disorders, with diseases such as 
atherosclerosis and diabetes, and with processes of carcinogenesis and ageing (1.2.7).  
Despite the association of oxidative stress with disease, RS are not purely deleterious, and 
certain RS, such as H2O2, are also involved in cellular signalling. The recently postulated 
“redox code” model states that the cell contains a “redox signalling network” composing a 
large number of redox-sensitive signalling proteins that are controlled by common “control 
nodes” such as GSH and thioredoxin. According to this model, oxidative stress cannot be 
explained only by an increase in RS levels, and is also caused by dysregulation of the “redox 
code”. The concept of radical-free oxidative stress is described in section 1.2.4.  
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Section 1.3 describes the Keap1-Nrf2 pathway and its role in response to oxidative stress, 
health and diseases. The transcription factor Nrf2, described in detail in 1.3.2, is a major 
component of the animal “redox code”; it is a modular protein composed of seven functional 
domains (Neh1 – Neh7), each of which plays a distinct role in regulation of the nuclear 
concentration of Nrf2. It regulates, by binding to antioxidant response element (ARE), the 
transcription of numerous genes involved in detoxification and production of cellular 
antioxidants, described in 1.3.3. The cellular concentration of Nrf2 is primarily controlled by 
Keap1 protein which binds to the Neh2 domain of Nrf2 to sequester it in the cytosol for 
ubiquitination and degradation. The Keap1 contains a number of “RS sensing” cysteine 
residues and its binding to Nrf2 is inhibited during oxidative stress to allow nuclear 
translocation of Nrf2 that results in upregulation of cellular defences to neutralize the excess 
RS. In addition to Keap1 dependant regulation (1.3.2.3), activity of Nrf2 is also controlled by 
Keap1-independent ubiquitination and degradation by β-TrCP, by other signalling proteins such 
as p21 and p62, by microRNAs and epigenetic mechanisms. These mechanisms are reviewed 
briefly in section 1.3.2.4. 
As reviewed in 1.3.3, Nrf2 has been implicated in protection against oxidative stress and 
disorders associated with oxidative stress. Numerous cell-based and mouse model studies have 
identified that Nrf2 knockout models are highly sensitive to carcinogens such as 
benzo[a]pyrene, drug toxicity (e.g. to acetaminophen and cisplatin) and environmental 
pollutants such as cigarette smoke. In addition, treatment with Nrf2 activators such as 
sulforaphane (SFN) demonstrated to protect mouse models and cell lines against oxidative 
stress induced by drugs or UV irradiation. Yet, while Nrf2 is essential for induction of cellular 
defences, analysis of tumours showed that Keap1-mediated degradation is dysfunctional in 
certain types of cancer, leading to enhanced transcription of Nrf2 regulated genes. These types 
of cancer are found to be highly aggressive and resistant to chemotherapeutics, and this 
phenomena has been dubbed “the dark side of Nrf2” (reviewed in 1.3.4). The dysfunction of 
Keap1-mediated degradation of Nrf2 was also found to be lethal in mouse models, and 
induction of Nrf2 regulated genes was implicated in skin pathologies and acceleration of late-
stage atherosclerosis (in mouse models). As evident from the “dark side of Nrf2” examples in 
cancer, atherosclerosis and skin diseases (1.3.4), Nrf2 plays complex role in animals and its 
upregulation is not always beneficial for the organism.  
Numerous diseases are associated with oxidative stress (1.2.6), but antioxidant therapies with 
direct antioxidants, such as ascorbic acid or α-tocopherol, have not been successful in 
preventing or curing oxidative stress-related diseases. The failure of clinical trials of 
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antioxidants is reviewed in 1.2.8, along with controversies in definitions of oxidative stress and 
antioxidants, and arguments against the causal link between oxidative stress and human 
diseases. As discussed in 1.2.8.4 and 1.3.3, activation of Nrf2-regulated cellular defences by 
indirect antioxidants such as SFN or other natural and synthetic compounds is a potential novel 
therapy for diseases caused by oxidative stress. Introduced in section 1.4, mycosporine-like 
amino acids (MAAs) are natural products involved in the protection of marine life and 
terrestrial microorganisms against UV radiation. In addition to being “microbial sunscreens”, 
MAAs are implicated in protection against heat shock, desiccation and oxidative stress (1.4.1).  
Sections 1.5 and 1.6 introduce methods and approaches used in this work. Computational 
methods for biological discovery are described in the section 1.5. These include methods for 
reconstruction of evolutionary relationships (computational phylogeny, 1.5.1) and virtual 
screening approaches for prediction of novel receptor-binding small compounds (1.5.2). The 
multidimensional protein identification technology (MudPIT), reviewed in 1.6, combines 
HPLC based protein separation, mass spectrometry and bioinformatics for identification of 
mass spectra to enable high-throughput identification of proteome. Combined with protein 
labelling techniques (1.6.1.2), MudPIT allows for the relative quantification of protein 
expression, and enables the study of proteome-wide response to oxidative stress or indirect 
antioxidants.  
1.8 Research aims and objectives 
The primary goal of this project was to identify a Keap1-Nrf2-ARE pathway in microorganisms 
and basal metazoans, and to reconstruct the evolution of Nrf2 in these organisms. A secondary 
goal of the project was to identify novel low molecular weight, natural product, Nrf2 activators 
produced by microorganisms. The project was based on the hypotheses that:  
1. The vertebrate Nrf2 signalling pathway evolved from the simple progenitors such as 
microorganisms or basal metazoans. The evolution of Nrf2 signalling was driven by 
currently unknown selective pressures. 
2. Secondary products of microorganisms have the potential to regulate the transcription 
of Nrf2 controlled genes in vertebrates  
3. A microorganism based Nrf2 activation assay can provide a feasible alternative to 
assays using animal or human cells.  
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2 Chapter 2: Bioinformatics analyses provide insight 
into distant homology of the Keap1–Nrf2 pathway 
 
The content of this chapter was published as: 
Gacesa R., Dunlap W.C., Long P.F. (2015). Bioinformatics analyses provide insight into 
distant homology of the Keap1–Nrf2 pathway. Free Radic Biol Med. 88(PtB):373-80.  
R.G. designed and developed the software used to identify distant homologs of Keap1 and Nrf2 
proteins in animals and fungi, assembled the data, performed the phylogenetic reconstruction of 
Keap1 and Nrf2 sequences, performed the virtual screening simulations, interpreted the results 
and drafted the manuscript.  
Supplementary material for this chapter is included as Appendix A. In-detail list of protein 
sequences used in the phylogenetic reconstruction is included in the electronic format on the 
Appendix Disk as Appendix A and is also available as online article supplement at 
http://www.sciencedirect.com/science/article/pii/S089158491500283X. 
2.1 Foreword to Chapter 2 
As reviewed in section 1.3, numerous studies have demonstrated the importance of Nrf2 in the 
regulation of cellular response to oxidative stress. The Keap1-Nrf2 pathway is well described in 
mouse animal models and human cell-line models, and known to exist in vertebrates and some 
invertebrates such as worm Caenorhabditis elegans (324) and fly Drosophila melanogaster 
(325). However, the presence of Nrf2 and Keap1 proteins in eukaryotic genomes has not been 
systematically evaluated, and it is currently unknown whether genomes of basal metazoans 
(such as cnidarians) or microorganisms contain homologs to vertebrate genes encoding Keap1 
and Nrf2 proteins. 
The work presented in this chapter is based on the hypothesis that microorganisms contain Nrf2 
or analogous pathway, and that Keap1-depandant inhibition of Nrf2 is retained across 
taxonomically divergent phyla. As such, it was postulated that microorganisms produce 
endogenous activators of vertebrate Nrf2. Mycosporine-like amino acids (MAAs), described in 
section 1.4, are secondary metabolites of cyanobacteria and certain fungi known to serve 
various protective functions in taxonomically diverse organisms including vertebrates. 
Considering these compounds are UV protectants and associated with resistance to desiccation, 
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heat shock and oxidative stress, it was postulated that MAA are potential activators of Nrf2 
regulated genes, and exert their multipurpose protective functions in part by activating Nrf2 
regulated cellular defences. This chapter presents results of comprehensive phylogenetic 
analysis of Nrf2 in large number of currently sequenced eukaryotic genomes, and virtual 
screening based evaluation of MAAs for potential indirect antioxidant activity via competitive 
inhibition of Keap1-Nrf2 binding. 
2.2 Abstract 
An essential requirement for the evolution of early eukaryotic life was the development of 
effective means to protect against metabolic oxidative stress and exposure to environmental 
toxicants. In present-day mammals, the master transcription factor Nrf2 regulates basal level 
homeostasis and inducible expression of numerous detoxifying and antioxidant genes. To 
examine early evolution of the Keap1-Nrf2 pathway, we present bioinformatics analyses of 
distant homology of mammalian Keap1 and Nrf2 proteins across the Kingdoms of Life. 
Software written for this analysis is made freely available on-line. Furthermore, utilizing 
protein modelling and virtual screening methods, we demonstrate potential for Nrf2 activation 
by competitive inhibition of its binding to Keap1, specifically by UV-protective fungal 
mycosporines and marine mycosporine-like amino acids (MAAs). We contend that co-
evolution of Nrf2-activating secondary metabolites by fungi and other extant microbiota may 
provide prospective compound leads for the design of new therapeutics to target activation of 
the human Keap1-Nrf2 pathway for treating degenerative diseases of ageing. 
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2.3 Introduction 
The emergence of oxygenic photosynthesis, evolved first by proto-cyanobacteria approximately 
3.4 billion years ago, gave rise to the Earth’s oxygen atmosphere rendering subsequent 
progression to eukaryotic and metazoan life possible (326). Such an oxidative environment, 
however, posed a significant challenge to early life forms, requiring effective means of 
oxidative cytoprotection. In mammals, the Kelch-like ECH-associated protein 1 (Keap1) forms 
a complex with the nuclear factor erythroid 2-related factor 2 (Nrf2). The Keap1-Nrf2 complex 
dissociates in response to reactive oxygen species (ROS), releasing Nrf2 that binds to the 
nuclear antioxidant response element (ARE) to coordinate transcription of multiple antioxidant, 
detoxifying and cell survival genes (67,327). Belonging to the ‘cap-n-collar’ family of 
transcription factors that have a distinct basic leucine-zipper motif (328), the domain elements 
of Nrf2 are highly conserved across many diverse species, with orthologs having been detected 
in Caenorhabditis elegans (SKN-1) (329), Drosophila melanogaster (Nrf2-like) (325) and 
yeast (Yap1) (330). A prokaryotic homolog of Nrf2 (possibly OxyR or SoxR) (331,332) has 
also been suggested to protect UV-tolerant bacteria by augmenting coenzyme Q reduction via 
activation of cellular NAD(P)H: quinone oxidoreductase (NQOR) (333,334). We contend that 
early adaptive features of the Keap1-Nrf2 pathway conserved in extant microbiota may serve as 
a novel pharmacomimetic model for the discovery of new therapeutic activators of the human 
oxidative stress response, such may retard the progression of age-related degenerative disease, 
stimulate the innate immune response and suppress carcinogenesis (154,335–337). 
Accordingly, a new bioinformatics conduit to search and map distant homology has been 
developed and, in addition, Bayesian inference methods have been used to construct 
phylogenetic trees of Keap1-Nrf2 evolution across major eukaryotic taxa. A protein model and 
virtual screen were also established to predict likely activation of the Keap1-Nrf2 pathway 
utilizing a library of structurally diverse natural products (338,339). 
2.4 Materials and Methods 
2.4.1 Data retrieval 
Custom databases of archaeal, bacterial and fungal proteins were constructed from the National 
Center for Biology Information (NCBI) Non-Redundant (NR) database (340) and the NCBI 
Taxonomy database (341). Sequences of human Keap1 and Nrf2 proteins, together with known 
homologs and predicted orthologs, were acquired from the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) database (342) and are provided in Appendix A-1. A novel distant 
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homology search pipeline (called DHSP) was developed to increase the sensitivity and 
precision of distant homology searches by utilizing multiple Hidden Markov models (HMMs). 
The pipeline, described in Appendix A-2, and freely available for download at 
https://github.com/rgacesa/DHSP, performs a psi-BLAST (343) sequence alignment search 
against the NR database to detect close homology to generate HMM models. DHSP uses 
HMMER3, a HMM based sequence alignment tool (344), for high sensitivity distant homology 
detection. To minimize false positive hits, DHSP performs searches using multiple HMM 
models employing the Smith-Waterman algorithm (261) to align potential distant homologs 
against known sequences, thereby filtering out those sequences that fail to align. A tool for 
mapping distant homologs against the NCBI taxonomic database was additionally developed. 
This tool, called Taxonomy Landscape Mapper (TLM) displays results in a user friendly visual 
format as described in Appendix A-3. TLM is made freely available for use at 
https://github.com/rgacesa/TLM.   
2.4.2 Phylogenetic reconstruction of Keap1 and Nrf2 homology 
Multiple alignments of Keap1 and Nrf2 homologs detected by DHSP and TLM were 
constructed utilizing ClustalW2 (345). Phylogenetic reconstruction of Keap1 and Nrf2 proteins 
were assembled using the MrBayes 3.2 Bayesian inference analysis tool (338) with a mixed 
model (aamodelpr=mixed) for automatic estimation of the amino acid matrix during a 
Metropolis-Hastings Markov Chain Monte Carlo (MCMC) simulation, which was run for 
2,000,000 generations using 25 chains. Post-run examination of parameters indicated 
convergence to the JTT amino-acid substitution model (with posterior probability of 100 %). 
Among-site rate variation was set to the gamma model with 4 categories. Other parameters of 
MrBayes run were left at default values. Probability and tree summaries were inspected 
manually to confirm simulation convergence, and all simulations resulting in “good 
convergence” were accepted if the average standard deviation of split frequencies was < 0.01 
with a convergence value (Potential Scale Reduction Factor) approaching 1.0 (346). 
Phylogenetic trees were inspected and edited using Archaeopteryx (347) and MEGA 6.1 (267) 





Chapter 2: Bioinformatics analyses provide insight into distant homology of the Keap1–Nrf2 pathway 
Page 68 of 230 
2.4.3 Virtual screen for competitive inhibitors of Keap1-Nrf2 binding 
The published data (348) extracted from the Protein Data Bank (PDB) (349) entitled “Crystal 
Structure of the Kelch-Neh2 Complex” (PDB-2FLU, 
http://www.rcsb.org/pdb/explore.do?structureId=2flu) was used to construct a virtual 
compound screening model to predict the release of Nrf2 by competitive inhibition of Keap1-
Nrf2 binding. A model of the human Keap1-Nrf2 interaction was prepared for UCSF DOCK 
6.0 (350) and AutoDock Vina (351) virtual screening algorithms  using the listed protocols. 
2.4.3.1 Model preparation for DOCK 6.0 screening 
Receptor preparations were performed using the standard protocols for DOCK 6.0 as follows:  
a) The selected protein was cleared of any artifacts, water, bound ions, secondary chains 
and ligands using the UCSF Chimera tools. 
b) The Chimera Dock Prep tool was used to prepare the receptor for docking by adding 
polar hydrogens, applying partial charges, removing solvent and non-complexed ions 
and fixing any errors in amino-acid residues by using the residue conformations library 
(352).  
c) A processed model was used to generate a molecular surface using the Chimera Write 
DMS tool.  
d) Potential docking areas (“spheres”) were determined using the DOCK 6.0 sphgen tool. 
Sphere clustering was performed by assessing the proximity to the ligand where 
possible (using sphere_selector), and by a combination of clustering by sphgen and 
manual inspection by showsphere when a ligand-receptor complex is not available. 
e) The DOCK 6.0 tools showbox and grid were used to generate boundaries of potential 
docking areas (“gridbox”). 
f) Models, spheres and gridbox were inspected using Chimera, and corrections to 
parameters (sphere clusters and sizes, gridbox size) were made to insure the use of high 
quality docking parameters. 
2.4.3.2 Model preparation for AutoDock Vina screening 
Receptor model preparations were performed using Autodock tools (ADT) following standard 
protocols (353) as follows:  
a) The selected protein was cleared of any artefacts, water, unbound ions, secondary 
chains and ligands. 
b) ADT were used to add polar hydrogens (for determining hydrogen bonds) and partial 
molecular charges (to ensure the correct electrostatic potential) to the model. 
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c) A gridbox was generated using ADT, and the model is converted to a pdbqt format 
using Open Babel toolkit. 
For ligand assessments, including mycosporine-like amino acid (MAA) predictions, the 
Avogadro chemical utility platform (354) was used to create and optimize compound binding 
models by molecular dynamics simulation using universal force field (UFF) parameters (355) 
and the steepest descent algorithm (356). To assess MAA-Keap1 docking results, a comparison 
set of approximately 1,100 Brazilian natural products was assembled from two ZINC catalogs 
(357–359) for predictive contrast. All ligands were prepared for docking using the AutoDock 
Tools (ADT) script “prepare_ligand4.py” (for AutoDock Vina) and the UCSF Chimera 
visualization toolkit (360) (for DOCK6). Both Autodock Vina and DOCK6 were configured for 
high docking precision with DOCK6 selected for a flexible docking protocol with 2,000 
orientations per ligand and 400 iterations for energy minimization, and the AutoDock Vina 
space search exhaustiveness was set to 20. The UCSF Chimera ViewDock utility was used to 
manually examine the docking results. Ligands were assessed first by the number of potential 
hydrogen bonds available for binding within the protein binding pocket, and all ligands forming 
less than 3 hydrogen bonds were rejected. Those selected were evaluated manually, and all 
ligands without potential binding to critical positions of the Keap1-Nrf2 docking pocket were 
discarded. Final evaluation of “viable” docking ligands, was performed by assessing the 
combined docking scores calculated as 2 x Vina docking energy + DOCK6 binding energy + 
DOCK6 docking score. Each variable in the equation was scaled by subtracting the mean value 
and dividing by the standard deviation. 
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2.5 Results 
2.5.1 Distant homology search pipeline (DHSP) 
Distant homology searches for animal and fungal homologs of human Keap1 and Nrf2 proteins 
were conducted using a custom built Distant Homology Search Pipeline (DHSP). DHSP is a 
semi-automatic tool for high sensitivity, high precision searching of distant homology. It was 
developed in Python and runs in a LINUX command line environment. The pipeline (Figure 
2.1) uses psi-BLAST against the NCBI NR database for close homology searching to generate 
HMM models from best psi-BLAST results. It uses a HMMER search for high sensitivity 
distant homology detection. To ensure a low number of false positive hits, it performs searches 
using multiple HMM models and the Smith-Waterman algorithm to align potential homologs 
against the original sequence, filtering out those that fail to align properly and match multiple 
HMM models.  
DHSP performs the following steps sequentially (pipeline parameters can be configured but the 
listed ones were used in this analysis):  
a) The selected “target” protein and several manually selected known homologs of the 
“target” are used as inputs. 
b) Psi-BLAST with three iterations is used to find close homology for each input 
sequence. 
c) For every input, the highest scoring 100 homologs with e-values below 1.0e-10 and 
coverage of at least 70 %
 
are aligned with Clustal Omega using default parameters.  
d) hmmbuild tool with default parameters is used to generate HMM models of selected 
input sequences. 
e) hmmsearch tool is used to search each of the custom databases with a HMM model of 
each input. Sequences with hmmsearch e-value cutoff of 1.0 or lower are accepted for 
further refinement. 
f) EMBOSS package water implementation of Smith-Waterman algorithm is used to 
align all potential homologs to the original protein sequence, using the BLOSUM62 
scoring matrix, gap-opening penalty 10.0 and gap-extension penalty 0.5. Sequences 
with a Similarity Value (as reported by EMBOSS package water implementation of 
Smith-Waterman and calculated as the sum of aligned identical amino acids and 
aligned highly conserved amino acids, divided by length of alignment) under 35 % are 
rejected. 
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g) Potential homologs detected by fewer than 40 % of HMM models (where one model is 
generated for the input sequence and each of its manually selected close homologs, see 
step a) are rejected. 
To facilitate comparison with other tools, DHSP runs parallel searches using BLAST, psi-
BLAST, HMMER, iterative HMMER and HHblits and compares the results from these tools. 
Results of the DHPS combined HMMER search and tool comparisons are grouped by NCBI 
taxonomy and are displayed graphically using the Taxonomy Landscape Mapper, described in 
section 2.5.2, and in pseudo-FASTA format designed for easy data post-processing by the 
TLM. Pseudo-FASTA is identical to standard FASTA format with addition of e-value within 
the sequence header in __eV{NUM#}Ve__ format (where NUM# is replaced by actual e-value 
of sequence similarity search and is used by TLM to assign scoring to generated taxonomical 
representation). The DHSP code is freely available at https://github.com/rgacesa/DHSP. 
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Figure 2.1 Workflow of the Distant Homology Search Pipeline (DHSP) 
The DHSP input consists of the “original” sequence targeted for homology search and several 
manually selected (known and annotated) homologs. Each of the input sequences is BLAST 
searched against the NR database and the “best” (highest bit-score) homologs are multiple-aligned 
and converted into a HMM model. Each of these models is used to search target database(s) 
containing protein sequences with potential for homology. Results for multiple HMM models are 
compared and their validity is verified by a number of HMM models that produced the match and by 
alignment to the “original” input sequence. Parallel homology searches by one or more commonly 
used tools are produced for comparison, and all results are mapped to the NCBI taxonomy database 
using TLM. 
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2.5.2 Taxonomy Landscape Mapper (TLM) 
Results of DHSP were mapped to NCBI taxonomy via the newly developed tool for homology 
search mapping. TLM links FASTA formatted sequences and the results of homology search 
tools (BLAST, psi-BLAST, HMMER, jack-HMMER and HHblits) to NCBI taxonomy (Figure 
2.2). Written in Python, it runs as a LINUX command-line program with a large set of options 
for customizing input and output data and for results filtering. Its output includes taxonomical 
distribution of input sequences in text format and visual representation of the results (Figure 
2.3). TLM code is freely available at https://github.com/rgacesa/TLM. 
 
Figure 2.2 TLM workflow schematic 
TLM extracts sequence identifiers and homology search scores from the results of HMMER, HHblits 
and BLAST searches. Sequences are linked to NCBI taxonomy via sequence identifier and assigned 
taxonomical classification. Data is subsequently paired with the entire NCBI taxonomy database 
represented as a directed graph. The TLM output consists of user-friendly tabular text output and 
raw text data formatted for input into the GraphViz drawing package. 
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Figure 2.3 Taxonomy landscape mapper output 
The Taxonomy landscape mapper generates output in raw text format suitable for direct conversion 
into vector graphics by GraphViz package. Taxonomy is represented as directed graph with nodes 
displayed according to taxonomical level and homology search score quality (green for very high 
scored hits, blue for high scored and yellow to red for “twilight zone” hits). Edges are coloured 
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2.5.3 Data mining of microbial protein databases 
Databases of archaea, bacteria, fungi and plant proteins were analysed for distant homology to 
human Keap1 and Nrf2 proteins using the newly developed software tools we named the 
Distant Homology Search Pipeline (DHSP) and the Taxonomy Landscape Mapper (TLM). All 
databases except for archaea were found to contain high numbers of Keap1 homologs 
(Appendix A-2). In contrast, close homologs to human Nrf2 domain Neh1 – Neh6 sequences 
were detected only in the database of fungal proteins (Appendices A-2 and A-3), primarily in 
Ascomycetes belonging to the Class Sordariomycetes, many of which are insect and plant 
pathogens (Table 2.1).  
Table 2.1 Keap1 and Nrf2 protein scoring of sequence homology in fungal genomes.  
The table shows species selected based upon the prediction score of detected homologs to Keap1 
and Nrf2 proteins, all having the presence of genes for mycosporine-like amino acid (MAA) 
biosynthesis. Nrf2 prediction scores are the sum of numbers of detected homologs for Nrf2 domain 
Neh1 – Neh6 conserved sequences. The Keap1 prediction scores are the sum of Keap1 conserved 
kelch1 – kelch6 and BTB domain sequences.  
Species (Common name) Prediction score 
Nrf2       Keap1 
Cordyceps militaris (Scarlet caterpillar club fungus) 8 46 
Beauveria bassiana (White muscardine fungus) 7 43 
Fusarium graminearum (Wheat head blight fungus) 10 66 
Colletotrichum gloeosporioides (Post-harvest fruit rot fungus) 8 79 
Magnaporthe oryzae (Rice blast fungus) 15 79 
Fusarium pseudograminearum (Wheat crown rot fungus) 10 60 
Verticillium dahlia (Verticillium wilt fungus) 10 40 
Colletotrichum higginsianum (Crucifer anthracnose fungus) 14 54 
Metarhizium acridum (Green muscardine fungus) 13 38 
Colletotrichum graminicola (Maze anthracnose fungus) 15 73 
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2.5.4 Phylogenetic reconstruction of Keap1-Nrf2 homologies 
In order to examine evolution of the Keap1-Nrf2 pathway, we performed phylogenetic 
reconstruction using predicted Keap1 and Nrf2 fungal homologs, as well as a selection of 
known homologs from key animal species. These animals comprise invertebrate and vertebrate 
species commonly used as model organisms in biology that include three species from the 
genus Caenorhabditis and the fruit fly Drosophila melanogaster (325,329). The sponge 
Amphimedon queenslandica and coral Acropora digitifera were chosen as examples of early 
metazoan taxa (phyla Porifera and Cnidaria). Vertebrate sequences were chosen from common 
model organisms (Rat, Mouse, Zebrafish and frog Xenopus laevis) and their close relatives. 
Platypus was chosen as an example of early mammals and the lancet Branchiostoma floridae 
was selected to represent an ancient vertebrate animal. All amino acid sequences are listed in 
Appendix A-5. Bayesian reconstruction of both Keap1 phylogeny (Figure 2.4) and Nrf2 
phylogeny (Figure 2.5) were consistent with conventional species evolution, with the expected 
grouping of major vertebrate taxa and a clear split between the vertebrates and invertebrates. 
Fungal Keap1 and Nrf2 sequences, however, were both highly divergent and could be grouped 
into 3 clades. Surprisingly, phylogenetic reconstruction of Nrf2 homologs placed all three 
Caenorhabditis proteins within the fungal groupings (Figure 2.5), instead of residing with other 
invertebrates as would be expected.   
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Figure 2.4 Bayesian phylogenetic reconstruction of Keap1 evolution.  
The Bayesian phylogenetic tree was constructed from 16 vertebrate Keap1 homologs, 7 invertebrate 
homologs and 42 fungal homologs. Fungi are coloured brown, invertebrates blue and vertebrates 
green. Bayesian posterior probabilities are displayed for taxonomical splits with posterior 
probabilities above 0.5, and splits with lower posterior probabilities have been collapsed. 
Invertebrate taxa where Nrf2 has been experimentally confirmed are marked with a blue star. 
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Figure 2.5 Bayesian phylogenetic reconstruction of Nrf2 evolution.  
The Bayesian phylogenetic tree was constructed from 16 vertebrate Nrf2 homologs, 7 invertebrate 
homologs and 42 fungal homologs. The fungi are coloured brown, invertebrates blue, vertebrates 
green and polyphyletic branches are coloured red. Bayesian posterior probabilities are displayed for 
each taxonomical split with posterior probability above 0.5, and splits with lower posterior 
probabilities have been collapsed. Invertebrate taxa where Nrf2 has been experimentally confirmed 
are marked with a blue star. 
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2.5.5 Protein modelling and virtual screening of Nrf2 activation 
Fungal genomes typically encode enzymes that express the biosynthesis of mycosporines and 
the related mycosporine-like amino acid (MAA) family of UV-protective and antioxidant 
metabolites (64,234). In order to assess whether MAAs have potential to initiate a protective 
response through the Keap1-Nrf2 pathway, we performed a virtual screen of approximately 
1,100 diverse natural products including 20 MAAs. Of the ligands tested, 75 met the criteria for 
potential inhibitors of the Keap1-Nrf2 interaction. These criteria were determined by the 
docking position of the ligand within the Keap1-Nrf2 interaction pocket, the potential to form 
hydrogen bonds with Keap1, and importantly the docking score. Out of the 75 compounds 
(Table 2.2), 25 are known to be Nrf2 activators, while another 11 compounds are known 
antioxidants but not reported previously to activate Nrf2. These 11 compounds included 3 
MAAs (mycosporine-glycine-valine, mycosporine-glycine and porphyra-334). Examples for 
the binding of betanidin and porphyra-334 within the docking region of Keap1 are shown in 
Figure 2.6.  
Table 2.2 Virtual screening results. 
Listed compounds are deemed “viable” according to their docking score, number of potential 
hydrogen bonds within the Keap1-Nrf2 binding pocket and by manual inspection of the docking 
profile. The table is sorted according to the biological function of docked ligands. Entries are given 
only for compounds with assigned structures; a complete list with unknown structure assignments is 
given in Appendix A-7.  
Compound Score Structure Assignment Biological function 
ZINC49048037 0.75 AGN-PC-07CJ71 acetylcholinesterase  
inhibitor (361) 
ZINC15120547 -2.66 Crassinervic acid antifungal (362) 
ZINC00622123 0.77 Griseofulvin antifungal (363) 
ZINC13411177 0.02 similar to Strictifolione antifungal (364) 
ZINC14447808 1.76 AGN-PC-077JEH antifungal (365) 
ZINC40973915 -9.01 similar to Ixoside antioxidant (366) 
ZINC31157290 -2.60 Secoxyloganin antioxidant (367) 
ZINC05998957 -2.17 Lirioresinol A antioxidant (368) 
ZINC15119278 -1.04 similar to Yatein antioxidant (369) 
ZINC00898006 -0.15 Rubrofusarin antioxidant (370) 
ZINC02563652 -0.04 Alloisoimperatorin antioxidant (371) 
ZINC01580260 0.23 Cleomiscosin A antioxidant (372) 
ZINC69482380 1.63 similar to Maclurin antioxidant (373) 
ZINC06037073 -0.97 similar to Emodin cytotoxic, anti-cancer (374) 
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ZINC84154280 -2.54 Geranyloxy-p-benzoic Acid farnesoid X receptor agonist (375) 
ZINC26490614 -2.69 Procyanidin B2 Nrf2 activator (376) 
ZINC30726399 -9.93 Betanidin Nrf2 activator (377) 
ZINC69482045 -6.62 similar to Ursoloic acid Nrf2 activator (378) 
ZINC69481913 -6.40 similar to Ursoloic acid Nrf2 activator (378) 
ZINC17263588 -6.17 Chlorogenic acid Nrf2 activator (379) 
ZINC84154032 -5.75 similar to Morroniside Nrf2 activator (380) 
ZINC84153764 -4.32 similar to Morroniside Nrf2 activator (380) 
ZINC04102166 -4.28 Geniposidic acid Nrf2 activator (381) 
ZINC01714287 -3.40 Piperine Nrf2 activator (382) 
ZINC03870412 -3.06 Epigallocatechin  
gallate (EGCG) 
Nrf2 activator (383) 
ZINC00073693 -2.12 Pinocembrin Nrf2 activator (384) 
ZINC12428433 -1.84 Butein Nrf2 activator (385) 
ZINC71316232 -1.69 similar to Chlorogenic acid Nrf2 activator (379) 
ZINC01531693 -1.57 similar to Piperine Nrf2 activator (382) 
ZINC03872070 -1.52 Chrysine Nrf2 activator (386) 
ZINC00897734 -1.50 similar to Quercetin Nrf2 activator (387) 
ZINC00156701 -1.41 Naringenin Nrf2 activator (388) 
ZINC00113309 1.69 Fraxetin Nrf2 activator (389) 
ZINC01561070 -0.11 similar to Quercetin Nrf2 activator (387) 
ZINC14728348 0.14 similar to Quercetin Nrf2 activator (387) 
ZINC05733652 -1.36 Diosmetin potential Nrf2 activator,  
antioxidant (390) 
ZINC33832113 -1.73 similar to Phlorizin potential Nrf2 activator (391) 
ZINC69482290 -3.37 similar to Glucoerucin potential Nrf2 activator (392) 
ZINC05733537 -0.86 Ermanin, similar to  
Quercetin (Nrf2 activator) 
potential Nrf2 activator (387) 
ZINC84153966 -3.86 similar to Acetoside potential Nrf2 activator (393) 
ZINC13108875 -2.42 similar to Burchellin potential pesticide (394)  
Mycosporine 
glycine-valine 






4.21 Mycosporine-like  
amino acid 
UV-protectant, 
 antioxidant (395) 




ZINC15252691 -5.23 Gaudichaudianic acid trypancide (396) 
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Figure 2.6 Betanidin (A) and porphyra-334 (B) substrate docking models.  
The protein binding models depict the cross-section of only the molecular surface of the human 
Keap1 kelch-like repeats β-propeller docking pocket. Predicted hydrogen bonds between ligand and 
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2.6 Discussion 
The Keap1-Nrf2 pathway is a major regulator of antioxidant protection in mammalian cells, 
and is responsible for the transcription of over 200 cytoprotective genes encoded by the nuclear 
antioxidant response element (ARE). Given that the Keap1-Nrf2 pathway is so important for 
cytoprotection in mammals, it might be expected that homology is evolutionary preserved from 
simple progenitors. This is consistent with a homologous Keap1-Nrf2 pathway confirmed in 
Drosophila melanogaster (325) and identified in Caenorhabditis elegans (329). Our distant 
homology search has revealed, for the first time, that Keap1 and Nrf2 homologs are present in 
fungal taxa (Table 2.1 and Appendix A-2) and absent in bacteria, archaea and plants (Appendix 
A-2). The presence of both Keap1 and Nrf2 homologs in fungi, and that fungi are evolutionary 
closer to animals (397) than all other taxa examined, encouraged further investigation. 
Phylogenetic reconstruction of Keap1 homology in key species from vertebrate, invertebrate 
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and fungal taxa (
 
Figure 2.4) demonstrated that Keap1 fits as expected within the “Tree of Life” (398). However, 
phylogenetic reconstruction of Nrf2 (Figure 2.5) showed an unusual discrepancy in the 
placement of the genus Caenorhabditis. Genomic data mining confirms that C. elegans does 
encode proteins highly similar to Keap1 (Appendix A-8), consistent with its position in the 
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Keap1 phylogenetic tree (
 
Figure 2.4). These Keap1-like proteins have not been implicated in inhibition the Nrf2 homolog 
of C. elegans,  specifically the protein designated SKN-1 (329,399), and closer phylogenetic 
examination of this functional placement is warranted. Instead, SKN-1 activity is regulated by 
interaction with protein WDR-23 in a manner strikingly similar to Nrf2-Keap1-Cul3 
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ubiquitination and degradation (400). Interestingly, while WDR-23 has no significant sequence 
similarity to Keap1 (Appendix A-8), the 3D structure is remarkably similar to that of Keap1, 
with both proteins containing a beta-propeller superstructure. Unlike Keap1, however, the 
WDR-23 beta-propeller is formed from WD-40 protein motif repeats (see 
http://www.rcsb.org/pdb/explore/explore.do?structureId=4LG9) rather than kelch-like repeats 
(see http://www.rcsb.org/pdb/explore.do?structureId=2flu). Importantly, recent research has 
established that Nrf2 activity is controlled additionally by the human beta-transducin repeat-
containing protein (β-TrCP) (167,168), which contains WD-40 protein motifs arranged into a 
beta-propeller superstructure (401). Comparison between C. elegans WDR-23 and the human 
β-TrCP protein (Appendix A-8) reveals significant similarity between these two WD-40 beta 
propeller proteins, indicating remarkably strong evolutionary continuity of function for Nrf2 
control shared between worms and higher animals. 
According to our predictions of Nrf2 homologs in various fungi (Figure 2.5 and Table 2.1) and 
previous findings of the Nrf2 homolog Yap1 in yeast (330), the Keap1-Nrf2 pathway has most 
certainly evolved after the eukarya separated from the prokarya, but prior to the fungal-
metazoan split. Therefore, beta-propeller inhibitor proteins of Nrf2 may have evolved in early 
animals more than once by convergent evolution, which might explain the observed differences 
of Nrf2 activation in C. elegans and that of higher animals. Prior bioinformatics analysis of the 
sea anemone Nematostella vectensis has also detected homologs of Nrf2, Keap1 and two small 
binding Maf proteins required for Nrf2-ARE gene promotion (402). Our analyses of coral 
(Acropora digitifiera) and sponge (Amphimedon queenslandica) genomes also revealed more 
than one small Maf homolog [data not shown], in addition to encoding both Keap1 and Nrf2 
homologs. These results indicate that species within the genus Caenorhabditis may have lost 
SKN-1 regulation by a Keap1-like protein (possibly R12E2.1), but have retained a β-TrCP like 
inhibitor WDR-23. This loss may be due to a lack of evolutionary pressure associated with the 
soil-dwelling, often hypoxic, lifestyle of these animals (403). Further investigation by inclusion 
of additional deep-branching taxa is required; nevertheless, our phylogenetic analyses show 
clearly that the Keap1-Nrf2 pathway predates the fungal-metazoan divergence. Developing an 
evolutionary clock to determine if there is a correlation between the emergences of Nrf2 with 
the generation of an oxygen atmosphere on Earth is an avenue worthy of future research.  
A virtual screening assay was performed to assess the potential for fungal metabolites to 
function as competitive inhibitors of Keap1-Nrf2 binding. Although there are no published data 
for the disruption of Keap1-Nrf2 binding by ixoside metabolites, our predictions (Table 2.2) 
match the high scoring antioxidants betanidin, chlorogenic acid and compounds similar to 
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ursolic acid, which are known activators of Nrf2 (377,378,404). We found also that the MAAs, 
mycosporine-glycine, mycosporine-glycine-valine and porphyra-334, may serve as viable 
docking ligands based on their docking score, docking profile and potential to form critical 
hydrogen bonds within the Keap1-Nrf2 docking pocket. All three MAAs, often expressed in 
high cellular concentrations, are widely accepted to be UV-inducible sunscreen protectants (64) 
and mycosporine-glycine and porphyra-334 are reported to have antioxidant properties 
(250,255). While docking scores of MAAs are on the average higher than many of the other 
viable ligands, implying potentially lower binding affinity, these compounds are predicted to 
form several hydrogen bonds with Keap1 binding pocket and have passed manual inspection of 
binding poses. Additional research will determine if these compounds may cause disruption of 
Keap1-Nrf2 binding to activate the transcription of nuclear ARE cytoprotective genes. Finding 
microorganisms with Keap1-Nrf2 homology offer an early evolutionary model for the adaptive 
signalling of the Keap1-Nrf2 pathway, as well as providing an endogenous source of stress-
inducible metabolites having potential to activate the nuclear ARE for therapeutic 
consideration.  
2.7 Conclusions 
Data mining of microbial protein databases has revealed distant homology to Keap1 and Nrf2 
proteins in fungi, especially amongst taxa of Phylum: Ascomycota / Class: Sordariomycetes. 
Phylogenetic reconstruction of Keap1-Nrf2 pathway shows that the pathway evolved prior to 
the fungal-metazoan divergence. Unexpectedly, the Nrf2 evolutionary tree shows mismatch for 
genus Caenorhabditis within the expected taxonomic model, potentially from sequence 
degeneration of Nrf2 or lack of evolutionary pressure possibly due to the soil-dwelling lifestyle 
of these worms. Lastly, virtual screening for competitive inhibition of Keap1-Nrf2 binding 
predicts the potential for Nrf2 activation by UV-protective mycosporine-like amino acids.
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3 Chapter 3: Rising levels of atmospheric oxygen and 
evolution of Nrf2 
 
The content of this chapter was published as: 
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atmospheric oxygen and evolution of Nrf2. Scientific Reports 6, Article number 27740 
R.G. designed the study, assembled the data, carried out phylogenetic analysis, interpreted the 
results and drafted the manuscript.  
Detailed bioinformatics methodology (sections 3.4.1 to 0) included in this chapter is published 
as part of Supplementary Data File 1: Bioinformatics methodology, and is also available online 
at http://www.nature.com/articles/srep27740#supplementary-information. 
In-detail list of sequences used in phylogenetic reconstruction is included in the electronic 
format on the Appendix Disk as Appendix B and is also available online at 
http://www.nature.com/articles/srep27740#supplementary-information. 
 
3.1 Foreword to Chapter 3 
The Chapter 2 of this thesis described the results of phylogenetic reconstruction of evolution of 
genes encoding Keap1 and Nrf2 proteins in eukaryotes, and demonstrated that all tested animal 
and fungal genomes contained homologs to vertebrate genes encoding Keap1 and Nrf2. 
Research presented in this chapter builds upon the conclusions of Chapter 2, and establishes the 
results of application of evolutionary clock hypothesis to the phylogenetic tree of Nrf2 protein. 
In addition, the evolutionary time-frame of Nrf2 is correlated with the atmospheric oxygen 
levels over geological time to assess the impact of the atmospheric oxygen levels on the 
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3.2 Abstract 
In mammals, the master transcription regulator of antioxidant defences is provided by the Nrf2 
protein. Phylogenetic analyses of Nrf2 sequences are used here to derive a molecular clock that 
manifests persuasive evidence that Nrf2 orthologues emerged, and then diverged, at two time 
points that correlate with well-established geochemical and palaeobiological chronologies 
during progression of the ‘Great Oxygenation Event’. We demonstrate that orthologues of Nrf2 
first appeared in fungi around 1.5 Ga during the Paleoproterozoic when photosynthetic oxygen 
was being absorbed into the oceans. A subsequent significant divergence in Nrf2 is seen during 
the split between fungi and the Metazoa approximately 1.0 – 1.2 Ga, at a time when oceanic 
ventilation released free oxygen to the atmosphere, but with most being absorbed by methane 
oxidation and oxidative weathering of land surfaces until approximately 800 Ma. Atmospheric 
oxygen levels thereafter accumulated giving rise to metazoan success known as the Cambrian 
explosion commencing at ~541 Ma. Atmospheric O2 levels then rose in the mid Paleozoic 
(359-252 Ma), and Nrf2 diverged once again at the division between mammals and non-
mammalian vertebrates during the Permian-Triassic boundary (~252 Ma). Understanding Nrf2 
evolution as an effective antioxidant response may have repercussions for improved human 
health. 
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3.3 Introduction 
The ‘Great Oxygenation Event’ (GOE), at 2.45-1.85 Ga is recognised as the most geologically 
critical environmental change impacting the history of life on Earth (405). Oxygen-producing 
photosynthetic cyanobacteria appeared much earlier, preceding the increase of atmospheric 
oxygen marked by the onset of the GOE (406), but this oxygen was removed from the 
atmosphere by rapid oxidation of reduced minerals, precipitating especially vast deposits of 
ferric oxide from the oxidation of dissolved oceanic ferrous iron. Only after this mineral 
oxygen sink approached saturation, a process colloquially referred to as the ‘Rusting of the 
Earth’, did atmospheric oxygen increase at the advent of the GOE, giving a time-lag from the 
origin of oxygen-producing photosynthetic cyanobacteria that seems to have lasted ~1 Ga 
(405).  The GOE provided biologically useable molecular oxygen necessary for aerobic 
respiration, a decidedly more efficient energy-generating process than pre-existing metabolic 
pathways, thus setting the stage for an evolutionary transition to the aerobe-dominated biota 
that continues to this day. 
An important problem key to the success of the history of aerobic life on Earth is how cellular 
processes co-adapted to overcome the metabolic toxicity that results from use of highly reactive 
molecular oxygen. In aerobic respiration, enzyme catalysed four-electron reduction of oxygen 
is considered to be a relatively safe process producing water at the terminal end of the 
mitochondrial electron transport chain. The reductive environment of cells, however, provides 
ample opportunities for oxygen to undergo successive non-enzymatic univalent reduction, these 
processes being exacerbated by electrophilic xenobiotics and abiotic agents such as solar ultra-
violet radiation. Oxidative stress is the net outcome of oxidative damage to biologically 
important molecules such as proteins, lipids, carbohydrates and nucleic acids caused by the 
generation of these reactive oxygen species (RS). To survive in such a reactive oxygen 
environment, living organisms produce or sequester a variety of water- and lipid-soluble 
antioxidant compounds such as vitamins C and E. Oxygen metabolising organisms additionally 
produce an arsenal of antioxidant enzymes that inactivate RS. Animal genomes often express 
over 200 antioxidant and xenobiotic detoxifying enzymes (407). The regulated induction and 
expression of these genes to protect against metabolically induced oxidative stress and 
electrophilic toxicity is co-ordinated by a small number of related nuclear transcription factors 
of the bZip/CNC family of proteins, the most important of these being the master regulator, 
nuclear factor erythroid 2-related factor 2 (Nrf2).  The Kelch-like ECH-associated protein 1 
(Keap1) forms an anchor complex with Nrf2. This complex dissociates in response to RS and 
toxic electrophiles, thereby releasing Nrf2 which then binds to the nuclear antioxidant response 
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element (ARE) and co-ordinates transcription of multiple antioxidant and detoxifying enzymes 
(217). 
The domain architecture of Nrf2 is highly conserved across many diverse species of aerobic 
organisms. Our previous phylogenetic analyses clearly revealed that, whilst absent in bacteria, 
archaea and plants, the Keap1–Nrf2 pathway predates the fungal–metazoan divergence (408). 
Here we present a ‘molecular clock’ which estimates that the evolutionary origins of Nrf2 is 
allied to the timing of the global transition from anaerobic to aerobic conditions, and provides 
first demonstration of a metabolic adaptation in multiple eukaryotic ancestors having evolved a 
significant molecular response to the GOE. 
3.4 Methods  
The Nrf2 phylogenetic tree was constructed using BEAST version 2.3.0 (409) using a selection 
of Nrf2 homologs sourced from major metazoan and fungal phyla, and basic leucine zipper 
transcription factors from plant and cyanobacteria are utilised as outgroups. Sequences were 
aligned using T-Coffee Expresso (410) and T-Coffee Psi-Coffee (410) aligners and were 
evaluated using the T-Coffee TCS method to verify multiple alignment transitional 
consistencies (411). The phylogenetic tree was calibrated based on best paleontological 
estimates for the emergence of Eukaryota, the metazoan-fungal split and a set of animal phyla 
divides using compiled data from previous studies (282,397,412,413). In order to assess the 
robustness of phylogenetic reconstruction and selective pressures in the evolution of Nrf2 based 
on increasing oxidative stress, data were split into subgroups (Mammals, Amniotes, Tetrapods, 
Vertebrates, Deuterostomia, Bilateria, Eumetazoa and early Eukarya datasets) to examine 
protein and DNA sequence divergence using MEGA 6 (267). For each group, sequences were 
aligned using ClustalW (345), and alignments were analysed using the HyPhy test of codon 
selection and a codon-based Z test of selection for DNA sequences (414). Accordingly, 
Maximum Likelihood and Neighbour Joining Trees were constructed for each group, and tree 
topologies were compared to verify consistency of results. Tests confirmed the robustness of 
taxonomical grouping and codon-based selection tests within and between animal subgroups 
(data not shown). Multiple alignments with Nrf2-like DNA plant sequences were not of 
sufficient quality to perform Codon-based tests of selection.  
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3.4.1 Selection of sequences for phylogenetic reconstruction 
Translated genomes of metazoan and fungi deposited in UniProt and NCBI RefSeq databases 
as of 01/06/2015 were data mined for homologs to human Nrf2 using HMMER (344) (HMM 
profiles generated for Nrf2 and Neh1 – Neh7 conserved sequences of Nrf2 using vertebrate 
Nrf2 sequences), psi-BLAST (343) and a previously developed Distant Homology Search 
Pipeline (DHSP (408)). If more than one homolog could be identified in a given genome, all 
potential homologs were investigated for Keap1 binding motifs DLG and ETGE and beta-
TRCP binding motif DSGIS using pattern matching, with one mismatch and putative homolog 
selected based on the presence of DLG / ETGE motifs and HMMER e-values for Neh motifs. 
In the case of ambiguous results, pairwise BLAST alignment with human, mouse and 
Drosophila Nrf2 sequences were used to select putative homologs. DNA sequences were 
selected as coding DNA for Nrf2 protein homologs if available, and by BLAST searches 
against NCBI nucleotide databases if putative Nrf2 homologs lacked annotated coding 
sequences.  
3.4.2 Reconstruction of dated phylogenetic tree 
A dated phylogenetic tree was constructed using the BEAUTI/BEAST 2.3.0 framework (409), 
using the following 63 protein sequences from a set of major metazoan phyla. Plant and 
bacterial sequences were used as out-groups (see Appendix B-1 for list of sequences). 
Sequences were aligned using T-Coffee (415), M-Coffee (265), T-Coffee Expresso (410), Psi-
Coffee (410), ClustalW (345), MUSCLE (416) and MAFFT (417) multiple alignment tools, 
with two independent runs for each tool. Each alignment was evaluated using T-Coffee TCS 
(411) for transitional consistency. Based on TCS scores, Expresso and Psi-Coffee were chosen 
as aligners of choice and three independent alignments were generated by each of these 
methods. Phylogenetic trees were constructed for each multiple alignment, using the following 
BEAST parameters:  
 JTT evolutionary model (273), with Gamma site rates (Substitution rate, Proportion of 
invariant sites and Shape estimated during simulation, 4 gamma categories) 
 Relaxed exponential clock model, with estimated rates and continuous rate variations 
along the tree 
 Simulation was run for 100 000 000 MCMC generations 
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Following date ranges were used for calibration points (282,397,412): 
 Bacteria-Eukarya divergence: ≈ 2200-4200 Ma (uniform prior probability; min 2200, 
max 4200 Ma; constrained as monophyletic outgroup) 
 Bird-Reptile split: ≈ 255-300 Ma (gamma distributed prior probability; alpha 1.25, beta 
10.0, offset 255.0 Ma) 
 Eumetazoa – Metazoa divergence: ≈ 550-950 Ma (gamma distributed prior probability; 
alpha 1.25, beta 85.0, offset 550.0 Ma) 
 Fungi – Animal divergence: ≈ 900-1500 Ma (normally distributed probability; mean 
1200, sigma 100 Ma) 
 Human – Chimpanzee split: ≈ 6 – 7 Ma (gamma distributed prior probability; alpha 1, 
beta 0.2, offset 6.0 Ma) 
 Human – Mouse split: ≈ 69 – 110 Ma (gamma distributed prior probability; alpha 1.25, 
beta 8.0, offset 69.0 Ma) 
 Plant – Animal split: ≈ 800 – 2000 Ma (normally distributed probability; mean 1400, 
sigma 200 Ma) 
 Vertebrates – Invertebrates split: ≈ 500 – 600 Ma (gamma distributed prior probability; 
alpha 2, beta 15.0, offset 500.0 Ma) 
Final trees were generated using treeannotator (BEAST 2.3.0 package) with burnin value 0.25, 
with other parameters left at default values. Trees were manually compared for consistency. 
The tree presented in the main article was generated using the Figtree tool with species from 
the same phylum collapsed for clarity, and posterior probabilities calculated as the mean 
between all BEAST runs. Comparison of trees found that all splits were highly consistent, even 
within clades with low posterior probability support. 
3.4.3 Selective pressure analysis 
Evolutionary selective pressure analysis was conducted using HyPhy test of codon selection 
and a codon-based Z test of selection (414) for DNA sequences by tools integrated into MEGA 
6.0 toolkit (267). DNA sequences used for these tests are listed in Appendix B-2. 
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3.4.4 Data robustness analysis 
In order to confirm the robustness of the data, DNA and protein sequences (Appendix B) were 
divided into the following subgroups, by mapping the NCBI sequence identified to the NCBI 
taxonomy database:  
 Mammals 
 Reptiles and Birds 
 Land dwelling vertebrates 
 All vertebrates 
 Bilaterian animals 
 Metazoa 
And each group was further analysed using MEGA 6.0 by following protocol:  
1. Sequences in the group were aligned using ClustalW and MUSCLE (using default 
parameters) 
2. Maximum likelihood models were analysed using the MEGA Maximum likelihood 
(ML) model selection tool (model with lowest BIC and AICc scores were picked as 
models for choice) 
3. Phylogenetic trees were reconstructed for each alignment using Neighbour joining and 
Maximum likelihood methods, using total deletion method and partial deletion method 
with cut-off of 95 % position coverage. 
4. HyPhy test of codon selection and a codon-based Z test of selection were performed on 
the group. 
In addition, multiple alignments used for dated tree reconstruction were also analysed using 
MrBayes, version 3.2 (338), using the following parameters for reconstruction of an undated 
phylogenetic tree:  
 Prior for amino acid model set to mixed (aamodelpr=mixed), with gamma model 
invariant sites 
 10 000 000 MCMC generations, with 8 parallel chains and 4 runs 
 Other parameters left at default values 
Results of all tests were compared, tree topologies and dN-dS values were found to have high 
consistency between and within groups, with ClustalW alignments and partial deletion methods 
Chapter 3: Rising levels of atmospheric oxygen and evolution of Nrf2 
Page 94 of 230 
generating results with high agreement to BEAST and MrBayes reconstructions. MUSCLE 
alignments and total deletion methods generated lower bootstrap values.  
3.5 Results and Discussion 
In order to reconstruct the evolutionary life history of Nrf2 in response to mounting oxidative 
stress, a Bayesian phylogenetic analysis of Nrf2 sequences retrieved from the genome 
sequences of many diverse taxa was performed together with a prediction of evolutionary 
pressure, calculated as ratio of synonymous to non-synonymous nucleotide base substitution 
rates. The results are presented as a phylogenetic tree which was converted to a “molecular 
clock” using widely accepted paleontological estimates for known splits between major animal 
phyla. The molecular clock was calibrated based on best paleontological estimates for the 
divergence of major phyla using compiled data from previous studies, reflecting the very recent 
hypothesis of Hedges et al. (2015) that speciation is independent of adaptation (282,412). The 
resulting phylogenetic reconstruction was mapped against the changing level of atmospheric 
oxygen over geological time – with the Phanerozoic oxygen levels taken as a composite of the 
data afforded from the GEOCARBSULF model of Berner (418–420), the glaciation-linked 
oxygen rise models of Harada et al. (421) and a compilation of other data (405,422–425).  It 
should be noted that the oxygen curve presented in Figure 3.1 is based on “best estimates” and 
should thus be considered semi-quantitative. While Phanerozoic oxygen trends are well 
established (418–420), with moderate error margin (419), there is still a level of uncertainty 
over Proterozoic oxygen estimates. Specifically, the estimated date of origin of photosynthesis 
ranges from 2,400 to 3,000 Ma (425–427) and the exact oxygen levels over the majority of the 
Proterozoic era are subject to controversy (428–430), as are oxygen level dynamics during the 
Ediacaran era (421,424,431). Thus, while future research might lead to fine tuning of the 
oxygen level data, the pattern of change presented in Figure 3.1 is considered reliable as 
regards the major trends in oxygen change over geological time. 
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Figure 3.1 Nrf2 phylogenetic tree relative to atmospheric oxygen levels 
The chart presents the Nrf2 phylogenetic tree relative to atmospheric oxygen levels during the latter 
period of Earth’s history. The chart presents the traditional “5-stage model” of oxygen evolution 
constructed from compiled data (405,418–425), with the trend line representing a “best guess” 
model; Stage 1 represents a period when the atmosphere and oceans were largely anoxic; Stage 2 
commences the ‘Great Oxygenation Event’; Stage 3 is the period during which atmospheric oxygen 
levels remained low due to continued absorption by the oceans and oxidative weathering of the 
terrestrial crust; Stage 4 is the period after saturation of global oxygen buffers, during which oxygen 
levels rise towards present (Stage 5) atmospheric levels (PAL). The Earth timeline and major 
geological periods (432) are compiled and coloured by age. Eukarya and cyanobacteria 
appearances are noted according to first confirmed fossil evidence (427). Proposed time frames are 
shown for major Nrf2 divergence and recruitment events. Taxa known or predicted to contain the 
Keap1-Nrf2 signaling pathway are denoted by the vertical green bar, while taxa containing Nrf2 only 
(without Keap1) are denoted in blue. Invertebrates with an experimentally validated Nrf2 system are 
marked with a star (*). Evolutionary pressure increases towards more recently evolved phyla as 
schematically shown by an increasing orange hue in the selective pressure bar (decrease in dN-dS 
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The results presented in Figure 3.1 allow inference of Nrf2 emergence and sequence 
diversification as speciation occurred and oxidative stress increased due to changes in 
atmospheric oxygen. These data would strongly suggest, therefore, that Nrf2 first appeared 
having evolved from an early eukaryotic peptide that contained a bZip/CNC domain sequence 
in Stage 3 of atmospheric oxygenation during the mid-Proterozoic when oxygen was released 
into the atmosphere but was rapidly absorbed into the Earth’s ocean sediments and terrestrial 
crust (423). The divergence of cyanobacterial Nrf2-like sequences, which we use as an out-
group in our evolutionary tree (Figure 3.1), differ in evolutionary time from the expected 
eukaryote-plant divergence (1500 Ma) (412), placing plant Nrf2-like sequences closer to 
cyanobacterial sequences rather than those of early eukaryotes. This significant difference in 
the bZip/CNC domain architecture of plants is consistent with a lack of nuclear Nrf2-like 
activation in the response of plants to oxidative stress (433) and absence of detectable 
homology to the Keap1-Nrf2 pathway in plant genomes (408). Perhaps Nrf2-like sequences in 
plants might be explained by horizontal transfer during early endosymbiosis, assuming such 
sequences were inherited from a cyanobacterial precursor of the plant chloroplast (434). 
Interestingly, the predicted oxygen level spike during Stage 2 of atmospheric oxygenation 
during the mid-Paleoproterozoic period does not seem associated with Nrf2 evolution (as 
evidenced by the lack of Nrf2 homology in cyanobacteria and plants (408)) and instead points 
to an Nrf2-like mechanism as a Metazoan adaptation.  
Evolutionary pressure determined by the Codon-based Z-test of selection on both nucleotide 
and amino acid sequences (414) (Table 3.1) reveals strong purifying selection of Nrf2 
sequences for all bilateral animals (all p-values ≤ 10-3) with the exception of nematode worms. 
Cnidaria and other basal metazoans display limited evidence for negative selection (p-values of 
all tests fall between 0.01 and 0.10). Nematodes and non-metazoan Nrf2 sequences exhibit no 
significant evidence for selective pressure (p-values of tests are > 0.10, as displayed in Table 
3.1). Regulation of the Nrf2 antioxidant response exists in simple invertebrates as demonstrated 
empirically for Caenorhabditis elegans. The Nrf2 homolog SKN-1 in C. elegans, although 
serving a similar function, has significant differences in structure and regulatory pathways 
(324,329), lacking also a regulatory Keap1 interaction that is present in Drosophila 
melanogaster (325). Notably, the SKN-1 sequence of C. elegans is closer to the homolog 
sequences of basal metazoans such as cnidarians, indicating that recruitment occurred prior to 
the metazoan radiation of the Cambrian Explosion. This time frame matches the transition from 
Stage 3 and the start of Stage 4 of atmosphere oxygenation during which oxygen absorbing 
buffers in the Earth’s oceans and crust were reaching saturation and atmospheric oxygen levels 
began to rise (405). This rise in atmospheric and ocean oxygen levels led to an increase in 
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aerobic metabolic stress causing evolutionary pressure towards the expansion of antioxidant 
response systems in animals. Tests for selective pressure indicate that Nrf2 sequences of basal 
metazoans were under limiting selective pressure, with averaged p-values for evolution 
neutrality > 1 (testing H0: dN = dS, Table 3.1). According to empirical evidence gained from 
Drosophila melanogaster (325,435), genomic Keap1 recruitment occurred in early 
invertebrates preceding the divergence of the Class Insecta after the Cambrian Explosion. This 
time frame coincides with rising levels of atmospheric O2 during Stage 4 of the Earth’s 
oxygenation and matches the increased evolutionary pressure (measured by Codon-based Z-test 
of selection, Table 3.1) detected in Nrf2 sequences from taxa of the early Bilateria. Together, 
these lines of evidence suggest that rising levels of oxygen led to recruitment of Keap1 for 
enhanced regulation of Nrf2 for the transcription of cytoprotective genes in the response of 











































Table 3.1 Codon-based Z test of selection matrix 
Table displays the Codon-based Z test of selection matrix performed on 42 DNA sequences of Nrf2 homologs from major eukaryotic phyla with cyanobacterial 
sequence used as outgroup (plant outgroup sequences could not be aligned with the dataset). Analyses were conducted using the Nei-Gojobori method, and 
results are grouped by major eukaryotic phyla with the phylum dN-dS value calculated as the mean of group members. All positions with less than 95% site 
coverage were eliminated. There were a total of 352 positions in the final dataset and fewer than 5% alignment gaps, missing data, and ambiguous bases were 
allowed at any position. Evolutionary analyses were conducted in MEGA6. Table shows dN-dS and the p-value for null hypothesis of strict neutrality (dN=dS) 
for each pair of phyla. Phyla likely to have lower selective pressure compared to vertebrates (median P-value > 10
-3
) are highlighted in yellow. Phyla without 
selective pressure (based on a p-value of 0.05 as the significance threshold) are highlighted in orange. 
Phylum Birds Reptiles Amphibia Fish Mollusca Acorn worm Echinoderm 
Proto- 
chordata Arthropods Cnidaria Nematoda 
Early 
Eukarya Fungi Bacteria dN-dS pValue 
  dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv dN-dS pv mean median 
Mammals -15.40 0.0 -15.95 0.00 -18.15 0.00 -16.65 0.00 -7.73 0.00 -11.46 0.00 -6.99 0.00 -7.90 0.00 -7.40 0.00 -5.10 0.02 -2.16 0.09 -3.07 0.02 -2.31 0.17 0.20 0.28 -8.88 0.00 
Birds   -10.54 0.00 -14.80 0.00 -13.64 0.00 -7.90 0.00 -9.90 0.00 -7.50 0.00 -7.20 0.00 -7.05 0.00 -5.38 0.00 -0.73 0.48 -3.10 0.01 -2.09 0.18 -0.12 0.68 -7.56 0.00 
Reptiles 
  
  -14.87 0.00 -13.60 0.00 -6.77 0.00 -10.50 0.00 -6.29 0.00 -6.87 0.00 -7.14 0.00 -3.88 0.00 -0.92 0.40 -4.02 0.00 -2.28 0.08 -0.60 0.45 -7.66 0.00 
Amphibia 
    
  -13.90 0.00 -6.64 0.00 -9.96 0.00 -6.02 0.00 -5.08 0.00 -7.53 0.00 -3.91 0.05 -0.85 0.45 -3.18 0.00 -1.58 0.17 0.53 0.60 -7.36 0.00 
Fish 
      
  -7.69 0.00 -8.51 0.00 -6.65 0.00 -6.34 0.00 -6.85 0.00 -4.51 0.00 -1.49 0.20 -4.07 0.06 -1.79 0.24 -0.49 0.47 -8.06 0.00 
Mollusca 
        
  -6.52 0.00 -8.76 0.00 -5.91 0.00 -7.92 0.00 -2.65 0.36 1.53 0.44 0.00 0.00 0.17 0.54 -0.81 0.42 -4.83 0.00 
Acorn worm 
          
  -6.52 0.00 -6.09 0.00 -5.93 0.00 -3.37 0.01 1.13 0.26 -6.25 0.00 -0.72 0.56 0.25 0.80 -6.02 0.00 
Echinoderm 
              
-7.19 0.00 -5.52 0.00 -5.34 0.00 -1.09 0.28 -4.27 0.00 -3.44 0.38 -1.75 0.08 -5.52 0.00 
Protochordata 
              
  -6.10 0.00 -3.78 0.00 -0.12 0.91 -4.62 0.00 0.72 0.49 -0.75 0.46 -4.80 0.00 
Arthropods 
                
  -4.73 0.01 -0.05 0.51 -5.10 0.03 -2.43 0.28 -1.67 0.13 -5.87 0.00 
Cnidaria 
                  
  0.77 0.47 -2.41 0.45 0.74 0.44 0.23 0.02 -3.27 0.01 
Nematoda 
                    
  -0.32 0.68 -1.29 0.34 -0.35 0.73 -0.42 0.44 
Early Eukarya 
                      
  -0.58 0.26 1.32 0.19 -2.83 0.02 
Fungi 
                        
  2.49 0.36 -1.03 0.31 
Bacteria 
                          
  -0.11 0.43 
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It is unclear whether fungi and early diverging metazoans possessed a one-protein (Nrf2 only) 
or two protein (Keap1-Nrf2) antioxidant response system. Nematodes having only a Nrf2-like 
sequence (329,436) are grouped with basal metazoans suggesting a one-protein system that 
likely evolved early in metazoan development. The position of nematode Nrf2-like sequences, 
however, differs from what would be expected from the generally accepted Tree of Life in 
which nematodes belong to a clade of “moulting animals” along with arthropods and several 
smaller phyla (437). The nematode Nrf2-like sequence SKN-1 also has a lower selective 
pressure (as measured by Codon-based Z-test of selection, Table 3.1) than the Nrf2 of most 
animals. Such, an alternative explanation is that recruitment of Keap1 had occurred shortly 
after Nrf2 evolution into an antioxidant response regulatory system at a time close to the 
animal-fungal divergence at late Stage 3 of atmospheric oxygenation. Homologous Keap1 
proteins of nematodes may have subsequently lost persistence of regulatory control over Nrf2-
like function in nematodes, perhaps due to a lack of environmental selective pressure attributed 
to the often hypoxic soil-dwelling lifestyle of worms. In contrast, tissues of cnidarians 
harbouring phototrophic endosymbionts can tolerate extremes of oxygen saturation (438), thus 
demanding efficient means to control oxidative damage. Accordingly, additional elaboration of 
Nrf2 activity in fungi and basal metazoans is essential to better elucidate evolutionary 
processes, which is enabled by the recent availability of several cnidarian genome annotations, 
including that of the scleractinian coral, Acropora digitifera (439).  
In summary, we demonstrate that orthologues of Nrf2 first appeared in fungi around 1.5 Ga 
(408) during the Paleoproterozoic when photosynthetic oxygen was being absorbed into the 
oceans culminating in prolonged low oxidative stress (405). A subsequent significant 
divergence in Nrf2 is seen to occur during the split between fungi and the Metazoa 
approximately 1.0 – 1.2 Ga (413); at a time when oceanic ventilation released free oxygen to 
the atmosphere, but with most of this being absorbed by methane oxidation and oxidative 
weathering of land surfaces until approximately 800 Ma (422,428). Atmospheric oxygen levels 
thereafter accumulated during the Neoproterozoic giving rise to metazoan success during the 
Ediacaran period (635-541 Ma) leading to the Cambrian explosion (radiation) commencing at 
~541 Ma (440). Atmospheric O2 levels then rose in the late Paleozoic (359-252 Ma), driving 
further Nrf2 sequence divergence and Keap1 recruitment for Keap1-Nrf2 regulation of the 
oxidative stress response at the division between mammals and non-mammalian vertebrates 
during the during the Late Triassic (~225 Ma) (441,442). Understanding the evolution of Nrf2 
and recruitment of other protein partners into an effective antioxidant response cascade might 
provide novel insights into the human ageing process since oxidative stress is believed to be 
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one of the key factors in ageing. This could, in turn, reveal possible new intervention strategies 
to improve metabolic health in our worldwide ageing population. 
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4 Chapter 4: Porphyra-334 and shinorine are 
antioxidants and antagonists of Keap1-Nrf2 binding 
The content of this chapter has been submitted for publication as: 
Gacesa R., Georgakopoulos N.D., Lawrence K.P., Yabe K., Dunlap W.C., Barlow D.J., Wells, 
G., Young A.R. and Long P.F. (2017). Porphyra-334 and shinorine are antioxidants and 
antagonists of Keap1-Nrf2 binding. FEBS letters (under review) 
R.G. performed the extraction, purification and analysis of MAAs, performed the DPPH assay, 
interpreted the results and drafted the manuscript. The ORAC assay, fluorescence polarisation 
and thermal shift assays were performed jointly by R.G. and G.N.D.  
4.1 Foreword to Chapter 4  
The Chapter 2 of this thesis presented the structure based virtual screening study to determine 
the potential for competitive inhibition of Keap1-Nrf2 binding by natural products. The results 
presented in Chapter 2 demonstrated that the mycosporine-like amino acids (MAAs) have the 
capacity to bind to human Keap1-Nrf2 binding pocket. This chapter presents the study to 
identify if the MAAs are competitive inhibitors of human Keap1-Nrf2 interaction in vitro. 
4.2 Abstract  
Mycosporine-like amino acids (MAAs) are UV-absorbing metabolites typically produced by 
cyanobacteria and marine algae, but their properties are not limited to direct sun screening 
protection. Herein, we demonstrate that the MAAs porphyra-334 and shinorine are prospective 
activators of the cytoprotective Keap1-Nrf2 pathway as determined using fluorescence 
polarization and thermal shift assays to detect Keap1 receptor antagonism. Their in-vitro 
antioxidant activities determined by the DPPH free-radical quenching assay were low in 
comparison to ascorbic acid. However, their antioxidant capacity determined by the ORAC 
assay to quench free radicals via hydrogen atom transfer is substantial. Accordingly, the dual 
nature of porphyra-334 and shinorine to provide antioxidant protection offers a unique 
chemoprotective strategy to retard the progression of multiple degenerative disorders of ageing.  
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4.3 Introduction 
The Kelch-like ECH-associated protein 1 (Keap1) is an actin bound homodimer that functions 
as a primary sensor of intracellular reduction-oxidation (redox) state regulation by controlling 
the activity of the master transcription nuclear factor erythroid 2–related factor 2 protein (Nrf2), 
which regulates the transcription of a large number of genes under control of the cis-acting 
enhancer termed the antioxidant response element (ARE) (157,443). The human Keap1 
monomer is a 69.7 kDa protein composed of 625 amino acids that is divided into 5 distinct 
domains (Figure 1). The Kelch-repeat domain consists of six repeating motifs (KR1–KR6) that 
form a six-bladed β-propeller structure at which Keap1 binds to the Neh2 domain of Nrf2 
(444). Under basal conditions, Nrf2 is targeted for ubiquitination and rapid 26S proteasomal 
degradation by Keap1 BTB domain bound Cullin3-Rbx1 E3 ubiquitin ligase (CRL
Keap1
) 
(135,137,156). This turnover of Nrf2 prevents unnecessary expression of genes under Nrf2 
transcriptional regulation (156). During conditions of oxidative stress, the ubiquitination and 
degradation of Nrf2 by CRL
Keap1
 is disrupted. Two separate models have been proposed for this 
dissociation: the “conformation cycling model” (137) and the “hinge and latch model” (135). In 
the conformation cycling model, it is proposed that, in the presence of cellular oxidants and 
exogenous electrophiles, covalent modification of Cys
151
 in the BTB domain of Keap1 causes 
conformational changes that prevent ubiquitination of Nrf2 by the CRL
Keap1
 protein complex 
(136,137). In the hinge and latch model, the Nrf2-Keap1 interaction is mediated by a high-
affinity ETGE motif in the Neh2 domain of Nrf2, which functions as a “hinge” by stabilising 
Nrf2 binding to the Kelch domain in the Keap1 dimer. A low-affinity DLG motif in the Neh2 
domain of Nrf2 functions as the “latch” by locking or unlocking the binding position of Nrf2, 
depending on the redox state of the cell. Under basal conditions, the DLG motif locks the Neh2 
domain in the correct position to enable ubiquitination of Nrf2 (112,445). However, the IVR 
domain of Keap1 is cysteine rich and these residues are sensitive also to oxidation 
(134,446,447). During conditions of oxidative stress, these cysteine residues become oxidized 
to unlock the Nrf2 “latch”, disrupting Nrf2 ubiquitination by the CRLKeap1 complex. As a 
consequence, Nrf2 is spared degradation at the proteosome, and newly translated Nrf2 proteins 
accumulate in the cell. Free Nrf2 then translocates to the nucleus where it forms a complex with 
small Maf proteins and interacts with the promoter region of the ARE to initiate the 
transcription of genes encoding a vast arsenal of proteins that protect against toxic 
contamination and regulate metabolic redox homeostasis (135,156,446). 
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Figure 4.1 Illustration of the Kelch-like ECH-associated protein 1 (Keap1)  
The Broad-complex, Tramtrack and Bric-a-Brac (BTB) domain, coloured blue, is responsible for the 
formation of the Keap1 dimer and for Nrf2 binding; the Kelch-repeat (KR) domain, forms a six-bladed 
β-propeller structure with DLG and ETGE motifs that bind with the Neh2 domain of Nrf2 
(135,446,448). The Intervening (IVR) domain is comprised of amino acid residues between BTB and 
Kelch repeats. Cysteine residues that function as electrophile sensors are denoted in the above 
illustration. 
Since oxidative stress has been implicated in numerous human diseases, the Keap1–Nrf2 
protein-protein interaction (PPI) has become an important target for the potential development 
of therapeutic and chemopreventive agents. Numerous compounds have been examined for 
their ability to induce Nrf2-dependent gene expression, including those of natural origin (e.g., 
curcumin, sulforaphane) and others that are synthetic (e.g., bardoxolone methyl, oltipraz). Most 
of these Nrf2 activators are electrophiles that covalently modify the sulfhydryl groups of keap1 
cysteine residues disrupting the ubiquitination and subsequent degradation of Nrf2 (448). These 
electrophilic inhibitors lack selectivity and thus increase the risk of “off-target” toxic effects 
due to indiscriminate reactions with cysteine residues in other cellular proteins. Accordingly, 
the discovery of direct, non-reactive, small molecule inhibitors of the Keap1–Nrf2 PPI appears 
to be the most promising strategy for Nrf2 activation to decrease the possibility of “off-target” 
toxic effects (449,450). 
Mycosporine-like amino acids (MAAs) are small secondary metabolites commonly produced 
by marine algae and seaweeds that reside in shallow-water environments and are typically 
exposed to high levels of solar radiation. MAAs are found also in the tissues of some marine 
vertebrates, such as fish, that occur by dietary accumulation from the marine food-chain. 
MAAs absorb ultraviolet light, typically between 310 and 340 nm, allowing MAAs to protect 
cells from damaging solar UV radiation. Yet, MAAs are multifunctional metabolites that 
protect also against free-radical damage and boost cellular tolerance to desiccation, hyper-
salinity and heat stress (64,451); there are more than 20 known MAAs in this class of natural 
metabolites. Previously, utilising protein modelling and virtual screening methods, we had 
predicted the potential for Nrf2 activation by competitive inhibition of its binding to Keap1, 
specifically by certain UV-protective MAAs (408). Here we provide in vitro empirical evidence 
to confirm our in-silico predictions that porphyra-334 (the principal MAA of Porphyra 
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yezoensis – Japanese seaweed “nori”) and shinorine (from Gloiopeltis furcata – Japanese 
seaweed “fukuro-funori”) may exert a cytoprotective function by specific, non-reactive binding 
to the Kelch-repeat domain of Keap1; additionally these MAAs are shown to have intrinsic 
antioxidant activity by quenching free oxygen radicals through hydrogen atom transfer. 
A) Shinorine 
 














Figure 4.2 Structures and biophysical characteristics of MAAs tested in this study.  
Figure shows chemical structures of the mycosporine-like amino acids, shinorine (A) and porphyra-
334 (B). The molecular formula, molecular mass, and the maximum wavelength of absorbance (λmax) 
are given for each MAA. 
4.4 Materials and Methods 
4.4.1 Materials 
All chemicals were purchased from commercial suppliers and used without further purification. 
Ascorbic acid, tBHQ, caffeic acid and DMSO were purchased from Sigma-Aldrich 
(Gillingham, Dorset, UK). Curcumin, DPPH, quercetin, and EGCG were purchased from 
Insight Biotechnology Ltd (Wembley, Middlesex, UK). Chlorogenic acid, trans-resveratrol and 
sulforaphane were purchased from Cambridge Bioscience Ltd (Cambridge, UK). Purified 
MAA compounds porphyra-334 and shinorine were kind gifts from Prof Kazuo Yabe. 
4.4.2 Analysis of mycosporine-like amino acids 
Identity and purity of mycosporine-like amino acid (MAA) samples was confirmed by HPLC 
analysis based on Carreto method (452), followed by the high resolution HPLC-MS/MS 
analysis to determine the mass and ion-fragmentation patterns of MAAs.  
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Each MAA sample was prepared by dissolving 1 mg of dry powder (previously stored at -20 °C 
in desiccator) in 1.5 mL of HPLC grade water. The solution was filtrated by 100-kDa ultrafilter 
(Ultra spin, Alltech) to remove water-insoluble materials and large molecules. HPLC analysis 
was performed on system composed of Shimadzu DGU-20A3 degasser, 2 x LC-20AD pump, 
CBM-20A communicator, SPD-M20A diode array detector and SIL-20A HT autosampler, 
using TPNA5011 Phenomnex C18 reverse phase column (Luna 5a 18C (2) 100A; 250 mm x 3 
mm, 5 µm, No. 568381-1). 50 μL of sample was injected and elution was performed at 0.2 
mL/min flow rate, using two solvent gradient elution, with Solvent A composed of HPLC grade 
water + 0.2% formic acid, pH corrected to 3.15 using NH4OH, and Solvent B composed of 
80% [HPLC grade water + 0.2% formic acid, pH corrected to 2.2 using NH4OH and formic 
acid] : 10% Acetonitrile : 10% MeOH. 
Table 4.1 Elution protocol for isolation of MAAs 
The table lists the elution program for MAA isolation. Solvents A and B are described in the text. 
Time (minutes) Concentration (A) Concentration (B) Notes 
0 – 2 100% 0%  
2 – 30 100% to 50% 0% to 50% Linear gradient 
30 – 35 50% 50%  
35 – 45 50% to 2% 50% to 98% Linear gradient 
45 – 50 2% 98%  
50 – 52 2% to 100% 98% to 0% Linear gradient 
52 – 60 100%   
 
High resolution mass spectrometry analysis was performed using HPLC system composed of 
Shimadzu DGU-20A3 degasser, 2 x LC-20AD pump, CBM-20A communicator, CTO-20A 
column oven, SPD-M20A diode array detector and SIL-20A HT autosampler coupled to the 
Bruker micrOTOF – qII mass spectrometer. The 50 μL of sample were injected into the system 
and elution was performed using the same solvents and program as the previous HPLC analysis 
(listed above).  
4.4.3 Fluorescence polarization (FP) assay 
The FP assay was carried out as previously described (159). Briefly, a solution of fluorescent 
peptide (FITC-β-DEETGEF-OH, 1 nM) and Keap1 Kelch domain (200 nM) in DPBS, pH 7.4 
were mixed in an untreated black 96 well plate (Corning) with varying concentrations of test 
compounds up to 100 µM (final DMSO concentration 11 %, final volume 100 μL) and 
incubated for 1 hr at room temperature in the dark. FP was measured using a PerkinElmer 
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EnVision™ Multilabel Plate Reader. All measurements were recorded in triplicate. The 
normalised data were fitted to a standard dose-response equation by non-linear regression using 
Origin Pro software (OriginLab) to determine IC50 values. 
4.4.4 Thermal shift assay  
The thermal shift assay was carried out as previously described (294). Briefly, a solution of the 
detection dye SYPRO
®
 orange (5X) and Keap1 Kelch domain protein (5 µM) in DPBS, pH 7.4 
were mixed in a MicroAmp
®
 Optical 96-well reaction plate (ThermoFisher) with varying 
concentrations of test compounds up to 100 µM (final DMSO concentration 10 %, final volume 
40 μL). The plate was sealed using an optical adhesive cover and wrapped with aluminium foil 
to protect the dye from light. The plate was then transferred to a plate centrifuge and spun 
briefly (200 x g, 1 min, at room temperature) to remove any air bubbles and to collect the 
reaction mixture at the bottom of the wells. The plate was incubated for 1 hr at room 
temperature and then placed into a 7500 Real Time PCR machine and heated using a standard 
protein melting protocol (453). The fluorescence intensity was recorded with excitation at 465 
nm and emission measured at 580 nm during a temperature scan from 25 °C to 95 °C with a 
temperature ramping rate of 1 °C/min. All measurements were performed in triplicate. The raw 
data were exported to MS Excel and analysis was performed using a custom script provided by 
Structural Genomics Consortium, University of Oxford. The temperature range over which 
protein unfolding occurred was established at temperatures below the maximum fluorescence 
intensity. The processed data were fitted to the Boltzmann equation by linear regression 
analysis using Origin Pro software. 
4.4.5 DPPH radical scavenging activity 
The percentage of antioxidant scavenging activity for each MAA was determined according to 
methodology described by Mishra et al. (454). Briefly, each MAA (62.5 μM, 117.7 μM and 
210.5 μM concentrations) and an ascorbic acid positive control (3.9 μM, 7.8 μM, 15.6 μM, 31.3 
μM, 62.5 μM and 312.5 μM concentrations) were prepared in DMSO. For each sample, the 
reaction mixture consisted of 0.1 mL of the test sample and 1.5 mL of 70 μM DPPH in 
methanol. The colour change from violet to yellow, when DPPH is reduced upon reaction with 
an antioxidant, was recorded at 515 nm using a UV/VIS spectrophotometer (model 7315, 
Jenway Ltd., Stone, Staffordshire, UK) after 30 mins of reaction at room temperature, with 
reaction mixtures shielded from light. The mixture of DMSO (0.1 mL) and DPPH (1.5 mL) 
served as the reaction blank. The percentage of DPPH radical scavenging activity was 
calculated as: % scavenging activity = 100 x (Ablank – Asample )/Ablank. The DPPH scavenging 
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activity was found to be proportional to the MAA concentration (for levels examined), and the 
515 nm absorbance of the fully reduced DPPH was set to zero. Experiments were performed in 
technical triplicates with three replicates, and % scavenging activities were plotted as the mean 
of the 9 triplicate/replicate values against test sample concentrations (μM). IC50 values were 
estimated from linear regression of the data. 
4.4.6 ORAC antioxidant assay 
The oxygen radical absorbance capacity (ORAC) for each MAA was carried out using the 
ORAC Antioxidant Assay Kit (Zenbio, North Carolina, USA) according to manufacturer’s 
instructions. Trolox standards were prepared in the assay buffer (0 - 100 M) along with serial 
dilutions of each MAA (500 - 0 μM) and an ascorbic acid positive control (0 - 100 μM). 150 l 
of the fluorescein working solution was added to central wells of a 96 well plate, with 25 l of 
each of the standards or MAA in duplicate, and the plate incubated at 37 °C for at least 15 
mins. The 2,2’-azobis(2-amidinopropane) dihydrochloride (AAPH; sold as 2,2’-azobis(2-
methylpropanimidamine) dihydrochloride) working solution was added to each well (25 l) to 
start the reaction. Fluorescence was measured in a preheated incubation chamber (37 °C) using 
a Spectra Max 384 Plus spectrophotometer with excitation/emission = 485/530 nm immediately 
(t = 0) and then every minute for 30 mins. Standard curves were generated for each compound 
and the area under the curve calculated. Each MAA tested was expressed as a Trolox 
equivalent concentration. 
4.5 Results 
4.5.1 HPLC and MS analysis of MAA samples 
The purity and identity of mycosporine-like amino acids shinorine and porphyra-334 (Figure 
4.2) was confirmed based on the HPLC retention times, comparison with Helioguard-365 
which is known to contain shinorine, palythine and porphyra-334 (455), and by high resolution 
tandem mass spectrometry. The results are presented in Figure 4.3 and Figure 4.4. 
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Figure 4.3 HPLC chromatograms of MAA samples and Helioguard 
Figure A) displays HPLC chromatogram of MAA samples Shinorine (green) and Porphyra-334 
(blue), while figure B) shows chromatogram of MAA samples mixed with Helioguard 365 (red), 
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Figure 4.4 MS/MS fragmentation patterns of shinorine and porphyra-334  
The figure A) displays the fragmentation patterns of ionized shinorine, while figure B) shows the 
MS/MS spectrum of porphyra-334. Masses of major MS/MS fragments are labelled and masses of 
the precursor ions are marked with orange circles (m/z = 333.1302 for shinorine and 347.1456 for 
porphyra-334). 
4.5.2 Keap1-binding activity of MAAs 
The MAAs porphyra-334 and shinorine together with eight selected antioxidants (ascorbic acid, 
tBHQ, caffeic acid, chlorogenic acid, curcumin, quercetin, EGCG, trans-resveratrol) plus the 
known electrophilic Nrf2 activator sulforaphane were evaluated for their interaction with the 
Kelch-repeat domain of the Keap1 protein using both in-vitro FP and thermal shift assays. In 
the FP assay, the test compounds competed with a ﬂuorescein labelled peptide (fluorescein-[β-
ala]DEETGEF-OH) based on the high affinity ETGE motif that binds Nrf2 to the Kelch-repeat 
domain (Figure 4.5). The protein-protein interaction of the fluorescein-[β-Ala]-DEETGEF-OH 
A) Shinorine 
B) Porphya-334 
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peptide had an IC50 of ~3 µM in the presence of the Kelch-repeat domain protein (159). Both 
porphyra-334 and shinorine gave nearly equivalent ligand-receptor IC50 values of ~100 μM, 
requiring a much greater concentration in the presence of excess Kelch-repeat domain protein 
than the binding of the high affinity, labelled synthetic peptide (159). In contrast, no significant 
interactions were detected between the eight known antioxidants or sulforaphane and the 
Kelch-repeat domain protein.  
 
Figure 4.5 Fluorescence polarization measurement of specific, non-reactive binding of 
MAAs to the Kelch-repeat domain of Keap1. 
Ligand-receptor binding was measured using a fluorescence polarization assay in comparison to a 
high affinity, labelled synthetic peptide. The FP inhibition (in percent) is displayed for small peptide 
positive control, MAAs shinorine and porphyra-334 and range of electrophile Nrf2 activators, at the 
compound concentration of 100 µM. 
The MAAs and eight selected antioxidants were then tested as ligands of the Kelch-repeat 
domain protein using the thermal shift assay. The assays involved treatment of the Kelch-repeat 
domain protein with these test compounds of interest, followed by denaturation by heating to 
separate the protein-ligand aggregates from the soluble protein fraction. Whereas unbound 
proteins denature and precipitate at elevated temperatures, ligand-bound proteins remain in 
solution. An unlabelled version of the peptide ([β-ala]DEETGEF-OH) used in the FP assay was 
used as the positive control in the thermal shift assays against which binding of the test 
compounds to the Kelch-repeat domain were compared. When used at 50 µM concentration, 
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the [β-Ala]-DEETGEF-OH peptide had a high ΔTm of 3.91 ± 0.04 °C. Both porphyra-334 and 
shinorine also demonstrated elevated binding values to the Kelch-repeat domain protein, albeit 
when used at 100 µM (porphyra-334 ΔTm = 0.93 ± 0.02 °C, shinorine ΔTm = 0.64 ± 0.11 °C). 
However, no signiﬁcant protein-ligand interactions were detectable when the 8 antioxidants or 
the electrophilic Nrf2 activator sulforaphane were tested. The thermal shift assays reflected the 
results of the FP assays for binding of MAAs and test substrates to the Kelch-repeat domain 
protein of Keap1.  
4.5.3 Antioxidant activity of MAAs 
Scavenging of the DPPH free radical is a common assay used to assess the antioxidant activity 
of a compound. Ascorbic acid is a well-known DPPH free-radical scavenger and is commonly 
used as a positive control, which was used also for comparison in this study. The IC50 value for 
ascorbic acid was 24.5 ± 1.1 μM in the methanol reaction medium. The free radical scavenging 
activities of MAAs were markedly lower compared to that of ascorbic acid. The IC50 values 
were: 185.2 ± 3.2 μM for porphyra-334 (equivalent to 13.23 % of the activity of ascorbic acid) 
and 399.0 ± 1.1 μM for shinorine (equivalent to 6.14 % of the activity of ascorbic acid).  
Another method commonly used to assess antioxidant activity is the ORAC assay, which is 
used to assess the hydrogen atom transfer capacity of a test compound to suppress peroxyl 
radical (ROO) induced oxidative damage measured by the fluorescence decay of fluorescein. 
Trolox, a water-soluble vitamin E analogue, is used as the standard against which other 
compounds are compared. Ascorbic acid was used also as an additional control reference. Both 
MAAs demonstrated significant activity (Figure 4.6) with porphyra-334 displaying an 
antioxidant capacity equal to 39.4 ± 9.4 % of equimolar Trolox and shinorine showing 12.2 ± 
6.12 % of the Trolox capacity. Ascorbic acid showed greater antioxidant capacity than did 
Trolox (equivalent to 126.9 ± 13.1 % of Trolox) and that of our test MAAs. 
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Figure 4.6 The oxygen radical absorbance capacity of MAAs.  
MAAs and reference controls of increasing concentration were assessed for their ability to quench 
the ROO radical as a measure of antioxidant activity. All compounds demonstrated significant 
activity (trolox p=0.0031; ascorbic acid p=0.0133; porphyra-334 p=0.0002; shinorine p=0.0044; all 
R
2
>0.9000 determined by linear regression analysis). Relative antioxidant capacity compared to 
trolox was calculated (ascorbic acid = 126.9 ± 13.1 %; porphyra-334 = 39.4 ± 9.4 %; shinorine = 
12.2 ± 6.12 %).  Each data point represents the mean value (n=3). 
4.6 Discussion 
Aerobic organisms are regularly challenged by various environmental oxidants and toxic 
electrophiles that include free radicals produced from exposure to UV, visible and IR radiation, 
xenobiotic pollutants and endogenously generated, reactive by-products of oxidative 
metabolism. Such, these organisms have long evolved a robust detoxification and redox 
signalling systems to prevent cellular damage (112,156). The transcription factor Nrf2, 
targeting ARE upstream promoter sites of many protective genes, is the principal regulator of 
mammalian cellular antioxidant defence and P-450 cytochrome detoxification proteins. While 
various intrinsic pathways and signalling cascades have been identified that contribute to the 
regulation of Nrf2 function (156,456), the key role of the repressor Keap1 protein is firmly 
established since disruption of Keap1-Nrf2 binding is sufficient to increase significantly 
nuclear Nrf2 activity (151,457). This is additionally supported by siRNA knockdown of Keap1 
mRNA (152) and Keap1-null ablation (151), both of which massively enhance free cellular 
Nrf2 accumulation. Furthermore, somatic mutations of Keap1, a characteristic of certain cancer 
phenotypes (153,217), result in constitutive  Nrf2 activation, as does the silencing of Keap1 
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Human Keap1 contains six ROS/electrophile-sensing cysteine residues (Cys151, Cys226, 
Cys273, Cys288, Cys434 and Cys613) which are prone to oxidation and covalent modification 
by electrophiles. These changes do not prevent Keap1-Nrf2 binding, but alter the basal-state 
“open” conformation, which prevents CRLKeap1 ubiquitination to release Keap1 upon Nrf2 
degradation (136).  As a result, free Keap1 is not regenerated, and newly synthesized Nrf2 
accumulates to promote gene transcription. Electrophile activators of Nrf2 and the majority of 
other known Nrf2 inducers, including sulphoraphane used in this study, function also by this 
mechanism of targeting critical Cys residues of Keap1 to activate Nrf2 transcription (156,459). 
The compounds examined in this study, with the exception of the Keap1-binding MAAs, are 
sometimes referred to as “indirect antioxidants” or “Nrf2-activating antioxidants” and would 
not be expected to show appreciable activity in the FP, thermal shift, DPPH or ORAC assays. 
These expectations were matched by our assay results. 
Non-electrophile activators of Nrf2, e.g. small-peptides (158,159) and small-molecule Nrf2 
activators (160,460), function by competitive inhibition of Keap1-Nrf2 binding. These 
compounds hinder the formation of the “closed” Keap1-Nrf2 conformation by binding to the 
Keap1 β-propeller structure responsible for DLG and ETGE binding. While less studied than 
electrophile-based Nrf2 activation, targeting of the Keap1-Nrf2 binding site by competitive 
inhibitors has potential to upregulate Nrf2 activity without the toxic danger of indiscriminate 
“off-target” effects. These compounds and peptides do not depend on covalent electrophile 
modification of protein cysteine residues and are prone to indiscriminate reactions with proteins 
of other cellular signalling networks (157). In this study we present empirical in vitro evidence 
for the MAAs porphyra-334 and shinorine to competitively interact with the Nrf2 binding site 
of the human Keap1 protein, as previously anticipated from bioinformatic, structure-based 
Kelch domain binding predictions (408). 
The first study to examine the antioxidant properties of MAAs, using the phosphatidylcholine 
peroxidation inhibition assay, found that imino-MAAs (shinorine, porphyra-334, palythine, 
asterina-330 and palythinol) were oxidatively robust to AAPH-generated peroxyl radicals, 
whereas the oxo-MAA mycosporine-glycine strongly inhibited radical-initiated 
phosphatidylcholine autoxidation in a concentration-dependent manner (250). 4-Deoxygadusol, 
presumed to be the immediate biochemical precursor of MAAs, was found also to have strong 
antioxidant properties (244) as demonstrated by voltamperogramic comparison of the 
electrochemical properties of 4-deoxygadusol, mycosporine-glycine and mycosporine-taurine 
(64). Numerous studies on the antioxidant properties of MAAs followed thereafter and have 
been extensively reviewed (232). Notably, the antioxidant capacities of porphyra-334 and 
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shinorine, together with other MAAs isolated from marine extracts (three seaweeds and one 
lichen), were compared using the ABTS radical-cation decolorization and superoxide-
scavenging pyrogallol autoxidation assays, which showed scarce activity in comparison to 
mycosporine-glycine. Yet, shinorine and porphyra-334 showed modest antioxidant activity 
using the β-carotene/linoleate bleaching assay (251). Contrasting reports by Rastogi et al. 
attribute significant antioxidant activities of cyanobacterial extracts containing a mixture of 
imino-MAAs, albeit the IC50 values of these MAAs were approximately 15 – 30 % that of the 
antioxidant activity of ascorbic acid as measured by DPPH-radical, ferric-reducing antioxidant 
power (FRAP) and superoxide radical scavenging activity (SRSA) assays (253,254). We report 
also that purified shinorine and porphyra-334 showed low antioxidant activity in the DPPH 
radical assay (252) but exhibited significant antioxidant activity using the ORAC assay, which 
is a measure of the oxygen radical absorbance capacity of a test substance.. Previously, only the 
MAA precursor gadusol had been examined using this assay, and its antioxidant capacity was 
found comparable to that of ascorbic acid (249).  Our DPPH assay findings are consistent with 
established data (232), whereas our ORAC assay results reveals that both pophyra-334 and 
shinorine have significant antioxidant capacity by quenching oxygen radicals by hydrogen atom 
transfer, rather than by reductive electron transfer (461).  
Several recent publications describe the immunoregulatory and anti-inflammatory properties of 
mycosporine-glycine, shinorine and porphyra-334 (252,462,463). Suh et al. (252) reported that 
treating the human fibroblast cell line HaCaT with mycosporine-glycine resulted in a 
significant decrease in UV-induced, inflammatory COX-2 mRNA levels, whereas all MAA 
treatments increased expression levels of the UV-suppressed, procollagen C proteinase 
enhancer and elastin genes. Becker et al. (462) found that both shinorine and porphyra-334 
induced nuclear factor NF-ĸB activity in the NF-ĸB/AP-1 reporter myelomonocyte cell line 
THP-1-blue, although NF-ĸB induction was greater with shinorine. Yet, while shinorine 
marginally enhanced LPS-superinduced NF-ĸB activity, porphyra-334 significantly reduced the 
NF-ĸB response in LPS-stimulated cells. Ryu et al. (463) had reported previously that 
porphyra-334, in concentration as low as 10μM, had an inhibitory effect on the expression of 
NF-ĸB dependent inflammatory genes, such as IL-6 and TNF-ĸ, in UVA-irradiated skin 
fibroblasts, but pertinent to this study is finding that porphyra-334 can activate the Nrf2 
signalling pathway in UVA-irradiated cells. However, nuclear Nrf2 translocation by porphyra-
334 without concurrent ROS production by UVA exposure had not been demonstrated, and it is 
thus unknown whether the Nrf2 activating activity of porphyra-334 is a result of direct 
inhibition of Keap1-Nrf2 binding or if porphyra-334 is an electrophile activator of Nrf2 and 
Chapter 4: Porphyra-334 and shinorine are antioxidants and antagonists of Keap1-Nrf2 binding 
Page 115 of 230 
activates cytoprotection by modifying critical cysterine residues of Keap1. Results of our 
ORAC and DPPH assays (Figure 4.6, Figure 4.5) and previously published studies (232) 
suggest that porphyra-334 is an antioxidant, and is thus unlikely to have pro-oxidant activity 
required to oxidise the critical Cys residues of Keap1. The products of MAA metabolism in 
human cells is are, however, currently unknown and it is possible that porphyra-334 is 
metabolised into electrophile activators of Nrf2 in vivo. In addition, while our previous virtual 
screening experiments and in-vitro results presented in this study (Figure 4.5) demonstrate that 
porphyra-334 is a direct inhibitor of Keap1-Nrf2 interaction in vitro, it is currently unknown if 
porphyra-334 also interacts with other Keap1-like proteins such as β-TrCP protein, an indirect 
modulator of Nrf2 activity. Thus, metabolism of MAAs and interaction of MAAs and other β-
propeller proteins are avenues worthy of future research.  
In conclusion, results presented herein lend support to our findings that porphyra-334 and 
shinorine are prospective activators of the cytoprotective Keap1-Nrf2 pathway by Keap1 
receptor antagonism. 
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5 Chapter 5: Proteomics approach to study the UV-
induced oxidative stress in yeast isolated from 
environments with high incidence of solar radiation 
 
5.1 Foreword to Chapter 5 
The phylogenetic studies of Keap1-Nrf2 pathway, presented in chapters 2 and 3, have identified 
sequences encoding the proteins similar to the vertebrate transcription factor Nrf2 in genomes 
of all major animal phyla and certain fungi. The study presented in this chapter used the 
multidimensional protein identification technology to quantify the protein expression level fold 
changes in the UV-tolerant yeast model exposed to long term UV-B irradiation. The yeast 
proteome was examined to identify if the yeast model expresses bZip proteins homologous to 
the animal Nrf2, as was predicted in studies presented in chapters 2 and 3. In addition, the 
quantified yeast proteome was annotated using biological databases to describe the UV-stress 
response of the UV-tolerant yeast isolated from environment exposed to high incidence of solar 
radiation. 
5.2 Introduction 
Ultra violet radiation (UVR) is a major hazard to biological systems and an important 
environmental source of oxidative stress. The UV-B band of UVR (λ = 280-315 nm) inflicts 
direct damage to cellular macromolecules by photo-oxidation of proteins (38) and by inducing 
the formation of DNA photo-adducts (37). In addition, both UV-A (λ = 315 – 400 nm) and UV-
B radiation cause oxidative stress by inducing the production of reactive oxygen species (RS) 
in irradiated cells (39,40). The basic leucine zipper domain (bZip) transcription factor Nrf2 and 
its inhibitor, the kelch-domain protein Keap1, play critical roles in regulation of response to 
oxidative stress in vertebrates (464). In an unstressed cell, Nrf2 is sequestered in the cytosol by 
Keap1, ubiqutinated by the Cullin3-Rbx1 E3 ubiquitin ligase – Keap1 (CRLKeap1) complex and 
proteosomally degraded. During oxidative stress, the increased cellular concentration of RS 
causes the oxidation of critical, “RS sensing”, cysteine residues of Keap1, which leads to 
conformational changes in the CRL
Keap1 
complex and prevents ubiquitination of the Nrf2 
protein (156). The inhibition of the CRL
Keap1
-mediated degradation of Nrf2 results in an 
increase in cytosolic concentration of newly synthesized Nrf2 and its translocation to the 
nucleus (137). The nuclear Nrf2 associates with small Maf proteins, and interacts with the 
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antioxidant response element (ARE) cis-acting enhancer sequences on the DNA to activate the 
transcription of a large number of genes that encode detoxification and antioxidant proteins 
(465,466).  
In addition to playing a major role in resistance to environmental pollutants (183) and 
chemically induced oxidative stress (186), the Nrf2 pathway also regulates response to UV-
induced oxidative stress (467). In a study by Kleszczyński et al, the induction of Nrf2-regulated 
genes by pre-treatment with Nrf2 activators sulforaphane and phenylethyl isothiocyanate was 
shown to protect human skin cells against UV exposure in cell cultures and ex vivo. In this 
study, the pre-treated, UV-exposed, cells had lower rates of apoptosis, reduced levels of 
biomarkers of sunburn, and higher levels of endogenous antioxidants such as catalase, when 
compared to non-treated controls (468). The Nrf2-mediated protection against UV-induced 
oxidative stress was also shown in mouse models, where treatment with sulforaphane-
containing broccoli sprouts significantly reduced the incidence rate of UV-induced skin cancer 
(469). Furthermore, a study with genetically modified mouse models found that mouse models 
lacking a Nrf2-encoding gene recover slowly from the UV-induced inflammation and are 
highly sensitive to photo-ageing (470).  
In the model yeast Saccharomyces cerevisiae, UV irradiation activates the RAS/cAMP/PKA 
signalling pathway independent of DNA damage. This pathway includes the GTPase RAS 
which controls the activity of adenylate cyclase (Cyr1) enzyme which stimulates the production 
of cyclic AMP (cAMP). The increased intracellular concentration of cAMP triggers the 
activation of cAMP-dependant protein kinase A (PKA), and initiates a phosphorylation cascade 
that activates the bZip transcription factor Gcn4 (471). Gcn4 is primarily associated with yeast 
response to starvation and controls the transcription of more than 30 genes that encode enzymes 
involved in biosynthesis of amino acids (472). The study of genetically modified S. cerevisiae 
strains by Engelberg et al (1994), however, found that S. cerevisiae mutants with high, 
constitutive, expression of Gcn4 are ~3.5 fold more resistant to UV irradiation compared to 
wild type yeasts, while the strains deficient in Gcn4-encoding gene are ~5-fold more sensitive 
to UV than wild type yeasts (471). In addition to RAS signalling, the other major UV-response 
pathway in S. cerevisiae is the Yap1-mediated response to UV-induced oxidative stress (473). 
The yeast transcription factor Yap1 is a bZip protein that binds to the AP-1 recognition element 
in the promotor regions of numerous yeast genes involved in the DNA repair and response to 
oxidative stress, such as glutathione biosynthesis enzymes and thioredoxins (474). While Yap1 
signalling is reminiscent of the Nrf2-mediated activation of response to oxidative stress in 
vertebrates, no interaction between kelch-like proteins and Yap1 has been reported as of yet 
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(475). In addition to RAS and Yap1 stress response signalling pathways, yeasts also possess 
DNA damage response pathways. These pathways are largely conserved across all eukaryotes 
and consist of sensors, primary and secondary signal transducers and effectors. The DNA 
damage is detected by “sensor” proteins, such as S. cerevisiae proteins Rad1, Rad9 and Hus1, 
and activates the signal transduction kinases (Mec1 and Tel1 in yeast S. cerevisiae) (476), 
which activate the secondary, downstream kinases such as Dun1 (477). The downstream 
kinases activate the currently unknown effector proteins that increase the transcription rates of 
enzymes involved in DNA repair and also arrest the cell cycle during the DNA repair (476). 
While the baker yeast S. cerevisiae is highly resistant to UV radiation, when compared to 
bacterial models (478), yeasts native to the environments with high incidence of solar radiation 
can tolerate the UV radiation levels lethal to S. cerevisiae. Examples of such yeasts include 
carotenogenic yeasts of the Sporobolomyces and Rhodotorula Genera (478,479), and the black 
yeasts of Genus Exophiala (478). The mechanisms of response to UV-induced stress have not 
been studied in these, UV-tolerant, yeasts, and it is currently not known if the stress response 
signalling, mediated by bZip proteins, is conserved between UV-tolerant yeasts, baker yeast S. 
cerevisiae and the animal Keap1-Nrf2 pathway. The UV-tolerant, Sporobolomyces, yeast 
model was selected as a model organism in this study because of its taxonomical classification 
(Phylum Basidiomycota as opposed to S. cerevisiae which belongs to Phylum Ascomycota), 
and to allow a study of effects of high levels of UV-B in range lethal to the S. cerevisiae. 
The aim of this study was to determine, at the proteome level, stress response mechanisms of 
the UV-tolerant yeast model isolated from the leaves of plants collected from the São Paulo 
region in Brazil, regularly exposed to high incidence of solar radiation (UV index ~13.9) (480). 
The yeast model, identified as Sporobolomyces sp. and designated LEV-2, was exposed to 
long-term UV-B irradiation, and proteomes of LEV-2 cultures exposed to different durations of 
UV-B (5 minutes to 24 hours) were quantified by MudPIT technology. The quantified proteins 
were functionally annotated using gene ontology (GO) terms (481), KEGG modules and KEGG 
pathways (342,482) to identify proteins involved in stress response and bZip transcription 
factors. In addition, the fold changes of proteins involved in stress response were examined to 
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5.3 Methodology 
5.3.1 Isolation of UV-tolerant yeasts from environmental samples 
Seven leaf samples were collected from the city campus of the University of São Paulo, from 
the following plants: Goaiba (Psidium guajava), Jacarandá (Jacaranda cuspidifolia), Ipê 
Amarelo (Tecoma serratifolia), Quaresmeira (Tibouchina granulosa), Mangueira (Mangifera 
indica), Tipuana (Tipuana tipu) and Jamelão (Syzgium cumini). The leaves were collected from 
the plants exposed to mid-day sun during summer (mid. January, predicted UV index ~13.9 
(480)). Collected leaves were cut into 0.5 x 0.5 cm pieces, and each piece was placed onto the 
surface of a Petri dish containing half-strength yeast-peptone-dextrose (YPD) solid media with 
antibiotics, composed of yeast extract (5 g/L), dextrose (10 g/L), peptone (10 g/L), agar (6 g/L) 
and antibiotics (100 mg/L chlortetracycline, 20 mg/L chloramphenicol and 20 mg/L 
streptomycin-sulphate, added into the media after the sterilization). 
The surfaces of Petri dishes were irradiated for 1 minute, using dual Philips Ultraviolet-B TL 
20W/12RS lamps, with UVR output of UV-B: 4 J/m
2
/s and UV-A: 1.75 J/m
2
/s. The UVR 
output of lamps was measured at 10 cm distance from the lamps, using a Bentham (double 
grating) DM150BC spectroradiometer with 2 400 g/mm grating blazed at 250 nm, IS4C 
integration sphere diffuser, DH3 (bi) photomultiplier and large aperture. Results of spectral 
analysis of UV lamps are presented in Appendix C-1. Samples were irradiated in open petri 
dishes, at a distance of 10 cm from the lamps. 
Irradiated samples were incubated for 24 hours at 25 °C, and yeast colonies (if any) were 
transplanted into sterile petri dishes containing half-strength YPD media with antibiotics. The 
process was repeated daily for 7 days, and yeast colonies were transplanted as necessary to 
isolate pure strains. The strains were considered pure if a single, distinct, colony could be 
isolated. The isolated microorganisms identified as yeasts (based on morphology and resistance 
to antibiotics) were retained for further analysis.  
5.3.2 UV-tolerance testing of yeast isolates 
The isolated yeast samples, the baker yeast Saccharomyces cerevisiae, and five UV-tolerant 
yeasts  previously isolated and identified by Casteliani et al. (479), designated LEV-2, LEV-9, 
LEV-12, LEV-13 and LEV-16, were tested for survival after exposure to long term UV-B 
irradiation. The LEV yeast isolates were kindly provided by Prof Itamar Soares (Laboratory of 
Environmental Microbiology, Embrapa Environment, Jaguariúna, SP, Brazil). The yeasts were 
cultivated in sterile half-strength YPD liquid medium, composed of yeast extract (5 g/L), 
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dextrose (10 g/L) and peptone (10 g/L), in cotton-plugged 250 mL Erlenmayer flasks, at 27 °C 
with shaking (100 rpm). Three replicates were grown for each sample. After 24 hours of 
growth, optical density at 600 nm (OD600) of each sample was standardized to OD600 = 1.0 (~3 
x 10
7
 cells / mL), by diluting the sample with sterile half-strength YPD liquid medium as 
necessary, and 25 mL aliquot of each yeast culture was taken for UV-tolerance testing. The 
yeast samples were irradiated by dual Philips Ultraviolet-B TL 20W/12RS lamps as follows: 
 Sample 1 (Control) was not exposed to UV 
 Sample 2 (1h) was irradiated for 1 hour 
 Sample 3 (2h) was irradiated for 2 hours 
 Sample 4 (4h) was irradiated for 4 hours 
 Sample 5 (8h) was irradiated for 8 hours 
 Sample 6 (24h) was irradiated for 24 hours 
Irradiation was performed at room temperature and temperature changes during the irradiation 
were assumed to be moderate and not critical for the outcome of experiment. During the 
irradiation, each sample was standardized to volume of 25 mL by adding sterile half-strength 
YPD media to account for any evaporation during the irradiation. The irradiated samples were 
vortex agitated for 30 seconds, and 1 mL aliquots were used to prepare three technical 
replicates of ten-fold serial dilutions. The 0.1 mL of the sample diluted 1:1000, containing ~3.0 
x 10
3 
cells, was used to inoculate half-strength YPD solid agar. Inoculated petri dishes were 
incubated at room temperature, and yeast colonies were counted after 48 hours. Survival curves 
were constructed from the mean values of the replicates, and the survival rates were calculated 
as SR (%) = 100 x [CFU (irradiated sample) / CFU (control sample)]. 
5.3.3 Preparation of UV-tolerant yeast isolate for proteomics 
The yeast culture was cultivated in half-strength YPD media for 24 hours. After 24 hours, cell 
numbers were estimated at OD600 and samples diluted to OD600 = 1.0, equivalent to 
approximately 3 x 10
7
 cells/mL. Measurements were performed using a UV/VIS 
spectrophotometer (model 7315, Jenway Ltd., Stone, Staffordshire, UK).  
Yeast culture was then divided into 20 x 25 mL aliquots (Sample 1 – Sample 10, in duplicate). 
The samples, in open petri dishes, were irradiated under dual Philips Ultraviolet-B TL 
20W/12RS lamps (UVR output of UV-B: 4 J/m
2
/s and UV-A: 1.75 J/m
2
/s) at a distance of 10 
cm from the lamps. The samples were stirred manually every 20 minutes during irradiation.  
Yeast samples were irradiated as follows: 
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 Sample 1 (Control) was not exposed to UV 
 Sample 2 (5’) was irradiated for 5 minutes 
 Sample 3 (10’) was irradiated for 10 minutes 
 Sample 4 (15’) was irradiated for 15 minutes 
 Sample 5 (1h) was irradiated for 1 hour 
 Sample 6 (2h) was irradiated for 2 hours 
 Sample 7 (4h) was irradiated for 4 hours 
 Sample 8 (8h) was irradiated for 8 hours 
 Sample 9 (24h) was irradiated for 24 hours 
 Sample 10 (Control 2) was not exposed to UV and was kept on the lab bench (artificial 
light, room temperature, no stirring) for 24 hours 
During the irradiation, each sample was standardised to volume of 25 mL by adding sterile 
half-strength YPD medium to account for any evaporation. Samples were vortex agitated for 30 
seconds, and three 1 mL aliquots were taken for DPPH antioxidant assay. The yeast cells in the 
remaining culture (22 mL) were collected by centrifugation at 1 000 x g for 15 minutes at room 
temperature. The supernatant was discarded and the cells transferred to 1.5 mL microcentrifuge 
tubes. To remove any residual liquid medium, pellets were re-suspended in phosphate-buffered 
saline (PBS) buffer and the cells collected by centrifugation at 12 300 x g for 15 minutes at 
room temperature. This procedure was repeated twice. Pellets were flash frozen by immersion 
into liquid nitrogen and stored at -80 °C until the proteomics analysis; frozen samples were 
transported on dry ice.  
 
5.3.4 DPPH assay of extracts of isolated yeast cultures 
Yeast cells were collected by centrifugation (5 minutes, 15 000 x g, room temperature) and re-
suspended in 1 mL of cell lysis buffer composed of 50 mM tris–buffered saline (TBS) pH 7.6, 
mixed with 0.1 % (w/v) Triton X (Sigma Aldrich). The cells were disrupted with a sonicator 
probe (Model: VC250, Sonics & Materials Inc.), using a duty cycle of 40 % and an output of 3. 
Samples were kept on ice, and sonication was performed in 10 x 1-minute cycles, with 1 
minute pause between the cycles. Cell lysis was confirmed by examination of the sample using 
a light microscope at magnification x400. The cell debris was removed by centrifugation (5 
minutes, 15 000 x g, room temperature), and the supernatant was tested for free radical 
quenching antioxidant activity using the DPPH assay. 
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The antioxidant activity of extracts of UV-irradiated yeast samples and controls was measured 
using the colorimetric assay based on the neutralization of stable free radical 2,2-diphenyl-1-
picrylhydrazyl (DPPH) (454). Briefly, 0.1 mL of each sample was mixed with 1.5 mL of 70 μM 
DPPH dissolved in methanol. The samples were shielded from light by aluminium foil and 
incubated for 30 minutes at room temperature, and the colour change from violet to yellow, 
when DPPH is reduced upon reaction with an antioxidant, was recorded at 515 nm using a 
UV/VIS spectrophotometer (model 7315, Jenway Ltd., Stone, Staffordshire, UK). A mixture of 
half-strength YPD medium (0.1 mL) and DPPH (1.5 mL) served as a control, and a mixture of 
methanol (0.1 mL) and DPPH (1.5 mL) served as the reaction blank. The percentage of DPPH 
radical scavenging activity was calculated as: Scavenging activity (%) = 100 x (Ablank - 
Asample )/Ablank. Experiments were performed in technical triplicates with three replicates, and 
scavenging activities were plotted as the mean of the 9 triplicate/replicate values against 
compound concentration.  
5.3.5 Mass spectrometry analysis 
The protein composition of the yeast samples was identified using Multidimensional Protein 
Identification Technology (MudPIT), with Tandem Mass Tags (TMT) used for relative 
quantification of labelled peptides, as follows:  
Ten frozen yeast cell pellets (Sample 1 – 10, in duplicate) were processed for proteomics 
analysis. Cell pellets were homogenised in 100 µL of ice-cold lysis buffer using a micro-pestle. 
The lysis buffer consisted of 100 mM Tris(hydroxymethyl)aminomethane hydrochloride (pH 
7.5), 300 mM NaCl, 2 % (v/v) Triton X-100, 1 % (w/v) sodium deoxycholate, 200 mM NaOH, 
2 % (w/w) SDS, 2 % (v/v) -mercaptoethanol, 2 x Complete Protease Inhibitor Cocktail 
(Roche) and 2 x Complete Phosphatase Inhibitor Cocktail (Roche). The cell pellets were 
homogenised for 30 seconds and placed on ice for 1 minute.  The procedure was repeated four 
more times. Cell debris was pelleted by centrifugation (14 000 x g, 14 minutes, 4 °C)
 
and the 
supernatants containing solubilised proteins were transferred to fresh 1.5 mL tubes and kept on 
ice.  
For each yeast sample, the solubilised proteins were transferred into a fresh 2 mL 
microcentrifuge tube for protein precipitation. The solubilised proteins were combined with 
800 µL of methanol, vortex agitated for 30 seconds and centrifuged at 14 000 x g for 1 minute 
at room temperature. Sample was mixed with 200 µL of chloroform, vortex agitated for 30 
seconds, and centrifuged at 14 000 g for 1 minute at room temperature. 600 µL of deionised 
water was added to the mixture, and the mixture was vortex agitated for 30 seconds and 
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centrifuged at 14 000 x g for 10 minutes at room temperature. The upper aqueous phase of the 
sample was discarded, 800 µL of methanol were added to the remainder of the sample, and the 
precipitated proteins were collected by centrifugation at 14 000 x g for 5 minutes at room 
temperature. The supernatant was discarded and the pellet consisting of precipitated proteins 
was dried in Savant SpeedVac Concentrator (Thermo Fisher Scientific) for 1 minute, at room 
temperature. Precipitated proteins were solubilised in 150 µL of buffer composed of 100 mM 
Triethylammonium bicarbonate (TEAB) and 10 mM of Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) (Sigma).  Protein pellets were dissolved by 10 minutes of vortex 
agitation at room temperature. A 10 µL aliquot was taken for protein concentration 
determination by Bradford assay (Bio-Rad) using bovine serum albumin (Sigma) as a standard, 
and the remaining sample was incubated in the buffer (composed of 100 mM TEAB and 10 
mM TCEP) for 1 hour at 55 °C to reduce protein disulphide bonds. For each yeast sample, a 
volume containing 30 µg of proteins (as calculated from Bradford assay) was transferred to a 
1.5 mL tube and adjusted to 100 µL with buffer containing 100 mM TEAB and 10 mM TCEP 
(Sigma). Samples were alkylated by addition of 10 µL of buffer containing 100 mM TEAB, 10 
mM TCEP and 198 mM iodoacetamide (Sigma), and incubated for 30 minutes at room 
temperature. The incubating samples were protected from light by aluminium foil.  Proteins 
were digested by adding 10 µL of trypsin (Promega) solution (60 ng/µL) in 100 mM TEAB and 
incubating overnight at 37 °C, protected from light by aluminium foil. 
Tandem Mass Tag (TMT) 10-plex reagents (Thermo Fisher Scientific TMT 10-plex kit, 
https://www.thermofisher.com/order/catalog/product/90110) were reconstituted according to 
the manufacturer’s instructions, by adding 41 µL of acetonitrile (ACN) to 0.8 mg of each TMT 
label.  The appropriate reconstituted label was added to the protein digests of yeast samples as 
follows: 
Sample TMT Label Reagent Sample TMT Label Reagent 
1 (Control) 126 6 (2 hours of UV) 129N 
2 (5 min of UV) 127N 7 (4 hours of UV) 129C 
3 (10 min of UV) 127C 8 (8 hours of UV) 130N 
4 (15 min of UV) 128N 9 (24 hours of UV) 130C 
5 (1 hour of UV) 128C  10 (Control) 131 
 
Samples were vortex agitated for 30 seconds and incubated at room temperature for one hour.  
The labelling reactions were quenched by the addition of 9 µL of 5 % (v/v) hydroxylamine 
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(Sigma) and incubated for 15 minutes.  The 10 samples were combined in equal amounts of 10 
µL. Excess labelling reagent was removed by solid phase extraction using a 1 mL Oasis HLB 
cartridge (Waters) as follows: The sample was prepared for purification in 4 % (v/v) ACN and 
0.1 % (v/v) trifluoroacetic acid (TFA). A vacuum manifold was used to apply buffers and 
sample to the solid phase extraction cartridge at a rate 1 mL/minute. The solid phase extraction 
cartridge was conditioned with 2 x 1 mL of conditioning buffer consisting of 95 % (v/v) ACN 
and 0.1 % (v/v) TFA in deionised water. Conditioned cartridge was washed twice with 1 mL of 
wash buffer composed of 5 % (v/v) ACN and 0.1 % (v/v) TFA in deionised water.  The sample 
was applied to the cartridge; the flow-through was collected and re-applied to the cartridge. 
Unbound contaminants were washed through with 5 x 1 mL of wash buffer, composed of 5 % 
(v/v) ACN and 0.1 % (v/v) TFA in deionised water, and the bound labelled peptides were 
eluted with 3 x 1 mL of elution buffer, composed of 85 % (v/v) ACN and 0.1 % (v/v) TFA in 
deionised water. The eluted labelled peptides were lyophilised in a SpeedVac (2 hours at room 
temperature). 
The TMT labelled samples 1 - 10, containing lyophilised peptides labelled with TMT reagents, 
were reconstituted in 1.8 mL OFFGEL buffer consisting of 9.6 % (v/v) glycerol and 0.96 % 
(v/v) ampholytes in the form of IPG buffer pH 3-10 (GE Healthcare Life Sciences) in deionised 
water. The peptides of were solubilised using a sonic water bath for 10 seconds, followed by 30 
minutes of vortex agitation at room temperature, and the insoluble material was removed by 15 
minutes of centrifugation at 14 000 x g, at room temperature. The supernatant was applied to an 
isoelectric focusing (IEF) strip pH 3-10 (GE Healthcare Life Sciences) according to the 
manufacturer’s instructions, and the labelled peptides were separated into 12 fractions and 
collected by an Agilent 3100 OFFGEL Fractionator. Isoelectric focusing was performed at 20 
°C
 
for a total of 20 kVh at a constant current of 50 µA. Once completed, the fractionation was 
held at 500 V until fraction collection. The fractions were collected in 1.5 mL tubes and 
acidified by the addition of TFA (final acid concentration of 0.1 % (v/v)). For each fraction, the 
salts, TFA and gel debris were removed by solid phase extraction using the procedure described 
above, with the exception that the fractionated peptides were eluted in 1 mL of buffer 
composed of 85 % (v/v) ACN and 0.1 % (v/v) formic acid in deionised water. Eluted peptides 
were lyophilised in a SpeedVac (2 hours at room temperature). 
The peptides were solubilised in 50 mM ammonium bicarbonate for separation of the peptide 
mixture by liquid chromatography and analysis by tandem mass spectrometry.  A portion of 
each fraction was analysed sequentially from fraction 1 (pH 3) to fraction 12 (pH 10).  
Chromatographic separations were performed using the Ultra-High Performance Liquid 
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Chromatography (UHPLC) system EASY-nLC II (Thermo Fisher Scientific). The peptides 
were separated using a reverse phase chromatography column 100 mm EASY-Column, with an 
internal diameter of 75 µm packed with a stationary phase of C18, 3 µm particles, and 120 Å 
porosity (Thermo Scientific). Peptides were eluted using a gradient of ACN (5 % to 40 % over 
100 minutes, increased to 80 % over 10 minutes and held at 80 % for 5 minutes) and 0.1 % 
(v/v) formic acid. The flow rate of solvent was 300 nL / minute. 
Mass spectra were acquired in the LTQ Orbitrap Velos Pro (Thermo Fisher Scientific) operated 
by Xcalibur
TM
 software. The instrument was set to record the mass spectra ranging from 350 to 
1800 m/z, at a resolution of 30,000. The 10 most intense precursor ions were subjected to 
sequencing by high-energy collision induced dissociation (CID) in the ion trap with a threshold 
of 5000 counts. The precursor ion selection isolation width was 2 units, and the normalised CID 
energy for precursor ion fragmentation was 35. Automatic gain control settings for FTMS 
survey scans were 105 counts and FT-MS/MS scans were 103 counts. Maximum acquisition 
time was 500 ms for survey scans and 250 ms for MS/MS scans. Charge-unassigned and 
single-charge state ions were excluded from the MS/MS analysis. 
5.3.6 Data analysis: database searching 
A database for spectra matching was constructed from the following sources:  
 UniProt (www.uniprot.org) yeast protein sequences for Sporidiobolus salmonicolor and 
Rhodosporidium toruloides. 
 Rhotordula minuta proteome (designation Rhomi1) acquired from The Fungal 
Genomics Resource (http://genome.jgi.doe.gov/programs/fungi/index.jsf). 
 Sporobolomyces linderae CBS 7893 proteome (designation Spoli1) acquired from The 
Fungal Genomics Resource (http://genome.jgi.doe.gov/programs/fungi/index.jsf). 
 Sporobolomyces roseus proteome (designation Sporo1) acquired from The Fungal 
Genomics Resource (http://genome.jgi.doe.gov/programs/fungi/index.jsf). 
 Fungal basic leucine zipper sequences assembled using the BLASTp (483) search of 
the NCBI non-redundant (NR) database (340). 
 Fungal proteins involved in biosynthesis of Mycosporine-like amino acids, assembled 
using the BLASTp (483) search of the NCBI non-redundant (NR) database (340). 
Due to limitations of Mascot software, which does not support merging of databases that utilize 
different formats of protein sequence identifiers (such as UniProt and GenBank), each dataset 
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was processed independently and the results were merged after the database matching of 
tandem mass spectra.  
Database matching of MS/MS spectra was performed using the Mascot software, version 2.2.03 
(Matrix Science). Databases were installed in Mascot; Xcalibur raw files were processed into 
peak lists with Proteome Discoverer 1.4 (Thermo Fisher Scientific). The Proteome Discoverer 
Daemon was used to process the raw files with multidimensional protein identification 
technology (MudPIT) specifying up to 3 missed cleavages, a precursor ion mass tolerance of 20 
ppm and a fragment ion tolerance of 0.8 Da. A variable/dynamic modification for oxidised 
methionine was set. Fixed/static modifications for carbamidomethylated cysteine and TMT-
tagged lysine and N-termini were set. A target false discovery rate (FDR) for high confidence 
peptide hits was set to 0.01 (1 %) and a target FDR for medium confidence peptide hits was set 
to 0.05 (5 %). An independent search was conducted to assess labelling efficiency, by 
specifying all modifications as variable/dynamic. For all high and medium confidence peptides, 
98 % were modified by TMT, 95 % of these were N-terminally labelled, and 96 % of lysines 
were modified by TMT labels. 
5.3.7 Data analysis: quantification and result pre-processing 
Detected proteins were grouped under the strict maximum parsimony principle. All detected 
peptides with a TMT modification of N-terminus were used to determine a normalisation factor 
for each label. All available reporter ion intensities were summed for each individual label, and 
the median of the summed intensities was determined for the ten labels. The normalisation 
factor for each label was obtained by expressing the median intensity over the sum of 
intensities, and applied to the raw reporter ion intensities for each respective label. Peptides for 
which all reported TMT reporter ions were detected and quantified were retained for further 
analysis. For each protein with multiple quantified peptide hits, the protein signal intensity was 
calculated as the mean value of TMT reporter ion intensities of peptides matched to the protein. 
The expression fold-changes of samples were calculated relative to Sample 1 (non-irradiated 
control). 
All quantified proteins were annotated using InterProScan software (484) to predict the likely 
biological functions based on Gene Ontology (GO) terms (481) and Pfam profiles (485). 
Protein sequences were also annotated by BlastKOALA software (482) to assign KEGG 
pathways and KEGG modules (342). The results of computational annotation were manually 
curated by examining the primary literature and the information deposited in UniProt and NCBI 
protein databases. Proteins for which computational annotation was not successful, or resulted 
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in prediction of “predicted protein” or “unknown protein”, were manually annotated by 
examining the results of BLASTp searches of UniProt and NCBI SwissProt databases, with E-
value cut-off 0.001, and the function was assigned to the protein based on the related proteins if 
possible. Computational annotations and visualisation of results were conducted using in-house 
R scripts and python scripts.  
5.3.7.1 Statistical analysis of annotated proteins with increased fold changes after 
UV-B exposure of yeast cells 
Statistical analysis used the Fisher’s exact test (486) to determine the GO terms over-
represented (more frequent then would be expected based on the random distribution) in the 
dataset of proteins with significant (2-fold or greater) fold change in at least one UV-exposed 
sample. The test was conducted using the following procedure: 
1) Quantified proteins were separated into sensitive dataset (Ds) and control dataset (Dc). 
Proteins were included into Ds if protein fold changes in at least one UV-exposed yeast 
sample were 2.0 or higher. The remaining proteins were included into Dc. 
2) For each GO term (tested GO term) from the list of all GO terms assigned to quantified 
proteins, the number of proteins was determined for: 
a) Proteins in Ds annotated with the tested GO term (nsGO) 
b) Proteins in Dc annotated with the tested GO term (ncGO) 
c) Proteins in Ds annotated with other GO terms (nsO) 
d) Proteins in Dc annotated with other GO terms (ncO) 
3) One sided Fisher’s exact test for over-representation of tested GO term in the Ds was 
performed on the following frequency distribution table: 
 Tested GO  Other GO 
Proteins in Ds nsGO  nsO 
Proteins in Dc ncGO  ncO 
The null hypothesis (H0) of the test was that the tested GO term is equally frequent amongst the 
proteins in dataset Dc and amongst the proteins in dataset Ds, while the alternative hypothesis 
(HA) was that the tested GO is over-represented amongst the proteins from Ds. The tested GO 
term was considered significantly over-represented for Fisher’s exact test p-value <= 0.05. To 
assess the robustness of this approach, equivalent Fisher’s exact tests were also performed 
where proteins were included into Ds dataset if the protein fold-changes were 1.5 or higher, and 
if the fold-changes were 4.0 or higher. In the results presented, the GO terms were considered 
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significantly over-represented if p-values of at least 2 out of these 3 tests were below the 0.05 
threshold, or if p-value was below 0.05 in the fold-change >= 4.0 test.   
Statistical analysis of over-representation of KEGG Pathways and KEGG Modules was 
performed using the methodology for statistical analysis of GO terms (described previously), 
with the exception that the GO terms were replaced with the KEGG Pathway terms or with the 
KEGG Modules during the step 2) of the statistical analysis. 
5.3.7.2 Statistical analysis of annotated proteins with fold change reduction after 
UV-B exposure of yeast cells 
The statistical analysis was conducted to determine the GO terms, KEGG pathways and KEGG 
modules significantly over-represented in the dataset of proteins showing a fold change 
reduction in UV-B exposed yeast cultures. This analysis was conducted using the methodology 
described in 5.3.7.1, with the exception that the proteins were included into the sensitive 
dataset (Ds) if the proteins showed the fold change reduction of 2.0 or higher in at least one 
UV-exposed yeast culture.  
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5.4 Results 
5.4.1 Isolation of UV-tolerant yeast samples 
Twelve yeasts isolated from the leaves of various Brazilian plants (designated Y1 to Y12), five 
yeast samples previously isolated by Casteliani et al. (LEV-2, LEV-9, LEV-12, LEV-13 and 
LEV-16) (479), and the baker yeast Saccharomyces cerevisiae were tested for viability after the 
exposure to UV-B irradiation. The baker yeast was used as a control based on the study by 
Pulschen et al. (2015), who used it as UV-sensitive yeast control to evaluate the viability of 
UV-resistant yeasts from high-altitude extreme environments (478).  
The survival rates of yeasts Y1 – Y12 exposed to UV-B irradiation are listed in Table 5.1. The 
UV-tolerance of these yeasts was no higher than the baker yeast S. cerevisiae control, and these 
isolates were not considered for further study. 
Table 5.1 Survival rates of UV-B irradiated yeast isolates Y1 – Y12 
Table lists the survival rates of yeast isolates Y1 to Y12, and the baker yeast S. cerevisiae (By) 
exposed to long-term UV-B radiation. The survival rates were determined as ratios of colony forming 
units (CFUs) of UV-irradiated yeast samples to CFUs of non-irradiated controls. Colonies were 
counted after 48 hours of yeast growth. The numbers listed are the mean values of three technical 
triplicates; errors are expressed as one standard deviation of the mean.  
Yeast sample Survival rate after the exposure to:  
1 hour of UV-B             8 hours of UV-B           24 hours of UV-B 
Y1 40 % ± 4 % 16 % ± 5 % 0 % 
Y2 25 % ± 6 % 10 % ± 1 % 2 ± 1 % 
Y3 17 % ± 2 % 0 % 0 % 
Y4 37 % ± 3 % 16 % ± 8 % 0 % 
Y5 28 % ± 3 % 13 % ± 4 % 0 % 
Y6 29 % ± 8 % 15 % ± 6 % 0 % 
Y7 22 % ± 2 % 1 % ± 1 % 0 % 
Y8 10 % ± 3 % 8 % ± 4 % 0 % 
Y9 17 % ± 6 % 0 % 0 % 
Y10 24 % ± 3 % 2 % ± 2 % 0 % 
Y11 35 % ± 3 % 10 % ± 3 % 0 % 
Y12 22 % ± 11 % 0 % 0 % 
By 27 % ± 4 % 13 % ± 5 % 0 % 
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The survival curves of yeast samples LEV-2, LEV-9, LEV-12, LEV-13 and LEV-16 are 
presented in Figure 5.1. UV-B exposure for 24 hours was lethal to the baker yeast S. cerevisiae, 
while the yeasts LEV-12 and LEV-16 showed survival rates below 10 %. The isolates LEV-2, 
LEV-9 and LEV-13 showed survival rates above 60 %. The isolate LEV-2 had the highest rate 
of survival amongst the tested yeasts with a survival rate of ~80 % after 8 hours of UV-B 
exposure and ~75 % after 24 hours of UV-B exposure. 
 
Figure 5.1  Survival rate of LEV yeast isolates upon exposure to UV-B 
The figure displays the survival rates of UV-B exposed yeast isolates (LEV-2, LEV-9, LEV-12, LEV-
13 and LEV-16) and baker yeast S. cerevisiae (By), colour coded as indicated on the chart. The 
survival rates were determined as ratios of CFUs of UV-irradiated yeast samples to CFUs of non-
irradiated controls. Colonies were counted after 48 hours of yeast growth. Points represent mean 
values of three technical replicates, and error bars indicate one standard deviation of the mean. 
The yeasts LEV-2, LEV-13 and LEV-9, which showed the high rate of survival after 24 hour 
exposure to UV-B, were next evaluated for antioxidant activity. The extracts of these yeasts, 
prepared by cell lysis and removal of insoluble material, were tested using the colorimetric 
assay based on the quenching of 2,2-diphenyl-1-picrylhydrazyl (DPPH), stable free radical 
(Figure 5.2). Extracts of all three tested yeasts showed an increase in DPPH quenching activity 
after 24 hours of UV-B irradiation. The increase in antioxidant activity was moderate (~25 % 
increase) for samples LEV-9 and LEV-13, while the extract of yeast LEV-2 showed ~75 % 
increase in antioxidant activity after 24 hours of UV-B irradiation. The yeast LEV-2 also 
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Figure 5.2 DPPH quenching activity of LEV yeast isolates exposed to UV-B 
The figure displays the DPPH free radical quenching activity of extracts of yeast isolates LEV-2 (A), 
LEV-9 (B) and LEV-13 (C). Yeast cultures were irradiated for time periods ranging from 5 minutes 
(sample T.5) to 24 hours (sample T.24), using dual Philips Ultraviolet-B TL 20W/12RS lamps, and 
yeast extracts were obtained by cell lysis and removal of insoluble material. The controls were half-
strength YPD medium (sample M), non-irradiated yeast cultures (sample T.0), and non-irradiated 
yeast cultures grown for 24 hours (sample T.24.C). Error bars indicate 1 standard deviation of the 
mean, calculated from the three experiments; DPPH quenching values of three technical triplicates 

















































































C) Yeast sample LEV-13 
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The extract of yeast LEV-2, previously identified as Sporobolomyces sp. (479), was chosen as 
the model organism for further study because of its high tolerance to UV-B (Figure 5.1) and the 
observed induction of DPPH free radical quenching activity (Figure 5.2). To assess if this yeast 
adapts to UV-induced stress during the UV-B exposure, the rate of yeast cell death was 
calculated for different time periods of UV-B exposure. The results presented in Figure 5.3 
indicate that the initial two hours of UV-B exposure cause moderate loss of viability in yeast 
LEV-2 (~9% during first hour, followed by ~6% reduction in viability in remaining yeasts in 
second hour), but the rate of cell death diminishes over the following time periods, and the cell 
death rate of LEV-2 yeast culture is ~0.6% of viable colony forming units per hour after 8 
hours of UV-B exposure. 
 
Figure 5.3 Death rate of yeast LEV-2 exposed to UV-B radiation 
Figure displays the rate of cell death of LEV-2 yeast irradiated using dual Philips Ultraviolet-B TL 
20W/12RS lamps for each of listed time periods. The cell death rate values are denoted above bars, 
and are expressed as percentage reduction in number of viable colony forming units per hour of UV-
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5.4.2 MudPIT analysis of UV-tolerant yeast LEV-2 
The Sporobolomyces yeast LEV-2 was grown in liquid medium and exposed to increasing 
duration of UV radiation. The irradiation was performed for time intervals ranging from 5 
minutes to 24 hours, with UV output of 4 J/m
2
/s UV-B and 1.75 J/m
2
/s UV-A. The solubilised 
proteins were extracted from UV-irradiated samples and non-irradiated controls, labelled by 
TMT chemical tags, and quantified by multidimensional protein identification technology 
(MudPIT). The analysis identified 751 proteins for which fold changes could be determined 
(Appendix C-2). Based on the previously published proteomics studies (487–489), protein 
expression fold changes of 2 or higher were considered significant. 
227 proteins (~30% of quantified proteins) showed a significant fold change increase (2 or 
higher) in irradiated yeast LEV-2 cultures (Figure 5.4/A). The median value of fold changes of 
these 227 proteins was ~1 for LEV-2 controls, and for samples exposed to UV-B for up to 4 
hours; ~1.5 for LEV-2 exposed to 8 hours of UV-B; and ~2.5 for LEV-2 exposed to 24 hours of 
UV-B. 279 proteins (~37% of quantified proteins) showed significant fold change decrease in 
UV-irradiated yeast cultures (Figure 5.4/B). For these 279 proteins, the median fold change 
value was ~1.0 for non-irradiated control and for LEV-2 exposed to 5, 10 and 15 minutes of 
UV, ~0.6 for LEV-2 culture irradiated for 1 hour or 8 hours, ~0.4 for LEV-2 exposed to 2 hours 
or 4 hours of UV, and ~0.8 for yeast culture irradiated for 24 hours and for non-irradiated yeast 
culture grown for 24 hours.  
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Figure 5.4 Expression profiles of proteins exhibiting a significant fold change 
The figure (A) displays the median values of fold changes for 227 yeast LEV-2 proteins that 
exhibited 2-fold or higher increase in expression in at least one UV-irradiated sample, relative to the 
non-irradiated control. The figure (B) shows the median values of expression fold changes for 279 
yeast LEV-2 proteins that exhibited significant (2-fold) or higher decrease in fold change in at least 
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B) Fold changes of LEV-2 proteins exhibiting  a significant 
decrease in fold change in UV-irradiated samples 
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5.4.3 Functional annotation of yeast LEV-2 proteome 
The 752 yeast LEV-2 proteins, quantified by MudPIT analysis, were annotated for predicted 
biological function using the InterProScan (484) tool to assign Gene Ontology (GO) terms 
(481) to the proteins. In addition, KEGG tools (482) were used to assign the predictions of 
biochemical pathways (KEGG pathways) and biological functions (KEGG Modules) to the 
quantified proteins. Statistical analysis based on Fisher’s exact test (486), described in section 
5.3.7.1, was performed to identify GO terms, KEGG modules and KEGG pathways over-
represented amongst the proteins showing fold change increases and fold change reductions in 
LEV-2 cultures exposed to UV-B radiation. 
For the dataset of 227 proteins exhibiting a fold change increase in LEV-2 isolate exposed to 
UV-B, the over-represented GO terms (Table 5.2/A) included GOs related to cellular transport 
systems, ribosome biogenesis, stress response, cellular signalling and cellular respiration. The 
annotations based on the KEGG pathways (Table 5.3/A) and KEGG modules (Table 5.4/A) 
also indicated that the functions and pathways related to stress response, cellular signalling and 
cellular respiration are over-represented in this dataset. In addition, the over-represented KEGG 
pathways also included pathways involved in metabolism of arginine, histidine and mannose. 
279 LEV-2 proteins exhibited a fold change reduction in UV-exposed yeast cultures. The GO 
terms over-represented amongst these proteins (Table 5.2/B) included GO terms related to 
protein biosynthesis, protein folding and degradation, ATP binding and synthesis, pentose-
phosphate pathway, biosynthesis of nucleotides and metabolism of certain amino acids such as 
glycine and serine. The annotation by KEGG pathways (Table 5.3/B) and KEGG modules 
(Table 5.4/B) identified that the pathways involved in carbohydrate metabolism and 
ribonucleotide biosynthesis are over-represented in this dataset. 
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Table 5.2 GO terms over-represented in datasets of LEV-2 proteins showing a significant fold 
in UV-B exposed yeast cultures 
The column A lists GO terms over-represented in a dataset of proteins exhibiting a significant fold 
change increase in UV-B exposed yeast LEV-2 samples, while the column B lists GO terms over-
represented amongst proteins showing a significant fold change reduction. Terms marked by a star 
(*) were over-represented in a dataset of proteins with expression fold change of 4.0. The GO terms 
were considered over-represented if Fisher’s exact test resulted in p-value below 0.05, when 
frequencies of terms were compared between all proteins and proteins with fold-changes 2.0 or 
higher. 
A) GO terms over-represented amongst proteins 
with fold change increase in UV-B exposed samples 
B) GO terms over-represented amongst proteins 
with fold change decrease in UV-B exposed samples 
ATP phosphoribosyltransferase activity (GO:0003879) 3-deoxy-7-phosphoheptulonate synthase activity 
(GO:0003849)* 
Cytochrome-c oxidase activity (GO:0004129) ATP binding (GO:0005524) 
Histidine biosynthetic process (GO:0000105)* ATP-dependent peptidase activity (GO:0004176) 
Intracellular (GO:0005622) Cytidylate kinase activity (GO:0004127) 
Mitochondrial inner membrane (GO:0005743) Cytoplasm (GO:0005737) 
Polyamine biosynthetic process (GO:0006596) De novo pyrimidine nucleobase biosynthetic process 
(GO:0006207)* 
Response to stress (GO:0006950) FK506 binding (GO:0005528)* 
Ribosome (GO:0005840) Glycine hydroxymethyltransferase activity (GO:0004372)* 
Small GTPase mediated signal transduction (GO:0007264) Glycine metabolic process (GO:0006544)* 
Structural constituent of ribosome (GO:0003735) Heme binding (GO:0020037) 
Translation (GO:0006412) Histone peptidyl-prolyl isomerization (GO:0000412)* 
Translational elongation (GO:0006414) L-serine metabolic process (GO:0006563)* 
Transmembrane transport (GO:0055085) Misfolded or incompletely synthesized protein catabolic 
process (GO:0006515) 
Transport (GO:0006810)* Nucleobase-containing compound kinase activity 
(GO:0019205) 
Transporter activity (GO:0005215) Nucleobase-containing compound metabolic process 
(GO:0006139) 
Unfolded protein binding (GO:0051082)* Pentose-phosphate shunt (GO:0006098) 
 Peptidyl-proline modification (GO:0018208)* 
 Protein binding (GO:0005515)* 
 Proteolysis (GO:0006508)* 
 Protein folding (GO:0006457) 
 Protein refolding (GO:0042026) 
 Pyrimidine nucleotide biosynthetic process (GO:0006221) 
 Serine-type endopeptidase activity (GO:0004252) 
 Transferase activity (GO:0016740)* 
 Translation initiation factor activity (GO:0003743) 
 Translational initiation (GO:0006413)* 
 Uridylate kinase activity (GO:0009041) 
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Table 5.3 KEGG pathways over-represented amongst the LEV-2 proteins showing a 
significant fold change in yeast LEV-2 exposed to UV-B 
The column A lists KEGG pathways over-represented in a dataset of proteins exhibiting a significant 
fold change increase in UV-B exposed yeast LEV-2 cultures, while the column B lists pathways 
over-represented amongst proteins showing a significant fold change decrease. The pathways were 
assigned by BlastKOALA search followed by KEGG pathway analysis. KEGG pathways marked by 
a star (*) were over-represented in a dataset of proteins with expression fold change of 4.0 or higher. 
The KEGG pathways were considered over-represented if Fisher’s exact test resulted in p-value 
below 0.05, when frequencies of KEGG pathway terms were compared between all proteins and 
proteins with fold-changes 2.0 or higher. 
A) KEGG pathways over-represented amongst the proteins 
with a fold change increase in UV-B exposed LEV-2 
B) KEGG pathways over-represented amongst the proteins 
with a fold change decrease in UV-B exposed LEV-2 
Arginine and proline metabolism* Cyanoamino acid metabolism* 
Calcium signaling pathway* HIF-1 signaling pathway 
cAMP signaling pathway One carbon pool by folate* 
cGMP-PKG signaling pathway Pyrimidine metabolism* 
Fructose and mannose metabolism  
Glutathione metabolism*  
Histidine metabolism  
Pentose and glucuronate interconversions  
PI3K-Akt signaling pathway*  
Ras signaling pathway  
Ribosome  
 
Table 5.4 KEGG modules over-represented amongst the LEV-2 proteins showing a significant 
fold change in yeast LEV-2 exposed to UV-B 
The column A lists KEGG modules over-represented in a dataset of proteins exhibiting a significant 
fold change increase in UV-B exposed yeast LEV-2 samples, and the column B shows KEGG 
modules over-represented in a dataset of proteins showing a significant fold change decrease. The 
KEGG modules were assigned by BlastKOALA search followed by KEGG module analysis. KEGG 
modules marked by a star (*) were over-represented in a dataset of proteins with expression fold 
change of 4.0 or higher. The KEGG modules were considered over-represented if Fisher’s exact test 
resulted in p-value below 0.05, when frequencies of KEGG module terms were compared between 
all proteins and proteins with fold-changes 2.0 or higher. 
A) KEGG modules over-represented amongst the proteins 
with a fold change increase in UV-B exposed LEV-2 
B) KEGG modules over-represented amongst the proteins 
with a fold change decrease in UV-B exposed LEV-2 
Cytochrome c oxidase C1-unit interconversion 
Polyamine biosynthesis, arginine => ornithine => putrescine* 
Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P 
+ pyruvate 
Ribosome, eukaryotes Pentose phosphate pathway (Pentose phosphate cycle) 
 Pyrimidine ribonucleotide biosynthesis, UMP => 
UDP/UTP,CDP/CTP* 
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5.4.4 Yeast LEV-2 proteins involved in response to UV-B induced stress 
The functional annotation of 751 quantified yeast LEV-2 proteins identified 105 proteins 
involved in cellular stress responses. Of these, four proteins were annotated as basic leucine 
zipper proteins, 22 as cellular signalling proteins, 17 as enzymes involved in biosynthesis of 
small molecule antioxidants, 22 as enzymatic antioxidants, six as enzymes involved in DNA 
repair, 24 as heat shock proteins, and 10 proteins were annotated as enzymes involved in the 
biosynthesis of mycosporine-like amino acids (MAAs). 
5.4.4.1 Basic-leucine zipper proteins 
Four basic leucine zipper (bZip) containing proteins, similar to human Nrf2 and AP-1 proteins, 
were identified and quantified by MudPIT analysis using the database of fungal bZip proteins 
(Figure 5.5). The protein similar to XP_007274754.1 (bZip transcription factor of fungi C. 
gloeosporioides) exhibited a significant fold change increase in LEV-2 yeast cultures exposed 
to 5 minutes, 1 hour, 2 hour and 4 hour of UV-B. The proteins similar to GAP83664.1 (bZip 
protein from R. necatrix) and XP_748177.1 (bZip protein from A. fumigatus) showed a 
significant fold change decrease in the yeast cultures exposed to 4 hours and 8 hours of UV-B, 
and the bZip protein KFA50940.1 showed no significant fold changes in UV-B exposed 
cultures. 
 
Figure 5.5 Fold change profiles of yeast LEV-2 bZip proteins 
Figure displays a heat-map of yeast isolate LEV-2 bZip protein fold changes in cultures exposed to 
UV-B for 5 minutes (T.5) to 24 hours (T.24h) and non-irradiated controls (T.0 and T.24h.C). The 
proteins with fold change reduction in the UV-exposed samples are coloured blue, while proteins 
with fold change increases are coloured red. Proteins showing a fold change lower than 1.5 are 
coloured light-grey. The protein identifiers of the proteins showing 2-fold or higher fold change in at 
least one UV-exposed yeast culture are also marked with a star (*). 
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5.4.4.2 Signalling proteins 
The quantitative MudPIT analysis identified 22 signalling proteins (Figure 5.6). These were 
annotated as proteins involved in various signalling pathways including FoxO signalling (490), 
MAPK signalling (491) and RAS signalling (471). Three 14-3-3 proteins were quantified, and 
all three exhibited fold change reduction in LEV-2 cultures irradiated for 1 hour to 4 hours. 
Four MAPK-signalling kinases were quantified, and all four exhibited fold-change increase in 
yeasts irradiated for 8 hours and 24 hours, while two MAPK-signalling kinases (similar to 
M6XZ23 and Spoli1_184897 proteins) also showed moderate (~1.5-fold or lower) reduction in 
expression in LEV-2 cultures irradiated for 1 hour to 4 hours. Annotation identified two 
proteins involved in FoxO signalling, both of which exhibited moderate fold change increase in 
LEV-2 exposed to 8 hours and 24 hours of UV-B. Two Ras-related proteins were quantified; 
both of these proteins showed fold change increase in LEV-2 exposed to 24 hours of UV-B, 
while the Ras-related protein M7WXY7 also showed moderate, ~1.5, fold change increase in 
yeast cultures exposed to 15 minutes of UV-B. Four cell division control (Cdc) proteins were 
quantified; of these, two proteins belonging to Cdc42 family showed fold change increase in 
yeasts exposed to 8 hours and 48 hours of UV-B, while two Cdc48 proteins exhibited fold 
change reduction in LEV-2 irradiated for 2 hours and 4 hours. A single Hippo-signalling 
protein was identified in this study; this protein did not show significant fold changes in UV-B 
irradiated LEV-2 cultures or in the controls. One calcium signalling protein calmodulin was 
identified and quantified, and showed a fold change increase in samples exposed to 1 hour to 4 
hours of UV-B. The MudPIT analysis also identified three adenylate kinases and two other 
kinases for which detailed annotation could not be determined. The adenylate kinases showed 
fold change decrease in LEV-2 exposed to 1 hour to 24 hours of UV-B, the kinase 
Rhomi1_185026 exhibited fold change increase in yeast irradiated for 24 hours, and the kinase 
Rhomi1_141225 showed moderate fold change increase in LEV-2 irradiated for 5 to 15 
minutes, 8 hours and 24 hours. 
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Figure 5.6 Fold change profiles of LEV-2 proteins involved in cellular signalling 
Figure displays a heat-map of fold changes of LEV-2 proteins involved in cellular signalling, cell 
cycle control and apoptosis. The fold changes are shown for LEV-2 cultures exposed to UV for 5 
minutes (T.5) to 24 hours (T.24h) and in the cultures of non-irradiated controls (T.0 and T.24h.C). 
The proteins showing a fold change reduction in the UV-exposed samples are coloured blue, while 
proteins with fold change increase are coloured red. Proteins showing a fold change lower than 1.5 
are coloured light-grey, and identifiers of proteins showing 2-fold or higher fold change in at least 
one UV-exposed yeast culture are also marked with a star (*).  
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5.4.4.3 Proteins involved in biosynthesis of antioxidants 
MudPIT analysis of yeast isolate LEV-2 exposed to UV-B irradiation identified and quantified 
17 proteins involved in biosynthesis of small-molecule antioxidants such as glutathione and 
ubiquinol (Figure 5.7). The hydroxyacylglutathione hydrolase (Rhomi1_37826), protein 
involved in biosynthesis of glutathione (492), showed fold change reduction in LEV-2 cultures 
exposed to 4 hours to 24 hours of UV-B. Four glutathione transferase (GST) enzymes, which 
mediate the phase II detoxification by catalysing the conjugation of xenobiotic functional group 
with glutathione (492), were identified. The GST protein M7WWF5 exhibited fold change 
reduction in samples irradiated for 1 hour to 24 hours, while GSTs Rhomi1_153124 and 
Rhomi1_19319 showed moderate fold change decrease in yeasts irradiated for 2 hours and 4 
hours. The GST protein Rhomi_153124 also showed a fold change increase in LEV-2 exposed 
to 15 minutes and 24 hours of UV-B. The PdxS/SNZ family lyases and pyridoxine 4-
dehydrogenases are involved in yeast biosynthesis of vitamin B6, and are associated with 
resistance to oxidative stress (493). Four lyases of PdxS/SNZ protein family were quantified by 
MudPIT analysis; these proteins showed fold change decrease in UV-irradiated samples (1 hour 
to 8 hours of UV-B). Single pyridoxine 4-dehydrogenase (Rhomi1_173574) was identified and 
quantified, and this protein showed no change in expression levels in UV-irradiated yeast 
cultures. Eight succinate dehydrogenase enzymes, involved in reduction of oxidised coenzyme 
Q10 to its reduced form (ubiquinol) (494), were identified and quantified in this study. Of 
these, protein P47052 showed no significant fold changes in any of the studied samples; 
A0A109FAY5 and Sporo_19407 exhibited moderate, ~1.5, fold change decrease in yeast LEV-
2 exposed to 4 hours of UV-B; Spoli1_173565 exhibited moderate fold change decrease in 
samples exposed for 1 hour, 4 hours and 8 hours; Rhomi1_182330 showed moderate fold 
change decrease in yeast irradiated for 2 hours and moderate fold change increase in sample 
exposed to 24 hours; and Sporo1_9115 and Rhomi1_167063 exhibited a fold change increase 
in yeast culture irradiated for 24 hours. 
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Figure 5.7 Expression profiles of LEV-2 enzymes involved in biosynthesis of antioxidants 
Figure displays the heat-map of the fold changes of yeast LEV-2 enzymes involved in the 
metabolism of small-molecule antioxidants. The LEV-2 cultures were exposed to UV for 5 minutes 
(T.5) to 24 hours (T.24h), and compared to non-irradiated controls (T.0 and T.24h.C). The proteins 
showing a fold change reduction in the UV-exposed samples are coloured blue, while proteins 
showing a fold change increase are coloured red. The proteins exhibiting fold-changes lower than 
1.5 are coloured light-grey, and the proteins showing 2-fold or higher fold change in at least one UV-
exposed sample are marked with a star (*). 
5.4.4.4 Enzymatic antioxidants 
The MudPIT study of UV-exposed yeast LEV-2 identified 22 enzymatic antioxidants, of which 
6 showed a significant fold change increase and 9 exhibited a significant fold change decrease 
in yeast LEV-2 cultures exposed to UV-B (Figure 5.8). The identified antioxidants included 
superoxide dismutase (SOD), catalase, aldehyde dehydrogenase (ALDH), glutathione 
peroxidase (GTRx), isocitrate dehydrogenase (IDH) and cytochrome-c peroxidase (CCP) 
proteins, all of which are major enzymatic antioxidants in yeasts as well as animals (495–500).  
One ADH and one benzaldehyde dehydrogenase enzyme were identified and quantified in this 
study, and both enzymes showed significant fold change increase in LEV-2 isolates exposed to 
24 hours of UV-B; the ADH also exhibited moderate, ~1.5, fold change increase in yeast 
exposed to 8 hours of UV-B. The single catalase was quantified; this enzyme showed moderate 
reduction in expression levels (~1.5 fold change decrease) in LEV-2 cultures exposed to 2 
hours to 8 hours of UV-B. Five CCP enzymes were quantified in yeast samples; two of these 
(Sporo1_16456 and A0A0D6ERS5) showed the fold change reduction in LEV-2 cultures 
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exposed to 1 hour to 24 hours of UV-B; CCP Sporo_190216 exhibited a fold change increase in 
samples exposed to 15 minutes, 8 hours and 24 hours of UV-B and fold change decrease in 
samples exposed to 1 hour and 2 hours of UV; CCP Rhomi1_42978 showed a fold change 
decrease in LEV-2 cultures exposed to 1 hour to 4 hours of UV and moderate fold change 
increase in culture irradiated for 24 hours; and CCP Rhomi1_149378 showed a fold change 
decrease in samples irradiated for 2 hours to 8 hours, and an increase in expression in LEV-2 
culture exposed to 15 minutes of UV-B. Two GTRx enzymes were identified by MudPIT 
proteomics analysis; the GTRx enzyme P38143 exhibited fold change reduction in yeasts 
exposed to 1 hour and 2 hours of UV, while the other GTRx (Rhomi1_146413) showed no 
changes in expression levels in UV-exposed yeast samples. The proteomics analysis identified 
two NAD+ dependant IDHs, both of which exhibited increase in fold changes in samples 
subjected to high dose of UV (8 to 24 hours of UV), and four NADP+ associated IDHs which 
displayed various degrees of fold change reduction in LEV-2 isolates exposed to 1 hour or 
longer UV-irradiation. Four SOD enzymes were identified and quantified, and showed 
significant fold change increase in LEV-2 samples irradiated for 24 hours. The SODs 
Rhomi1_168331 and Spoli1_20960 also exhibited fold-change increase in yeast exposed to 8 
hours, and the SOD Rhomi1_86056 showed increase in fold changes in LEV-2 irradiated for 5 
to 15 minutes and for 1 hour. 
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Figure 5.8 Fold change profiles of LEV-2 enzymatic antioxidants 
The heat-map shows fold changes of enzymatic antioxidants of yeast LEV-2. The yeast cultures 
were exposed to UV for 5 minutes (T.5) to 24 hours (T.24h), and non-irradiated cultures were used 
as controls (T.0 and T.24h.C). The proteins showing fold change reduction in the UV-exposed 
samples are coloured blue, while proteins with fold change increase are coloured red. The proteins 
exhibiting fold change lower than 1.5 are coloured light-grey, and identifiers of proteins showing 
significant (2-fold or higher) fold change in at least one UV-exposed sample are also marked with a 
star (*). 
 
5.4.4.5 Enzymes involved in repair and replication of DNA 
The functional annotation of yeast LEV-2 proteins quantified by MudPIT approach identified 6 
enzymes involved in repair and replication of DNA (Figure 5.9). The DNA ligase 
(Rhomi1_151258) and DNA-directed DNA polymerase (Rhomi1_90583) showed a fold change 
increase in yeast samples irradiated for 24 hours. The DNA ligase (Rhomi1_151268), DNA-
directed DNA polymerase (Rhomi_155605) and DNA helicase (A0A125PJD0) also exhibited a 
moderate fold change reduction (fold change ~1.5) in yeast samples exposed to 2 hours and 4 
hours of UV. 
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Figure 5.9 Fold change profiles of LEV-2 DNA repair and replication enzymes 
Figure displays the heat-map of fold changes of yeast LEV-2 enzymes involved in the repair and 
replication of DNA. The cultures of yeast LEV-2 were exposed to UV for 5 minutes (T.5) to 24 hours 
(T.24h), and compared to non-irradiated controls (T.0 and T.24h.C). The proteins showing a fold 
change reduction in the UV-exposed samples are coloured blue, while proteins showing a fold 
change increase are coloured red. The proteins exhibiting fold-changes lower than 1.5 are coloured 
light-grey, and the identifiers of proteins showing significant, 2-fold or higher, fold change in at least 
one UV-exposed sample are marked with a star (*). 
5.4.4.6 Yeast heat-shock proteins and chaperonins 
The 24 heat shock proteins (HSPs) were identified and quantified in this study (Figure 5.10). 
Two small, 10 kDa, HSPs exhibited fold change increase in LEV-2 samples exposed to 8 hours 
and 24 hours of UV-B. The fold changes of all three identified chaperonin ATPase were 
increased in LEV-2 cultures exposed to 24 hours of UV-B. The ATPase TCP-1 subunit theta 
(Rhomi1_150780) also exhibited fold change increase in LEV-2 irradiated for 4 hours and 8 
hours, while the ATPase TCP-1 subunits epsilon (Rhomi1_159882) and beta (A0A120E9R4) 
showed fold change reduction in LEV-2 irradiated for 2 hours. The six 60 kDa HSPs and nine 
70 kDa HSPs were quantified; these proteins exhibited a fold change reduction in LEV-2 
cultures exposed to 1 hour to 8 hours of UV-B, and some of these proteins (Spoli1_199568, 
Rhomi1_3145, P19882, A0A0K3CKS4, A0A109FFK7 and P16474) also showed moderate 
fold change increase in yeasts irradiated for 24 hours. Of the four identified large, 90 kDa, 
HSPs, all four exhibited high fold change increase in LEV-2 cultures irradiated for 24 hours, 
while three 90 kDa HSPs (A0A0D6EKA8, A0A109FF04 and Sporo1_21071) also displayed a 
fold change increase in yeast irradiated for 8 hours, and the HSP A0A109FKA3 also showed a 
fold change reduction in samples irradiated for 2 hours and 4 hours. 
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Figure 5.10 Fold changes of LEV-2 heat-shock proteins and chaperonins 
Figure displays a heat-map of fold changes of yeast LEV-2 heat-shock proteins and chaperonins. 
The yeast LEV-2 cultures were exposed to UVR for 5 minutes (T.5) to 24 hours (T.24h), and 
compared to non-irradiated controls (T.0 and T.24h.C). Proteins with fold change reduction in the 
UV-exposed cultures are coloured blue, while the proteins exhibiting a fold change increase are 
coloured red. Proteins with the fold changes lower than 1.5 are coloured light-grey, and the protein 
identifiers of proteins showing a significant, 2-fold or higher, fold change in UV-exposed samples are 
marked with a star (*). 
5.4.4.7 Proteins involved in biosynthesis of mycosporine-like amino acids 
Database matching of mass spectra generated from the proteins isolated from yeast LEV-2 
cultures exposed to UV-B radiation and from non-irradiated controls identified 10 proteins 
involved in the biosynthesis of MAAs. The listed proteins were quantified in all yeast cultures, 
with the exception of hybrid non-ribosomal peptide synthetase (NRPS) protein, which was not 
quantified in the LEV-2 cultures exposed to 1 hour and 8 hours of UV (Figure 5.11). Phospho-
2-dehydro-3-deoxyheptonate aldolase showed a significant fold change decrease in LEV-2 
cultures exposed to UV-B for 1 hour to 24 hours. The hybrid NRPS protein showed a fold 
change increase in LEV-2 cultures exposed to 5 minutes, 15 minutes, 2 hours and 24 hours of 
UV-B, and in non-irradiated control grown for 24 hours. The chorismate synthase enzyme 
showed a fold change increase in the yeast sample exposed to 24 hours of UV-B. All of the five 
identified transaldolase enzymes exhibited a fold change decrease in LEV-2 irradiated for 2 
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hours and 4 hours. 3-dehydroquinate synthase exhibited a moderate fold change decrease in 
yeast culture exposed to 24 hours of UV-B, and a moderate fold change increase in non-
irradiated yeast culture grown for 24 hours. 
 
Figure 5.11 Expression profiles of LEV-2 enzymes involved in biosynthesis of MAAs 
Heat-map shows the fold changes of yeast enzymes involved in biosynthesis of MAAs. The yeast 
LEV-2 cultures were exposed to UV for 5 minutes (T.5) to 24 hours (T.24h), and non-irradiated 
cultures were used as controls (T.0 and T.24h.C). The proteins showing a fold change reduction are 
coloured blue, while proteins with fold change increase are coloured red. The proteins exhibiting fold 
change lower than 1.5 are coloured light-grey, and unquantified samples are coloured dark grey. 
Protein identifiers of proteins showing a significant, 2-fold or higher, fold change are marked with a 
star (*). 
5.5 Discussion 
The purpose of this study was to describe, at the proteome level, the stress response 
mechanisms of a UV-tolerant yeast model, and to determine if the bZip proteins play a role in 
the stress response of UV-tolerant yeasts. The Sporobolomyces yeast LEV-2, previously 
isolated from the leaves of Brazilian plants (479), was chosen as the model organism for this 
study based on its high UV-tolerance (Figure 5.1, Figure 5.3), and because it was shown that 
cell extracts of LEV-2 cultures exhibited an increase in antioxidant, DPPH free radical 
quenching, activity during long-term exposure to UV-B (Figure 5.2/A). In addition, the 
previous analysis of this yeast placed it into Division Basidiomycota (479), unlike the 
commonly studied baker yeast Saccharomyces cerevisiae, which belongs to Division 
Ascomycota. The Ascomycota and Basidiomycota fungi are evolutionary distant, and are 
considered to have diverged ~650 million years ago (501,502). Thus, this study enabled the 
comparison of stress response mechanisms between the major, evolutionary distant, divisions 
of fungi.  
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The yeast LEV-2 was grown in liquid medium to mid-exponential phase of growth and exposed 
to UV-B irradiation for up to 24 hours. Solubilised proteins were extracted from the culture 
after 5 min, 10 min, 15 min, 1 hour, 2 hours, 4 hours, 8 hours and 24 hours of irradiation. A 
total of 751 proteins could be identified and quantified using TMT-labels and MudPIT high 
throughput proteomics, and the proteins were functionally annotated by InterProScan (484), 
KEGG tools (342,482) and literature searches.  
5.5.1 UV-B irradiation induces the stress response of yeast LEV-2 
In addition to causing direct DNA damage by inducing the formation of DNA photo-adducts 
(37), UV radiation stimulates the production of reactive, oxygen-derived, chemical species 
(RS) in the UV-exposed cells, and induces oxidative stress (39,40). The evidence of UV-caused 
oxidative damage has been found in multiple cell lines and in-vivo models. For example, UV-B 
radiation has been found to induce the production of RS in human cell lines by enhancing the 
RS generating activity of catalase (39), to induce production of RS in cyanobacteria, as 
detected by RS-sensing probe 2’,7’-dichlorodihydrofluorescein diacetate (503,504), and is 
considered also to be a major source of oxidative damage to yeast cells (505). UV-A radiation 
was also found to cause single stranded DNA breaks associated with oxidative damage in 
mouse models (40) and in human skin (506).  
In this study, the functional annotation of 227 proteins showing the fold change increase in 
yeast LEV-2 cultures exposed to UV-B (Figure 5.3/A) identified a high number of proteins 
associated with stress-response and cellular signalling (Tables 5.2/A-5.4/A). The increase in 
fold changes of these proteins in LEV-2 cultures exposed to 8 hours and 24 hours of UV-B 
(Table 5.3/A) correlated with the increase of antioxidant activity of cell extracts of LEV-2 
cultures exposed to 8 hours and 24 hours of UV-B, as measured by the DPPH free radical 
quenching assay (Figure 5.2/A), suggesting that the yeast LEV-2 increased the rate of 
biosynthesis of antioxidant enzymes when exposed to UV-B.  
While UV-stress responses of UV-tolerant Sporobolomyces yeasts have not been previously 
studied, the stress responses of yeast Saccharomyces cerevisiae exposed to various 
environmental stresses, including heat-shock, pH changes, oxidants such as H2O2 and 
cadmium, hyper-osmotic shock, starvation, and ionizing radiation, have previously been 
quantified using microarrays (507). These studies identified that the expression levels of large 
number of mRNA transcripts (~900 genes) change when the yeast is exposed to stress, but the 
changes in transcript levels are transient, and often adjust to levels close to unstressed cells 
during the conditions of prolonged stress (507,508). The fold changes of proteins in UV-B 
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exposed yeast LEV-2 cultures (Figure 5.4) match the patterns observed in these microarray 
studies of yeasts exposed to environmental stresses (507,508), suggesting that the stress 
response mechanisms are conserved between yeast S. cerevisiae and Sporobolomyces yeast 
LEV-2.  
The conservation of stress response patterns between yeasts of Genus Saccharomyces (Division 
Ascomycota) and Genus Sporobolomyces (Division Basidiomycota) would indicate that the 
stress response mechanisms are conserved between fungal lineages that diverged approximately 
650 million years ago (501,502), and that the majority of Basidiomycota and Ascomycota fungi 
possess homologous stress response mechanisms. This is further supported by the recent 
proteomics study by Villegas et al (2014), which examined the stress response of yeast of the 
Genus Rhodotorula (Division Basidiomycota) exposed to oxidative stress induced by high 
levels of copper, and identified an increase in expression levels of stress response proteins such 
as heat shock proteins and superoxide dismutase in stressed yeasts (509). This similarity of 
stress response in evolutionary distant groups of fungi is possibly because the stress signalling 
mechanisms evolved during the early evolution of eukaryotic life. Our previous phylogenetic 
studies of evolution of the Nrf2 pathway suggested that the bZip-protein based response to 
oxidative stress evolved in early eukaryotes as an adaptation to oxidative environment caused 
by the rising oxygen levels during the geological time (510). The expression fold change 
patterns of stress response proteins, including the bZip proteins and other signalling proteins of 
UV-stressed Sporobolomyces yeast LEV-2 were further examined to evaluate if the stress 
response is conserved between the yeast S. cerevisiae and LEV-2, and the results are discussed 
in the following section. 
5.5.2 Stress response proteins of yeast LEV-2  
MudPit analysis of UV-irradiated cultures of Sporobolomyces yeast LEV-2 quantified 105 
proteins involved in cellular stress response (section 5.4.4). Stress response proteins were 
functionally annotated using the InterProScan, KEGG tools and manual annotation. 
5.5.2.1 Basic-leucine zipper proteins 
In animals, the bZip transcription factor Nrf2 activates the transcription of a large number of 
genes (125,129) encoding detoxification and antioxidant enzymes such as aldehyde 
dehydrogenases, glutaredoxins and thioredoxins, as well as enzymes involved in biosynthesis 
of glutathione (96). The function of the bZip transcription factor Nrf2 was characterized by 
high-throughput technology such as Chip-seq and microarrays (125,129), and its role in 
protection against oxidative stress was confirmed in cell lines and animal models (96). For 
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example, genetically modified mouse models deficient in Nrf2-encoding gene were found to be 
highly sensitive to carcinogens such as benzo[a]pyrene (184), to environmental pollutants such 
as diesel exhaust (183), and to toxicity of drugs such as acetaminophen (185). In addition, 
pharmaceuticals that activate Nrf2-signalling, such as sulforaphane (SFN) and butylated 
hydroxyanisole, were shown to activate the transcription of Nrf2-regulated genes, such as GST, 
GCLC and NQ01, in wild type mouse models, but not in Nrf2-knockout models (122). The 
activation of Nrf2 by SFN has also been shown to protect the human cell models and mouse 
animal models against UV-induced oxidative stress (467,470,511). The bZip proteins 
homologous to vertebrate Nrf2 protein have also been studied in invertebrates such as the fly 
Drosophila melanogaster and the nematode Caenorhabditis elegans, and were found also to 
regulate the response to oxidative stress in these invertebrate models (325,329,512).  
The genome of baker yeast S. cerevisiae encodes several bZip transcription factors including 
Gcn4 and eight Yap proteins (Yap1 – Yap8). The bZip protein Gcn4 activates the biosynthesis 
of amino acids, and is involved in response to starvation, but also in UV-stress (472), as 
evinced from low UV-tolerance of Gcn4 knockout yeast models (471). The bZip transcription 
factor Yap1 is a major regulator of oxidative stress response in S. cerevisiae, while Yap2, Yap5 
and Yap8 proteins play a role in response to metal-induced stress, Yap4 and Yap6 in regulating 
response to osmotic stress, and the roles of Yap3 and Yap7 are currently unknown (475). The 
function of Yap1 was inferred because YAP1-knockout yeasts, but not yeasts deficient in other 
YAP genes, were found to possess low activity of antioxidant enzymes such as superoxide 
dismutase and glutathione reductase, and display low adaptability to oxidative stress (513). In 
addition, the Yap1-binding motif on DNA has been found in promotor regions of antioxidant 
genes such as GSH1 and TRX2 (475). The homologs of Yap1 protein have been empirically 
validated in yeasts Candida albicans (Cap1 protein) and Schizosaccharomyces pombe (Pap1 
protein) (514), suggesting that bZip-regulated response to oxidative stress is conserved between 
yeasts of Division Ascomycota. While the Yap1 homologs have not been experimentally 
confirmed in Sporobolomyces (Division Basidiomycota) yeasts, our previous bioinformatics 
study found that genomes of Basidiomycota fungi encode homologs of bZip proteins similar to 
animal bZip transcription factor Nrf2 (408), and the recent study by Jindrich and Degnan 
(2016), identified also that animal bZip-encoding genes evolved from the bZip-encoding gene 
of unicellular eukaryote ancestor of fungi and animals (515).  
MudPIT proteomics analysis of Sporobolomyces yeast LEV-2 identified four bZip proteins 
similar to fungal bZip transcription factors (Figure 5.5), suggesting that bZip proteins are 
conserved between S. cerevisiae and Sporobolomyces yeasts. The LEV-2 bZip protein, 
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designated LEV-2_XP_748177.1, showed a significant fold change increase in UV-irradiated 
LEV-2 cultures (Figure 5.5), suggesting that LEV-2_XP_748177.1 is a LEV-2 homolog of S. 
cerevisiae Yap1 and plays a role in stress signalling in the yeast LEV-2. This is because the 
expression of Yap1 is increased in S. cerevisiae cultures exposed to oxidants such as H2O2 and 
paraquat (516), while the expression of other S. cerevisiae Yap proteins is not changed 
significantly during oxidative stress (475,517). The fold change patterns of bZip protein LEV-
2_XP_748177.1 in yeast LEV-2 exposed to long term UV-B irradiation (Figure 5.5) were 
followed by the fold change increase in stress-response proteins of yeast LEV-2 (Figure 5.4), 
and these fold changes showed striking resemblance to changes in expression levels of bZip 
transcription factor Nrf2 in human liver cancer (HepG2) cells and rat renal epithelial cells 
exposed to electrophiles such as tBHQ and β-NF (518) or to heme (519). In these studies, 
exposure to Nrf2 activator caused an increase in cellular concentration of Nrf2 after ~30 
minutes to 1 hour, followed by an increase in expression of Nrf2-regulated genes after 2 or 
more hours.  
While the observed protein fold changes in LEV-2 cultures exposed to UV-B suggest that the 
bZip protein LEV-2_XP_748177 of Sporobolomyces yeast LEV-2 is a homolog of S. cerevisiae 
bZip transcription factor Yap1 and of vertebrate bZip transcription factor Nrf2, other signalling 
proteins might also be involved in stress response in yeast LEV-2. For example, 
RAS/cAMP/PKA signalling and bZip protein Gcn4 are known to be involved in UV-response 
of yeast S. cerevisiae (471). Thus further studies, potentially involving gene deletion of LEV-
2_XP_748177-encoding gene in yeast LEV-2 or gene-knockdown by siRNA, are required to 
exclude the possibility that the observed changes in proteome of yeast LEV-2 exposed to UV-B 
radiation are mediated by other signalling pathways. It should be noted also that the genome of 
yeast LEV-2 is currently not available, and the presence of bZip proteins in LEV-2 was inferred 
by database matching of tandem mass spectra generated from tryptic digests of LEV-2 proteins. 
Therefore, primary amino-acid sequence of discovered bZip proteins could not be established, 
and genome sequencing yeast LEV-2 is required to elucidate the DNA sequence of bZip 
protein encoding genes of yeast LEV-2. The assembly of LEV-2 genome would facilitate the 
phylogenetic analysis of LEV-2 bZip proteins and sequence similarity comparisons of LEV-2 
bZip proteins to vertebrate and known yeast bZip proteins. In addition, the knowledge of DNA 
sequence of bZip-encoding genes of the yeast LEV-2 would allow the design of PCR primers 
for real-time PCR analysis of bZip-encoding mRNA transcripts in yeast LEV-2 exposed to 
oxidative stress, and the design of siRNAs for knock-down experiments.  
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In addition to the XP_748177.1 like protein, three other bZip proteins were identified and 
quantified in the proteome of yeast LEV-2, and the expression levels of these proteins were 
reduced or unchanged in UV-B irradiated yeast cultures (Figure 5.5). These proteins are likely 
to be homologs of yeast S. cerevisiae Yap proteins (Yap2 – Yap8) not involved in response to 
oxidative stress. This is because the yeast S. cerevisiae Yap2 – Yap8 proteins do not show 
significant fold changes in S. cerevisiae exposed to oxidants (475,507,508,517), and do not 
regulate the response to oxidative stress (473). For example, Yap5 protein is involved in iron 
metabolism (520), Yap6 regulates the response to osmotic stress, and functions of Yap3 and 
Yap7 are currently unknown (475).  
5.5.2.2 Signalling and apoptosis related proteins 
The proteomics study of LEV-2 yeast identified 22 proteins associated with different cellular 
signalling pathways. These proteins were further classified based on the pathway: 
The 14-3-3 proteins 
The 14-3-3 proteins are involved in numerous cellular processes, including signal transduction, 
cell-cycle control and apoptosis, and signalling roles of these proteins are an active field of 
research (521). Three 14-3-3 proteins were identified in this study, and the fold changes of 
these proteins were significantly reduced by moderately long UV-B irradiation (1 hour to 4 
hours of UV-B exposure). This reduction in expression co-occurs with increase in cell death 
observed in samples under 1 hour to 4 hours of UV-B (Figure 5.1), suggesting the link between 
levels of 14-3-3 proteins and cell death, possibly by UV-induced apoptosis. This is in 
agreement with studies of Zhang et al. (1999), who identified a strong correlation between 
expression of 14-3-3 proteins and apoptosis in HeLa cell line model (522). It is currently 
unknown whether 14-3-3 proteins play identical roles in human cell line models and in yeasts, 
and different stresses were reported to affect the expression of 14-3-3 proteins in yeast S. 
cerevisiae in different fashion, depending on the source of stress. For example, Yoshimoto et 
al. (2002) found that calcium induced stress caused the reduction in expression levels of 14-3-3 
proteins in S. cerevisiae, as measured by microarrays (523). The similar microarrays-based 
study by Gasch et al. (2002) identified that changes in levels of 14-3-3 proteins depend on the 
source of stress, with protein levels increased in yeast S. cerevisiae exposed to heat-shock, and 
reduced in the sample exposed to H2O2 (508).  
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MAPK signalling proteins 
The mitogen-activated protein kinase (MAPK) signalling pathway mediates transduction of 
extracellular signals, and is essential for multiple cellular functions, such as cell differentiation, 
proliferation, initiation of apoptosis and adaptation to environmental stresses (491). The basic 
assembly of MAPK signalling comprises three kinases - MAPK kinase kinase (MAPKKK), 
MAPK kinase (MAPKK), and MAP kinase (MAPK) - that transduce extracellular signal by 
sequential phosphorylation reactions. MAPKKK phosphorylates MAPKK, which in turn 
phosphorylates MAPK, and the phosphorylated MAPK phosphorylates transcription factors 
such as Sko1 which control transcription of genes involved in stress response (524). This three-
component module is conserved between yeasts and animals (524), and the increase in 
expression of MAPK kinases has been associated with increase in resistance to oxidative stress 
in yeasts S. cerevisiae and S. pombe (514), invertebrates such as C. elegans (525), mouse 
animal models and human cell lines (524,526). For example, S. cerevisiae and S. pombe yeasts 
deficient in MAPK kinase encoding genes are hypersensitive to salt-induced stress, heat shock 
and nutritional limitation (514); in C. elegans, oxidative stress induced by sodium arsenite, 
paraquat, or t-butyl peroxide increases the expression of MAPK kinase p38, while the deletion 
of gene encoding the MAPK kinase SEK-1 increases sensitivity to oxidative stress (525);  
human HeLa cells exposed to H2O2-induced oxidative stress exhibit an increase in expression 
of multiple MAPK kinases, and the inhibition of extracellular MAPK signalling kinases 
increases the apoptosis rate in stressed cells (526).  
The cell division control proteins 42 (Cdc42) were shown to be involved in activation of yeast 
high osmolarity glycerol (HOG) MAPK pathway (527). The HOG pathway involves a series of 
kinases which activate Hog1 MAP kinase in response to severe osmotic stress, and the mutation 
of yeast S. cerevisiae gene encoding Cdc42 proteins has been shown to inhibit the yeast 
response to osmotic stress, while mutants over-expressing Cdc42 proteins have been found to 
exhibit an increase in stress response (527). This is because Cdc42 proteins interact with, and 
activate, the Ste20 MAP4K component of HOG pathway in yeast, and this interaction is 
essential for signal transduction during osmotic stress (528). This function of Cdc42 proteins in 
MAPK pathway is conserved between yeast and mammals, and it has been shown that stress-
activated MAPK pathway kinases such as JNK1 and p38 are activated by the Cdc42 protein in 
human tissue extracts (529) as well as monkey kidney cell (COS-1) cultures (530).  
Four kinases associated with MAPK signalling pathways, and two Cdc42 proteins, were 
identified by MudPIT analysis of Sporobolomyces yeast LEV-2. These six proteins showed fold 
change increases in yeast cultures exposed to long term, 8 hours or longer, UV-B radiation 
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(Figure 5.6). These results suggest that a MAPK signalling is activated by UV-B radiation in 
yeast LEV-2, and that these signalling pathways are evolutionary conserved between 
Ascomycota yeasts such as S. cerevisiae and S. pombe, and the Sporobolomyces yeast LEV-2. 
While MAPK pathway has not yet been studied in Sporobolomyces yeasts, this pathway was 
empirically characterized and found to mediate a response to stress in Basidiomycota fungi 
Cryptococcus neoformans exposed to fungicide fludioxonil and to high levels of NaCl (531). In 
this study, the increase in MAPK signalling kinases was found to correlate with the fold change 
increase of enzymatic antioxidants, such as SODs (Figure 5.8), and with the fold change 
increases of certain heat shock proteins (Figure 5.10) observed in LEV-2 cultures exposed to 8 
hours and 24 hours of UV-B radiation. In addition, the cell extracts of LEV-2 cultures 
irradiated for 8 hours and 24 hours also showed the increase in DPPH free radical scavenging 
activity (Figure 5.2). These results, and the assumption that MAPK-mediated stress response is 
conserved across all eukaryotes (524) indicate that MAPK signalling is likely involved in 
activating stress response in UV-irradiated yeast LEV-2. It is however, known that other 
signalling pathways, such as Yap1 signalling (475), are also involved in yeast stress response, 
and further empirical studies, such as inactivation of genes encoding MAPK kinases in yeast 
LEV-2, are required to establish the importance of MAPK signalling in yeast LEV-2 in 
comparison to other signalling pathways, such as the Yap1 pathway. 
FoxO signalling 
FoxO signalling proteins represent a subfamily of the forkhead family of transcription factors, 
and are highly conserved across all animal phyla, with orthologs discovered in cnidarian Hydra 
vulgaris, worm C. elegans, fly D. melanogaster, mouse and rat models and human cell lines 
(532). These proteins have been associated with resistance to oxidative stress, control of life-
span, regulation of cell cycle arrest, and induction of apoptosis (532). In the nematode C. 
elegans, FoxO signalling is mediated by the forkhead transcription factor Daf-16, and the 
increase in expression of this protein was shown to increase the worm life-span and resistance 
to oxidative stress (533). The increase in FoxO signalling was found also to mediate stress 
response in a mammalian cell line: H2O2-induced oxidative stress caused the fold change 
increase of the p66shc protein, mammalian homolog of Daf-16, while cells deficient in p66shc-
encoding gene were found to be highly sensitive to H2O2 (534).  
The yeast S. cerevisiae forkhead proteins HCM1, FKH1 and FKH2 proteins are homologs of 
animal FoxO proteins, and have been shown to regulate stress response and longevity of S. 
cerevisiae (490,535,536). For example, the study by Postnikoff et al. (2012) found that S. 
cerevisiae mutants deficient in genes encoding FKH1 and FKH2 proteins had a shorter life-
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span and lower resistance to H2O2 than wild-type yeasts, while S. cerevisiae genetically 
modified to overexpress FKH proteins showed an increase in life-span and resistance to H2O2 
(490). The study by Maoz et al. (2015) also found that S. cerevisiae genetically modified to 
overexpress FoxO homolog HCM1 had a high rate of transcription of genes encoding catalase 
and superoxide dismutase enzymes; in addition, these yeasts were highly resistant to oxidative 
stress induced by H2O2, and had a higher lifespan than wild-type yeasts (535). 
Two FKH proteins were identified and quantified in this study (Figure 5.6), and levels of these 
proteins were moderately increased (fold change ~1.5) in the yeast LEV-2 cultures exposed to 
long-term UV-B radiation (8 hours and 24 hours). This increase in expression of FKH proteins 
co-occurred with the increase of free radical quenching activity of cell extracts of LEV-2 yeast 
cultures exposed to UV-B radiation (Figure 5.2) and with a significant fold change increase of 
superoxide dismutase enzymes (Figure 5.8). These expression patterns match the results of 
previous studies that quantified the expression of FKH proteins of yeast S. cerevisiae exposed 
to H2O2-induced stress (490,535), and imply that a fold change increase in FKH proteins is 
associated with yeast LEV-2 resistance to UV-induced oxidative stress. These results also 
suggest that the FoxO pathway is conserved between yeast S. cerevisiae and Sporobolomyces 
yeasts such as LEV-2.  
Ras signalling proteins  
In yeasts, such as the model yeast Saccharomyces cerevisiae, the Ras signalling pathway 
controls the DNA damage-independent response to UV-induced stress. This stress response 
pathway is comprised of membrane associated Ras proteins that activate the adenylate cyclase 
enzymes to stimulate the production of cyclic AMP (cAMP). The increased cytosolic 
concentration of cAMP activates a protein kinase A (PKA) controlled phosphorylation cascade 
that increases the translation of bZip transcription factor Gcn4 (471), and leads to induction of 
genes involved in biosynthesis of amino acids (472). The yeast Ras signalling pathway is 
considered to be homologous to mammalian UV-response pathway that includes Ras associated 
proteins Ha-Ras and Raf-1 as well as transcription factors such as NF-kB and AP-1 (471,537), 
and is distinct from yeast response to DNA damage, which is mediated by the DNA damage 
responsive protein kinase Dun1 (477). This is because Ras signalling involves membrane 
associated Ras proteins rather than DNA damage sensing kinases. In addition, Ras signalling is 
involved in regulation of amino acid biosynthesis, but not in regulation of DNA repair, and 
transcription of Ras associated proteins is induced by UV in S. cerevisiae strains deficient in 
Dun1-encoding gene (471). While primarily associated with response to starvation and with 
induction of amino acid biosynthesis (538), Ras signalling was shown to also regulate the 
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protection against UV-induced stress in the yeast S. cerevisiae. This is because the S. cerevisiae 
strains deficient in gene encoding transcription factor Gcn4 are highly sensitive to UV 
irradiation, while the strains engineered to constitutively over-express Gcn4 are highly resistant 
to UV (471).  
In this study, the Ras-associated proteins Rap-7A and Rap-11A of Sporobolomyces yeast LEV-
2 showed a moderate, 1.5-fold, increase in LEV-2 yeast cultures exposed to 24 hours of UV-B 
(Figure 5.6), suggesting that Ras signalling is enhanced in yeast LEV-2 during long-term UV-B 
irradiation. This increase in fold change co-occurred with the low death rate observed for LEV-
2 cultures exposed to 8 hours and 24 hours of UV-B (Figure 5.3), suggesting that the Ras-
associated proteins of yeast LEV-2 induce the adaptation to UV-B stress, and that the function 
of Ras-associated proteins is conserved between S. cerevisiae and the yeast LEV-2. The 
observed reduction in yeast LEV-2 cell death is, however, also associated with an increase in 
expression of enzymatic antioxidants (Figure 5.8) and other signalling pathways involving bZip 
transcription factors (Figure 5.5), FoxO signalling, and MAPK signalling (Figure 5.6). Thus, 
further research is required to quantify the contributions of individual signalling pathways to 
the stress response of the UV-exposed yeast LEV-2. 
The Ras-related calcium-binding protein calmodulin is an important component of stress 
signalling in the yeast S. cerevisiae, and yeast strains deficient in the calmodulin-encoding gene 









 (539). The calmodulin and Ca
2+
/calmodulin-dependent phosphatase calcineurin 
mediate the response to elevated levels of cytosolic Ca
2+
 caused by oxidative stress, osmotic 
shock and other sources of stress (539,540). Calcineurin responds to stress-associated elevation 
of Ca
2+
 levels in the cell by dephosphorylating the transcription factor Crz1p. The 
dephosporilated Crz1p translocates to the nucleus, where it activates transcription of genes 
encoding numerous proteins involved in cell survival (539). For example, the microarray study 
of Yoshimoto et al. (2002) identified that over 150 genes are under transcriptional control by 
Crz1p in the yeast S. cerevisiae, including genes involved in control of ion transport and 
homeostasis, cell wall synthesis/maintenance, lipid and sterol metabolism, vesicle transport, 
and cellular signalling (523). The stress response function of calmodulin signalling is conserved 
between the baker yeast S. cerevisiae and the pathogenic yeast Candida albicans, and it was 
shown that C. albicans deficient in genes encoding calmodulin-dependent protein kinases is 
highly sensitive to H2O2-induced oxidative stress (541). This pathway, however, is not involved 
in the stress response of fungus Aspergillus nidulans (540), indicating that the function of 
calmodulin is not conserved across the different fungal phyla. In this study, the LEV-2 
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calmodulin protein (Figure 5.6) showed a fold change increase in yeast cultures exposed to 1 
hour to 4 hours of UV-B, and showed the pattern similar to LEV-2 bZip transcription factor, 
which also showed a fold change increase in UV-B exposed LEV-2 cultures (Figure 5.5). 
Studies of different cell models such as hepatocytes, lymphocytes and endothelial cells, showed 
that oxidative stress disrupts the function of cellular Ca
2+
 transporters and increases the 
concentration of Ca
2+
 in the cytosol (542). Thus, the observed fold change increase in the yeast 
LEV-2 calmodulin protein suggests that the calmodulin activity is increased in the yeast LEV-2 
in response to an increase in cytosolic concentration of Ca
2+
 due to UV-induced oxidative 
stress. This would indicate that calmodulin is an early sensor of cellular stress in yeast LEV-2, 
and the function of this protein is conserved between yeast S. cerevisiae and Sporobolomyces 
yeast LEV-2. 
Cell cycle control and apoptosis 
Yeasts, and other unicellular organisms, were traditionally considered not to possess the 
mechanisms for induction of programmed, apoptotic, cell death, but the expression of 
mammalian proapoptotic genes such as BAX and TP53 was shown to induce the apoptotic cell 
death in yeast Saccharomyces cerevisiae (543,544). In addition, it was shown that a moderate 
concentration of H2O2 (3 – 5 mM) induces apoptotic cell death in S. cerevisiae, while a high 
concentration of H2O2 (180 mM) causes necrotic cell death (543). The discovery of the S. 
cerevisiae caspase YCA1 and the yeast apoptosis-inducing factor-1 (AIF1), and studies that 
demonstrated that cell death is reduced in S. cerevisiae yeasts deficient in genes encoding these 
proteins, further confirmed that certain apoptotic cell death mechanisms are conserved between 
yeasts and animals (545). The yeast LEV-2 homologs of genes encoding Yca1 and Aif1 
proteins were not discovered in this study, possibly because amino acid sequences of these 
proteins in yeast LEV-2 are significantly different from the proteins of fungi for which 
proteomes were available, and which were used for database matching of tandem mass spectra 
generated from the tryptic fragments of LEV-2 proteins. The cell division proteins 48 and Ras 
associated proteins were, however, successfully identified and quantified (Figure 5.6), and 
these proteins are known to be involved in apoptosis in yeast S. cerevisiae (546,547). 
The cell division proteins 48, referred to as Cdc48 in yeasts, and p97 proteins in animals, are 
multipurpose proteins conserved across fungi and animals, and essential for growth of the yeast 
S. cerevisae (548). These proteins have been associated with numerous functions including 
protein degradation, protein aggregation, control of cell cycle and apoptosis, and transcription 
and replication of DNA (548). The yeast Cdc48 proteins, and animal homologs, were also 
shown to play a role in endoplasmic reticulum (ER) stress; these proteins are involved in 
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extraction of misfolded proteins from the ER into the cytosol, where the misfolded proteins are 
subsequently degraded (549). Mutation in the S. cerevisiae CDC48 gene has been shown to 
increase the rate of apoptosis in yeast (547), and an increase in apoptosis was also shown in 
human cell line, and in the fly Drosophila melanogaster when the translation of VCP protein, 
the animal homolog of Cdc48, is knocked-down by siRNAs (550). The fold change reduction 
of Cdc48 proteins of yeast LEV-2 was observed in yeast cultures exposed to 2 hours and 4 
hours of UVR (Figure 5.6), coinciding with the fold change decrease in proteins associated 
with catabolism of misfolded proteins, protein folding and protein refolding (Table 5.2/A, 
Figure 5.4/B). In addition, the cell death rate of yeast LEV-2 cultures exposed to 2 hours and 4 
hours of UV-B was considerably higher than the death rate of LEV-2 cultures exposed to 8 
hours or 24 hours of UV-B (the time period where the Cdc48 proteins do not show fold change 
decrease). These results suggest that Cdc48 proteins are linked to misfolded protein stress, and 
possibly to apoptosis, in Sporobolomyces yeast LEV-2, and imply that function of Cdc48 
proteins is conserved between Basidiomycota fungi and Ascomycota fungi. 
In addition to the UV response, Ras and Ras-related (Rap) proteins have been associated with 
control of cell cycle and apoptosis in yeast S. cerevisiae (551), and constitutive high expression 
of Ras signalling proteins was demonstrated to reduce the lifespan, and induce the apoptotic 
cell death, of yeast S. cerevisiae (552,553). The study by Gourlay and Ayscough (2006) found 
that constitutive activation of Ras signalling, induced by knock-out of genes that encode the 
Ras regulating proteins Sla1p or End3p, leads to an increase in cAMP levels in yeast, followed 
by the accumulation of RS in the cytosol and apoptotic cell death (553). Similar results were 
reported by Heeren et al. (2004), who found that mutations in RAS genes of S. cerevisiae led to 
redox imbalance characterized by the excretion of cytosolic glutathione, elevated RS 
concentration, reduction in yeast life-span, and apoptotic cell death (552). The activation of 
apoptosis by Ras/cAMP/PKA signalling was also demonstrated for the pathogenic yeast 
Candida albicans, where the mutations that block Ras signalling, such as deletions of RAS1 and 
CDC35 genes, were found to suppress the apoptotic response to acetic acid or H2O2, while 
mutations that stimulate Ras signalling, such as RAS1
val13
 mutation, accelerated the rate of 
apoptosis when C. albicans was exposed to acetic acid or H2O2 (554) . Unlike yeasts, the 
constitutive expression of Ras signalling has been associated with carcinogenesis in animals. 
For example, mutations in HRAS, KRAS and NRAS oncogenes that lead to constitutive 
transcription of Ras-controlled genes have been associated with human cancers and 
carcinogenesis in animal models (555).  
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The MudPIT study of the UV-B irradiated Sporobolomyces yeast LEV-2 quantified six Ras-
associated proteins (Figure 5.6). The levels of these proteins, however, did not show significant 
fold change increase in LEV-2 exposed to 1 hour - 4 hours of UV-B irradiation, which is the 
time period of high cell death rate (Figure 5.3). This result indicates that UV-B induced cell 
death of yeast LEV-2 is not due to over-expression of Ras signalling, and is likely caused by 
other mechanisms, such as UV-induced generation of RS leading to oxidative stress. In 
addition, the yeast LEV-2 death rate (Figure 5.3) showed a marked decrease in yeast LEV-2 
cultures exposed to 8 hours of UV-B and 24 hours of UV-B; this reduction in cell death 
coincided with the fold change increases in enzymatic antioxidants (Figure 5.8), 10 kDa and 90 
kDa heat shock proteins (Figure 5.10), and proteins involved in the MAPK, Ras and FoxO 
signalling pathways (Figure 5.6). Furthermore, the antioxidant activity of cell extracts of LEV-
2 yeasts, as measured by DPPH free radical quenching was also highly elevated after 8 hours 
and 24 hours of UV-B exposure (Figure 5.2). These results indicate that the increase in 
antioxidant activity is linked with reduction in yeast LEV-2 cell death, suggesting that the 
primary cause of cell death of yeast LEV-2 exposed to UV-B is oxidative stress, possibly 
leading to apoptosis, rather than direct, UV-inflicted, DNA damage. While this is consistent 
with previous studies that identified that moderate oxidative stress induces apoptosis rather than 
necrosis (543) in yeast S. cerevisiae, it should be noted that measurement of yeast viability after 
UV-B irradiation is not sufficient to differentiate between apoptotic cell death and necrotic cell 
death, and a recent study of yeast apoptosis recommend a combination of assays to determine 
the rate of yeast apoptosis (545). Thus, further testing, preferably by a combination of assays to 
determine the cell viability, accumulation of RS, DNA fragmentation, and cell integrity, are 
required to measure the ratio of necrotic to apoptotic death in LEV-2 yeasts exposed to UV-B. 
Other signalling proteins  
Five protein kinases, not related to MAPK pathway, were identified in the yeast sample (Figure 
5.6). Of those, three adenylate kinases had low expression levels in samples subjected to 1 hour 
or longer UV irradiation, while two kinases of unknown specificity, exhibited significantly 
increased (fold change > 2) expression levels in yeast sample exposed to 24 hours of UVR. The 
protein kinases are involved in a large number of signalling pathways (556), and further 
research is required to elucidate the functions of these proteins in LEV-2. 
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5.5.2.3 Proteins involved in biosynthesis of antioxidants 
MudPIT analysis of yeast LEV-2 identified and quantified 17 proteins involved in biosynthesis 
of small-molecule antioxidants such as glutathione and ubiquinol. The identified proteins 
(Figure 5.7) included enzymes involved in biosynthesis of glutathione (492) such as 
hydroxyacylglutathione hydrolases (HAGHs) and glutathione S-transferases (GSTs), enzymes 
involved in biosynthesis of vitamin B6 (PdxS/SNZ family lyases and pyridoxine 4-
dehydrogenases) (493), and succinate dehydrogenase (SdHs) enzymes, which reduce oxidised 
coenzyme Q10 to its reduced form (ubiquinol) (494). 
UV-mediated induction of oxidative stress and depletion of cellular small molecule 
antioxidants was previously observed in multiple models including animal cell lines, plants, 
yeasts and bacteria (39,40). For example, Heck et al. (2003) found that UV-B light is absorbed 
by catalase and increases the H2O2 generating activity of this enzyme in human and mouse 
keratinocytes, and in hamster fibroblasts (39). A study by Podda et al. (1998) found that 
simulated solar UV radiation depletes small molecule antioxidants ubiquinol, α-tocopherol and 
ascorbic acid in the cell culture of human skin, in a linear, dose-dependent fashion (557). UV 
radiation was shown also to induce RS generation in cyanobacteria (558), algae (559), and 
plants (560), and is also considered to be a major source of oxidative stress in yeasts (505).  
In this study, the fold changes of the majority of enzymes involved in biosynthesis of small 
molecule antioxidants were moderately reduced in the LEV-2 yeast cultures irradiated for 1 
hour to 8 hours (Figure 5.7). This fold change reduction co-occurred with the reduction in 
antioxidant activity of cell extracts of LEV-2 yeast cultures exposed to 1 to 4 hours of UV-B, as 
measured by DPPH free radical quenching assay (Figure 5.2), indicating that the UV-B 
radiation, and the associated oxidative stress, deplete the small molecule antioxidants of 
Sporobolomyces yeast LEV-2. These results are in agreement with the reports of Gasch et al. 
(507,508), who used microarrays to study the protein expression of S. cerevisiae subjected to 
environmental stresses such as heat shock and exposure to H2O2 and found that temperature-
induced stresses induced a fold change reduction in GST, SdHs and SNZ proteins (507,508) of 
S. cerevisiae, consistent with the fold change patterns observed in this study. While the studies 
by Gasch et al. (507,508) did not measure the effects of UV-B radiation, it has been shown 
previously that heat-shock, similarly to UV-B, induces oxidative stress in yeasts. That is 
because S. cerevisiae strains deficient in genes encoding antioxidant enzymes, such as catalase, 
SoD and cytochrome c peroxidase, are highly sensitive to heat-shock, while yeasts engineered 
to over-express these enzymes have an elevated resistance to heat shock and oxidative stress 
(561).  
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Notably, certain enzymes involved in biosynthesis of small-molecule antioxidants, such as 
glutamate cysteine ligase (GCL) and GSH synthetase (GS) (562), were not identified in this 
study. This is possibly due to the lack of the genome sequence for LEV-2 sample, which 
necessitated the use of related yeast proteomes for the database matching of MS spectra 
generated from LEV-2 proteins, and likely reduced the number of identified proteins.   
5.5.2.4 Enzymatic antioxidants 
Enzymatic antioxidants include enzymes that convert RS into less reactive chemical species, 
such as superoxide dismutase (SOD), superoxide reductase (SOR) and catalase (CAT); enzymes 
involved in recycling of non-enzymatic small molecule antioxidants (e.g. glutathione 
reductase); and enzymatic systems that reduce oxidised cellular macromolecules, such as 
thioredoxin and glutaredoxin systems (54,68). While the individual enzymatic antioxidants are 
non-essential, presumably because cellular antioxidant systems have a considerable level of 
redundancy, the yeast S. cerevisiae (563,564) and mouse animal models (11) deficient in 
certain antioxidant enzymes, such as mitochondrial SODs, were shown to be hypersensitive to 
oxidative stress. In addition, animal cell lines in which the biosynthesis of enzymatic 
antioxidants was induced by Nrf2 activators such as sulforaphane were found to be highly 
resistant to UV-induced oxidative stress (468) and to oxidants such as H2O2 (565). Analogous 
increase in resistance to oxidative stress was also found in mouse models exposed to the Nrf2 
activator sulforaphane (469), and in yeasts genetically engineered to over-express the bZip 
transcription factor Yap1 (566). Enzymatic antioxidants are highly conserved across the 
domains of life, and the expression of human superoxide dismutase enzyme in yeast found was 
found to increase yeast resistance to oxidants such as paraquat (567). 
Aldehyde dehydrogenases (ADHs) are involved in the metabolism of toxic aldehydes produced 
during oxidative stress (497). One ADH and a benzaldehyde dehydrogenase were identified and 
quantified by the MudPIT analysis of Sporobolomyces yeast LEV-2, and both enzymes showed 
fold change increase in LEV-2 cultures exposed to 24 hours of UV-B irradiation (Figure 5.8). 
Superoxide dismutases (SODs) catalyse the conversion of a superoxide anion to H2O2 and O2, 
and play a critical role in protection against oxidative stress in all eukaryotes, including yeasts 
(496). Four SODs were identified in this study, and the expression levels of SODs were 
increased in UV-B irradiated LEV-2 cultures (Figure 5.8). This fold change increase of ADHs 
and SODs correlated with the increase in antioxidant, DPPH quenching, activity of extracts of 
yeast LEV-2 cultures exposed to 8 hours and 24 hours of UV-B (Figure 5.2/A), and with the 
observed reduction in yeast LEV-2 cell death (Figure 5.3), indicating that these enzymes 
protect yeast LEV-2 against UV-induced oxidative stress. These results are consistent with 
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previous studies of yeast S. cerevisiae exposed to oxidants such as H2O2 and to heat-shock 
induced oxidative stress (508), and suggests that the function of SODs and ADHs is conserved 
between S. cerevisiae and the yeast LEV-2. 
Catalases (Cat) facilitate the breakdown of H2O2 to O2 and H2O, and are major antioxidant 
enzymes in yeasts (496). A catalase identified in this study showed a moderate fold change 
reduction in yeast cultures irradiated for 2 hours to 8 hours ((Figure 5.8). Cytochrome C 
peroxidases (CCPs) catalyse the conversion of H2O2 to H2O, and have been implicated in yeast 
response to heat shock and oxidative stress (496,498). All of the five identified CCPs had 
reduced expression levels in yeast samples exposed to moderate duration of UV-B doses (1 
hour to 4 hours), and the results were ambiguous for LEV-2 cultures irradaated for 8 hours and 
24 hours. Isocitrate dehydrogenase (IDH) enzymes are involved in citric acid cycle, and 
catalyse the two-step oxidative carboxylation of isocitrate to α-ketoglutarate. IDHs exist in 
multiple isoforms which differ in the use of NAD+ or NADP+ as a cofactor, and in cellular 
localization to cytosol or mitochondria. While not direct antioxidants, IDHs play a part in 
cellular defences against RS by reducing NAD(P)+ to NAD(P)H to enable the regeneration of 
glutathione (GHS) and thioredoxins (495,500). This study identified two NAD+ dependant 
IDHs, both of which showed fold change increase in LEV-2 cultures irradiated for 8 hours and 
24 hours, and four NADP+ associated IDHs which displayed fold change reduction after 1 hour 
or longer UV-B exposure. The observed fold change reduction of LEV-2 IDH, CCP and Cat 
enzymes corresponds to the reduction in DPPH quenching observed for LEV-2 cultures 
exposed to 1 hour to 4 hours of UV-B (Figure 5.2), and is possibly a result of depletion of these 
enzymes by UV-B induced oxidative stress. Oxidative stress was reported to deplete 
antioxidants, especially GSH, in the yeast S. cerevisiae (568), but the extent of antioxidant 
depletion varied with the source and duration of stress (496,508). The depletion of GSH was 
reported also for UV-irradiated human skin models (557), indicating that oxidative stress has a 
similar effect on enzymatic antioxidants in diverse eukaryotic organisms. 
Glutathione peroxidase (Gpx) enzymes catalyse conversion of RS, such as H2O2, to non-
reactive compounds such as H2O, and are major eukaryotic enzymatic antioxidants (499). Two 
Gpx enzymes were identified in this study, and the lack of major fold changes of these enzymes 
(Figure 5.8) indicates that Gpx enzymes are stable during the oxidative stress. This is possibly 
because these enzymes catalyse RS conversion (ROOH + 2GSH  ROH + GSSG + H2O 
reaction) rather than the direct reduction of RS. This is in agreement with previous yeast studies 
of Gasch et al. (2000) and Yoshimoto et al. (2002), who identified that Gpx-encoding mRNAs 
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do not exhibit significant changes in stressed yeast S. cerevisiae (majority of identified fold-
changes were <= 1.5) (508,523).  
In summary, the fold change increase LEV-2 SOD, IDH and ADH enzymes exposed to UV-B 
induced stress suggest that this yeast responds to UV-B by increasing the production of 
enzymatic antioxidants. This fold change increase co-occurred with the reduction in yeast cell 
death rate (Figure 5.3) and with the increase in antioxidant activity, as measured by DPPH free 
radical quenching (Figure 5.2), and followed the fold change increase in bZip protein 
LEV_2_XP_007274754, which shares sequence similarity to yeast S. cerevisiae bZip 
transcription factor Yap1 and the animal bZip transcription factor Nrf2. This suggests that the 
Sporobolomyces yeast LEV-2 response to UV-induced oxidative stress is evolutionary 
conserved between yeast S. cerevisiae and animals, but further, phylogenetic, studies are 
required to describe the evolutionary relationship between enzymatic antioxidants of yeast 
LEV-2 and enzymatic antioxidant systems of other yeasts (such as S. cerevisiae) and animals. 
5.5.2.5 DNA repair and replication 
UV radiation is a genotoxic environmental agent that inflicts DNA damage by causing the 
oxidative stress and by inflicting direct damage to the DNA macromolecule. UV-A and UV-B 
light induce the cellular production of reactive oxygen-derived species, such as H2O2 (39,40), 
and the evidence for UV-induced oxidative damage has been found in algae (559), plants (560), 
animals (39,557) and bacteria (504). UV-induced oxidative stress is also considered to be a 
major source of UV-induced damage in yeasts (569). During oxidative stress, the highly 
reactive hydroxyl radicals (OH•) react with the DNA molecule and cause the formation of 
single and double stranded DNA breaks, base modifications and cross-linkage with proteins 
(5). In addition to inducing oxidative stress, UV-B light is also absorbed by DNA pyrimidine 
bases, thymine and cytosine, and induces photoreactions that lead to formation of  mutagenic 
DNA photoproducts, such as cyclobutane–pyrimidine dimers (CPDs) and 6–4 photoproducts 
(570), as well as formation of single stranded DNA breaks (37).  
The maintenance of DNA is essential for all forms of life, and DNA repair mechanisms are 
well conserved across all domains of life, including bacteria, yeasts and animals (571). The 
photoreactivation mechanism that utilizes photolyase enzymes to repair CPDs and 6–4 
photoproducts is considered to be the oldest and the simplest mechanism of DNA repair, as evinced 
by existence of photolyases in all domains of life, including archaea, and by the fact that it only 
utilizes a single enzyme (572). Contrasted to photoreactivation are excision repair mechanisms that 
do not repair the DNA damage, but instead remove the damaged section of DNA and replace it with 
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newly synthesized nucleotides (569). These mechanisms comprise three major categories: base 
excision repair (BER), which repairs small changes in DNA that do not alter the DNA helix 
structure; nucleotide excision repair (NER) which replaces “bulky” DNA adducts such as thymine 
dimers and 6,4-photoproducts; and mismatch repair mechanisms that repair erroneous insertions, 
deletions and incorporations of nucleic bases during DNA replication and recombination (571,573). 
Unlike the photoreactivation which utilizes only a single enzyme, excision repair pathways are 
comprised of numerous enzymes. For example, the BER pathway utilizes DNA glycosylase to 
recognize DNA damage and remove damaged nucleic base; apurinic/apyrimidinic (AP) 
endonuclease, AP lyase and phosphodiesterase to excise the deoxyribose phosphate residue left-over 
after removal of damaged nucleic base; DNA polymerase to repair the introduced DNA gap; and 
DNA ligase to connect the newly synthesized DNA with the rest of the DNA strand. The NER 
mechanism is also comprised of multiple enzymes including proteins that recognize DNA damage, 
endonucleases, helicases, ligases and other proteins required for regulation of the process (569). 
Notably, not all organisms possess all of the described DNA repair mechanisms; for example, 
photolyases required for photoreactivation repair of CPDs have been reported in bacteria, fungi, 
plants, invertebrates and many vertebrates, but not in humans, while photolyases that reverse 6–4 
photoproducts  have been found in fly Drosophila, frog Xenopus laevis, and certain snakes, but not 
in E. coli, yeast S. cerevisiae or humans (569).  
Six yeast enzymes involved in the repair and replication of DNA were identified and quantified 
in this study (Figure 5.9). Identified proteins included DNA polymerases, DNA helicase, 
exonuclease and DNA ligase, all of which are involved in repair of single strand DNA breaks 
by BER and in the repair of double-strand breaks by non-homologous end-joining (574,575). In 
addition, one dUTP pyrophosphatase enzyme was identified and quantified; this enzyme is 
essential for DNA replication and repair as it prevents erroneous incorporation of uracil into the 
DNA (576). The expression levels of these enzymes were increased in the yeast LEV-2 sample 
exposed to 24 hours of UV irradiation (Figure 5.9), indicating that long-term UV-induced stress 
activates DNA repair in yeast LEV-2. This increase in expression of DNA repair enzymes 
correlated with the reduction in yeast cell death (Figure 5.3), suggesting that the yeast LEV-2 
adapts to UV-induced stress by increasing the rate of DNA repair. 
Notably, photolyase enzymes were not identified in this study, possibly because these proteins 
have high molecular mass and charge (for example, the yeast S. cerevisiae photolyase encoded 
by PHR1 gene is a 66 kDa protein with pI value of 9.2), and it was demonstrated that MudPIT 
detection rates are low for large, charged proteins (577).  
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5.5.2.6 Heat-shock proteins and related proteins 
Heat shock proteins (HSPs) and chaperones are highly conserved across all domains of life 
(578). HSPs are mainly involved in resistance to heat-induced stress, while chaperones also 
play a role in protein folding and unfolding, assembly of protein complexes, protein transport, 
cell-cycle control and protection against apoptosis (579). The MudPIT analysis of LEV-2 yeast 
exposed to long-term UV irradiation identified and quantified 24 proteins annotated as heat-
shock proteins or chaperones (Figure 5.10). The expression of the majority of HSPs was 
increased in samples exposed to 24 hours of UV-B, co-occurring with the increase in 
expression of other stress resistance proteins (Figure 5.4) and reduction in cell death (Figure 
5.1). This increase in expression was particularly noticeable for 10 kDa mitochondrial HSPs, 
Chaperonin ATPases TCP-1 and 90 kDa HSP proteins, indicating these families of HSP 
proteins play a major part of stress response in yeast LEV-2. This is possibly because the 90 
kDa HSPs are involved in cellular signalling in addition to the function in stress response (580), 
and the TCP-1 chaperonins also mediate the ATP-dependent renaturation of proteins to assist in 
repair of UV and oxidative damage (581).  
Interestingly, the expression levels of multiple HSP proteins, classified as 60 kDa HSPs and 70 
kDa HSPs, were reduced in the LEV-2 samples exposed to 1 hour - 4 hours of UV-B (Figure 
5.10). These results match a previous study of Gasch et al. (2000) that measured mRNA levels 
in yeast S. cerevisiae exposed to different sources of stress, and identified a significant increase 
in levels of mRNAs encoding 12 kDa, 30 kDa, 42 kDa and 104 kDa HSPs during heat shock, 
while levels of mRNAs encoding other HSPs were largely unchanged (508). The related study 
of Yoshimoto et al. (2002), measured mRNA levels of yeast S. cerevisiae under different 
environmental stresses (not including UV), and also identified that changes in levels of HSP-
encoding mRNAs vary with the source and the duration of stress  (508,523). The reduction in 
HSP levels observed for UV-exposed yeast LEV-2 is possibly due to the reduction in protein 
biosynthesis observed in samples exposed to 1 hour, 2 hours and 4 hours of UV-B (Figure 5.4) 
and indicates that 60 kDa HSPs and 70 kDa HSPs are unlikely to be a major part of UV 
response in this yeast. 
5.5.2.7 Enzymes involved in MAA biosynthesis 
Extremophile fungi inhabiting environments under high solar irradiance are known to produce 
UV-protective mycosporines such as mycosporine-glutamicol-glucoside (582,583), and certain 
freshwater Rhodotorula and Cryptococcus yeasts have been shown to produce UV-protective 
red pigments and fungal mycosporines when exposed to UV (584). The proteome of UV-
tolerant yeast LEV-2 was analysed for enzymes involved in biosynthesis of mycosporines and 
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mycosporine-like amino acids (MAAs) to identify whether this yeast produces these 
compounds in response to UV-induced stress. Several enzymes involved in the shikimic acid 
pathway and biosynthesis of MAAs (Figure 5.12) were identified and quantified in the 
proteome of LEV-2 (Figure 5.11). These included enzymes involved in the biosynthesis of 
chorismate (chorismate mutase and chorismate synthase) and MAA biosynthesis enzymes 3-
dehydroquinate synthase (DHQS), Transaldolase (TA) and hybrid NRPS-like synthase. 
However, multiple enzymes critical for MAA biosynthesis were not detected in this yeast 
(OMT, EVS, DHQS and DAHPS), and the expression levels of identified proteins were 
reduced in irradiated LEV-2 cultures (Figure 5.11), suggesting that yeast LEV-2 does not 
produce MAAs or mycosporines when exposed to UV-B radiation.  
 
Figure 5.12 Postulated biosynthetic pathways to MAAs.  
Mycosporine-like amino acid (MAA) biosynthesis involves shikimate pathway branching away from 
production of shikimic acid at DHQ, with DHQS playing critical role in synthesis of 4-deoxygadusol 
(4-DG). Alternate route of production is via pentose-phosphate pathway and involves multi-step 
conversion of SH-7P into 4-DG by EVS and OMT enzymes; Pathways converge at 4-DG, precursor 
of mycosporines and MAAs. Full arrows show experimentally validated reactions and enzymes, 
while dotted arrows show postulated reactions catalysed by one or more unknown enzymes. 
Enzymes detected in this study are marked with star. Figure adapted from (585). 
To empirically verify the presence (or absence) of the MAAs, UV absorbance spectra were 
measured for the methanol extracts of cell pellets of UV-irradiated LEV-2 cultures and non-
irradiated controls. The UV absorbance of irradiated LEV-2 cultures was considerably higher 
than the absorbance of non-irradiated controls (Figure 5.13), suggesting that yeast LEV-2 
produces UV-absorbing compounds during UV-B exposure. The methanol extract of irradiated 
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LEV-2 cultures, however, was red-pigmented (as opposed to MAA extracts, which are 
colourless), the absorbance maximum of the extract was ~300 nm, which is different from 
known MAAs, and the preliminary HPLC analysis of the methanol extract of the irradiated 
LEV-2 culture did not detect the absorbance peak characteristic of known MAAs [data not 
shown]. These results suggested that the Sporobolomyces sp. yeast LEV-2 does not produce 
MAAs, but instead produces currently uncharacterized UV-absorbing red pigment. This is in 
accordance with previous research of Moliné et al. (2009) who found that yeasts producing 
carotenoid red pigments are highly tolerant to UV, when compared to unpigmented yeast 
strains (505).  
  
Figure 5.13 UV absorbance and pigment produced by yeast sample LEV-2  
The figure displays UV-absorbance spectrum methanol extract of LEV-2 yeast culture cultivated 
without the UV exposure (blue) overlaid with the spectrum of extract of LEV-2 culture exposed to 
UV-B (red). The samples were cultivated for 24 hours and standardised to ~3 x 10
7
 cells/mL. The 
curves present mean values of absorbance spectra of three experiments. The photograph of 
methanol extracts of UV-exposed culture (T.24h) and non-irradiated control (Control) is presented in 
figure B); the photograph has been cropped and no post-processing was performed. 
5.5.3 Proposed model of yeast LEV-2 stress response 
The results of the quantified proteome of LEV-2 exposed to extended UV-B irradiation, 
presented in section 5.4, were related to the antioxidant activity of cell-lysis extracts of LEV-2 
cultures, measured by the DPPH assay (Figure 5.2), and to survival rates of LEV-2 cultures 
exposed to long-term UV-B irradiation (Figure 5.1) to construct the model of UV-stress 
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This comparison of yeast viability, antioxidant activity and protein fold changes of UV-exposed 
LEV-2 suggested that a moderately long UV-B irradiation (~1 hour) caused the fold change 
reduction in the yeast LEV-2 proteins involved in the carbohydrate metabolism, energy 
metabolism and protein biosynthesis (Figure 5.4), caused the moderate (~25%) reduction in the 
yeast viability (Figure 5.1), and triggered fold change increase in cellular signalling proteins 
related to Ras and Yap1 pathways (Figure 5.5, Figure 5.6). The continued irradiation further 
reduced the energy metabolism and viability of yeast cultures, with the maximal impact 
observed after 4 hours of UV-B. The expression level fold changes of proteins involved in 
yeast energy metabolism, however, increased after 8 hours of UV-B exposure and reverted to 
levels close to the control after 24 hours of UV-B exposure (Figure 5.4). This co-occurred with 
the reduction of yeast cell death, observed after 8 hours or longer UV-B exposure (Figure 5.3), 
and with an increase in expression levels of LEV-2 stress-response proteins such as enzymatic 
antioxidants (Figure 5.8) and certain heat-shock proteins (Figure 5.10). The levels of stress-
response proteins also correlated with the free-radical quenching activity of the yeast cell 
extracts, as measured by the DPPH free radical scavenging assay (Figure 5.2).  
These results can be best explained by proposing a yeast stress response and adaptation model, 
illustrated in the Figure 5.14. The model postulates that yeast UV response can be modelled in 
a four-step process: 1) UV exposure inflicts direct damage to the cell and induces oxidative 
stress, which in the short term induces bZip protein mediated signalling, analogous to Nrf2 
signalling in animals or Yap1 signalling in the yeast S. cerevisiae (“signalling” phase); 2) The 
damage caused by the extended exposure to UV impairs carbohydrate and energy metabolism 
of the cell, and RS deplete cellular antioxidants (“stress” phase); 3) As the cellular defences are 
expressed, the yeast undergoes an “adaptation” phase where newly synthetized antioxidant 
enzymes (SODs, Cat, GTRx and NQR) and small molecule antioxidants (e.g. glutathione, 
ascorbic acid and α-tocopherol), DNA-repair enzymes, and UV-protective metabolites such as 
UV-absorbing carotenoids reduce the stress level and cellular metabolism starts recovery; 4) 
this leads to a “stress resistant” phase of growth where cellular metabolism and growth stabilize 
at a rate lower then pre-stress conditions.  
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Figure 5.14 Proposed proteomics-based cellular response model for the Sporobolomyces 
yeast LEV-2 response to extended UV-B exposure 
Figure presents the proposed model of stress response of UV-tolerant yeast LEV-2. The fold 
changes of proteins involved in stress response (blue line), and proteins involved in carbohydrate 
metabolism (red line) correspond to main (left side) Y-axis. The yeast survival curve (green line) and 
the DPPH quenching activity of yeast cell extracts (purple line) are expressed in percentages and 
correspond to the secondary (right side) Y-axis. The phases of stress response are denoted on the 
bottom on the chart. The chart is based on MudPIT experiment of LEV-2 yeast, and the grey shaded 
part of the chart represents the predicted patterns of yeast proteome, based on the “adaptation 
model” explained in the text. 
The induction of stress resistance by low-intensity, sub-lethal, stress has been previously 
described in different eukaryotic models, including the yeast S. cerevisiae (586), mammalian 
cell cultures (587) and in-vivo animal models (469). For example, in a study by Davies et al. 
(1995), S. cerevisiae cultures conditioned by exposure to low concentration (0.4 mM) of H2O2 
were found to survive, with ~90% viability rate, the subsequent exposure to high concentration 
(3 mM) of H2O2, lethal to unconditioned yeasts. The microarray studies of S. cerevisiae 
exposed to different environmental stresses, such as heat-shock, H2O2 and toxic metals, found 
also that induction of proteins involved in stress response is transient, and the expression levels 
revert to levels close to non-stressed yeast during the prolonged stress as yeast adapts to stress 
(507). Similar adaptation was observed for the fly D. melanogaster and for mouse cell cultures, 
where the exposure to a low dose of H2O2 conditioned the observed animals or cells to the 
following oxidative shock caused by high concentration of H2O2 (588). In animals, the 
adaptation to oxidative stress is mediated by the Nrf2 pathway; The low dose of oxidant, such 
as H2O2, induces the transcription of antioxidant and cytoprotective genes regulated by the bZip 
transcription factor Nrf2, and stimulates an increase in tolerance to oxidative stress (464). 
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Numerous studies of mouse models and animal cell lines have demonstrated that pre-treatment 
by Nrf2-activators such as SFN increased tolerance to oxidative stress in animals (156). For 
example, Nrf2 upregulation was found to protect human cells against cigarette smoke (93), UV-
induced oxidative damage (225) and toxicity of drugs such as cisplatin (186). The activation of 
Nrf2 was also shown to protect mouse models against UV-induced carcinogenesis (469), while 
the Nrf2-knockout mouse models were shown to lack the ability to adapt to oxidative stress 
caused by carcinogens such as benzo[a]pyrene (184), and by drugs such as acetaminophen 
(185). bZip transcription factors have been shown to be evolutionary conserved between yeasts 
and animals (408,510), and S. cerevisiae bZip protein Yap1 regulates the response to oxidative 
stress in yeast (475), indicating that the molecular mechanism of adaptation to oxidative stress 
is evolutionary conserved between yeasts and animals.  
In this study, the Sporobolomyces yeast LEV-2 bZip protein LEV-2_XP_007274754.1 showed 
a significant fold change increase in yeast cultures exposed to UV-B (Figure 5.5). The increase 
in expression of the bZip protein matched the results of previous studies that showed increase 
in expression of S. cerevisiae Yap1 protein in yeast exposed to oxidative stress (516) and the 
increase in bZip protein in animal cells exposed to oxidants (518,519). This suggests that the 
LEV-2 bZip protein LEV-2_XP_007274754.1 is a homolog of the S. cerevisiae transcription 
factor Yap1 and the vertebrate transcription factor Nrf2, and that the bZip protein mediated 
response to oxidative stress is conserved between LEV-2, S. cerevisiae and animals, as was 
previously predicted by our in-silico studies (408,510). It should be noted, however, that further 
studies are required to quantify the relative contributions of different signalling pathways in 
stress response of yeast LEV-2. 
5.6 Conclusions and further research 
The primary objective of this study was to determine if homologs of the vertebrate bZip protein 
Nrf2 play a role in stress response of UV-tolerant yeasts, such as carotenoid-producing yeasts 
of Genus Sporobolomyces. The quantitative MudPIT analysis of the Sporobolomyces yeast 
LEV-2 exposed to long term UV-B irradiation was followed by the functional annotation of the 
yeast LEV-2 proteome. This study identified four basic leucine zipper (bZip) proteins, and 
suggested that a bZip protein designated LEV-2_XP_007274754.1 is a homolog of the yeast 
bZip protein Yap1 and animal bZip protein Nrf2, and initiates the response to UV-induced 
oxidative stress in yeast LEV-2.  
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The secondary goal of this study was to describe the UV-stress response of yeast LEV-2, and 
evaluate if the stress response is conserved between LEV-2, other yeasts such as S. cerevisiae 
and animal models. A quantitative MudPIT proteomics analysis of LEV-2 cultures exposed to 
extended UV-B irradiation led to the proposal of a 4-step model, where 1) short-term UV 
irradiation induces cellular signalling; 2) depletion of cellular antioxidants and reduction in 
cellular metabolism; 3) adaptation by high expression of antioxidant enzymes and production 
of UV-absorbing red pigments; and 4) shift into stress-resistant phase of growth characterized 
by high expression of antioxidants and reduced metabolism. This model (Figure 5.14) matches 
the adaptation to stress observed also in S. cerevisiae and in animals, indicating that the 
molecular mechanisms of adaptation to oxidative stress are evolutionary conserved between 
Basidiomycota fungi, Ascomycota fungi, and animals.  
Further, currently ongoing, research will focus on the sequencing and assembly of the genome 
of the yeast LEV-2 to facilitate phylogenetic studies of bZip proteins and antioxidant enzymes 
of LEV-2 and to enable the database matching of tandem mass spectra generated from LEV-2 
proteins to kelch-like proteins encoded by this yeast. The DNA sequences of bZip proteins and 
kelch-like proteins of LEV-2 will allow for the design of primers for qPCR analysis to compare 
the mRNA levels of these proteins between the UV-exposed LEV-2 and a non-irradiated 
control. The yeast genome sequence will also be used to determine the protein sequences of 
bZip and kelch-domain proteins in LEV-2. This will enable the investigation of protein-protein 
interactions of these proteins in UV-stressed LEV-2 to investigate whether the yeast bZip 
proteins interact with kelch-like proteins, as observed in the animal Keap1-Nrf2 pathway.  
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6.1 Evolution of Keap1-Nrf2 pathway 
The first hypothesis of this project was that the vertebrate basic leucine zipper (bZip) 
transcription factor Nrf2 has homologs in microorganisms, and that these homologs are 
involved in the regulation of microbial response to oxidative stress.  
This hypothesis was tested by the phylogenetic analysis of the evolution of Nrf2 and its 
inhibitor Keap1. During the first part of this phylogenetic study, presented in chapter 2, a novel 
HMM-based pipeline for data mining of distant homologs was developed and utilized to 
identify the microbial homologs of Nrf2 and Keap1 in the GenBank and UniProt protein 
databases. The sequences encoding the homologs of vertebrate Nrf2 protein were identified in 
sequenced genomes of fungi and animals, but not in bacterial genomes, while the sequences 
encoding proteins related to human Keap1 protein were identified in genomes of organisms 
from all domains of life. Phylogenetic reconstructions of these sequences identified that the 
evolution of genes encoding homologs of Keap1 and Nrf2 proteins followed the putative 
evolution of major eukaryotic phyla, with the exception of sequences in nematode worms, 
which were grouped with sponges (for Keap1 protein sequences) or fungi (for Nrf2 protein 
sequences). These results indicated that the Nrf2 based signalling evolved prior to the 
divergence of fungi and Metazoa, and that homologs of vertebrate Nrf2-encoding genes exist in 
fungi and animals. The unexpected position of Genus Caenorhabditis implied that the Nrf2 
signalling of nematode worms differs from the rest of animals (408), which is consistent with 
empirical studies that found that the SKN-1 protein, a C. elegans homolog of vertebrate Nrf2, 
does not interact with Kelch-like proteins (324), but is instead controlled by WDR-23 protein 
similar to human beta-transducin repeat-containing protein (β-TrCP) (436). The C. elegans 
WDR-23 and human β-TrCP proteins share structural topology and sequence similarity (408), 
and the vertebrate Nrf2 is known to be ubiquitinated and degraded in Keap1-independent 
fashion by β-TrCP:SCF E3 ubiquitin ligase complex (140), implying that nematodes possess 
Keap1-independent, but not Keap1-dependant mechanism of Nrf2 regulation. These results also 
suggest that C. elegans might not be a suitable model for studies of molecular mechanisms 
controlling the activity of Nrf2 in higher animals, and that the other invertebrates such as the fly 
Drosophila melanogaster, which shares Keap1-dependant control of Nrf2 (435), are more 
suitable invertebrate models for the studies of Keap1-Nrf2 interaction. 
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Based on the results presented in chapter 2, it was postulated that the evolution of Keap1-Nrf2 
pathway might have been driven by the evolutionary pressures incurred by the rise of oxygen 
levels during the great oxygenation event (GOE). This assumption was tested by reconstructing 
the temporal framework of evolution of Nrf2 proteins, and by comparing the fossil-calibrated 
phylogenetic tree to geophysics models of the atmospheric oxygen levels over geological time 
periods. The results of this study (510), presented in the chapter 3, indicate that the time frame 
of major divergence points in evolution of Nrf2 co-occurs with the rise in oxygen levels in 
stages 4 and 5 of oxygenation of the atmosphere (405), during which the atmospheric 
concentration of oxygen started to rise towards the present levels. The analysis of evolutionary 
pressures on the Nrf2-encoding DNA sequences from microorganisms and animals indicated 
that the cyanobacterial Nrf2-like sequence (used as an outgroup) and fungal sequences were not 
under significant evolutionary pressure, presumably due to low oxygen levels in Precambrian 
era, while animal sequences were under strong selective pressure to retain the functional Nrf2 
sequence, possibly caused by the pressure to retain the Nrf2-mediated stress response in the 
oxidizing environment of the Phanerozoic era. The examination of protein sequence of Nrf2 
homolog of the worm Caenorhabditis elegans and the DNA sequence encoding it matched the 
results of our previous study (408), and indicated that SKN-1 gene (C. elegans homolog of gene 
encoding the Nrf2 protein in humans), was not under significant selective pressure and that the 
time-frame for its divergence from the basal metazoan phylum did not match fossil records or 
the commonly accepted model of animal evolution (589). This was in contrast to all the other 
examined animal Nrf2-encoding genes which were found to be under selective pressure and 
matched the putative model of animal evolution 
In summary, the research presented in chapters 2 and 3 of this thesis provided phylogenetic, in-
silico, evidence to support the hypothesized existence of homologs of Nrf2 in fungi and all 
major animal phyla, and demonstrated the co-occurrence of major changes in atmospheric 
oxygen levels with the evolution of Nrf2 signalling. Phylogenetic reconstructions suggested 
that nematodes have markedly different control of Nrf2 signalling than other animals, and 
might not be a suitable model for the study of Keap1-dependant mechanisms of Nrf2 
degradation in animals. These studies also suggested that basal metazoans, such as cnidarians 
or sponges, might possess the Keap1-dependant control of Nrf2 activity; this is in accordance 
with the previous bioinformatics study of the sea anemone Nematostella vectensis by Goldstone 
(2008), who identified that the genome of N. vectensis encodes the homologs of proteins 
involved in the Keap1-Nrf2 pathway (402), but these in-silico results are yet to be empirically 
confirmed. 
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6.2 Mycosporine-like amino acids for activation of Nrf2 
The second hypothesis of this project was that some microorganisms produce small molecule 
secondary metabolites for endogenous control of a bZip protein mediated response to oxidative 
stress, and that such compounds have the potential to control the activity of Nrf2 in vertebrates. 
The mycosporine-like amino acids (MAAs) are a class of low molecular mass, UV-absorbing 
compounds, produced by a wide range of microorganisms (64). While primarily associated 
with UV protection (230), certain MAAs are also natural antioxidants (232), and have also been 
associated with protection against osmotic, desiccation and thermal stresses (64,231–234).  
The research described in chapter 2 utilized the in-silico model of Keap1-Nrf2 protein-protein 
interaction (PPI) to evaluate if the MAAs have the potential to inhibit the ubiquitination and 
degradation of Nrf2 by binding to the Keap1 kelch domain β-propeller to disrupt the interaction 
between Keap1 and Nrf2 proteins. This structure based virtual screen identified that certain 
MAAs, such as mycosporine-glycine and porphyra-334, have the potential to bind to the human 
Keap1-Nrf2 binding pocket, and implied that MAAs could disrupt the CRL
Keap1 
protein 
complex to inhibit the degradation of Nrf2 and enhance the expression of proteins encoded by  
genes regulated by the transcription factor Nrf2.  
The in-silico study was translated into an in-vitro model in the study presented in chapter 4. 
This study used the fluorescence polarization (FP) assay (159) and the thermal shift assay (294) 
to quantify the competitive inhibition of human Keap1-Nrf2 protein-protein interaction (PPI) 
by MAAs porphyra-334, shinorine and palythine. The Keap1-Nrf2 PPI was modelled in vitro 
using the human Keap1 Kelch-repeats β-propeller domain and the synthetic peptide FITC-β-
DEETGEF-OH containing the ETGE motif with high affinity for the Keap1 β-propeller (135). 
The results of these assays demonstrated that MAAs porphyra-334 and shinorine are 
competitive inhibitors of Keap1-Nrf2 binding in vitro. While the activities of these compounds 
were not very high (with 50% inhibition of Keap1-peptide binding attained at concentration of 
~100 µM), it is important to note that inhibition of the CRLKeap1 protein complex activity does 
not necessary require the inhibition of high affinity Keap1-(Nrf2-ETGE motif) binding, but can 
also be achieved by the inhibition of low affinity Keap1-(Nrf2-DLG motif) interaction (135). 
The low affinity, Keap1-(Nrf2-DLG motif), interaction was not investigated in the study 
presented in chapter 4, but as the MAAs interact with Keap1 β-propeller, it would be expected 
that MAAs also inhibit the Keap1-(Nrf2-DLG motif) interaction. That is because the DLG 
motif of Nrf2 interacts with the same binding pocket on the Keap1 β-propeller as the ETGE 
motif (135). The analysis of Nrf2-DLG and Nrf2-ETGE motif binding affinities for the Keap1 
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β-propeller was performed by Tong et al. (2006), and the study concluded that the affinity of 
Nrf2-ETGE motif for the Keap1 β-propeller is approximately 2 orders of magnitude higher than 
the affinity of Nrf2-DLG motif (590). Because of this, the MAAs porphyra-334 and shinorine 
have the potential to disrupt the activity of CRL
Keap1 
complex at concentration considerably 
lower than 100 µM. While the study of Nrf2 activation by MAAs in vivo was beyond the scope 
of this thesis, a recent study by Ryu et al. (2015) (463) reported that MAA porphyra-334 
activated the Nrf2 signalling pathway in UV-A irradiated human cell model, which is in 
accordance with in-silico models and in-vitro studies presented in chapters 2 and 4. The study 
by Ryu et al. found that porphyra-334 is active in concentrations as low as 10µM, which is 
below the 100 µM used in our in-vitro experiments, and is consistent with the assumption that 
activation of Nrf2 by inhibition of Keap1 binding to Nrf2-DLG is achievable by porphyra-334 
in concentration considerably lower than 100 µM. 
In summary, the in-silico study presented in chapter 2 and the in-vitro experiments described in 
chapter 4 demonstrate that certain MAAs, produced by marine microorganisms and algae, have 
the potential activate the Nrf2 signalling in animals. This activity of MAAs is yet to be 
validated in vivo. 
6.3 Investigation of a yeast model of Nrf2-mediated stress response 
The third hypothesis of this research project was that a microorganism based Nrf2 activation 
assay can provide a feasible alternative to animal cell-based assays for pre-animal studies. This 
hypothesis was tested by examining, at the proteome level, the UV-B response of the UV-
tolerant yeast Sporobolomyces sp. designated LEV-2. The study presented in the chapter 5 of 
this thesis used the quantitative MudPIT approach to quantify the expression of yeast proteins 
in LEV-2 yeast cultures exposed to UV-B radiation, ranging from no UV to 24 hours of 
exposure. The study identified 751 yeast proteins for which expression levels could be 
quantified for all samples. The fold changes of ~30% of quantified yeast proteins  were 
significantly reduced in UV-irradiated samples exposed to 1 and 2 hours of UV-B, while the 
fold changes of ~37% of proteins were significantly increased in LEV-2 exposed to 24 hours of 
UV-B. The functional annotation of these proteins indicated that yeast metabolism and stress-
response are inhibited after a moderately long (1 hour) exposure to UV, and this effect was 
confirmed by DPPH free radical quenching assay of yeast cell lysates. The long-term exposure 
to UV-B led to recovery of yeast metabolism and an increase in expression of LEV-2 stress-
response proteins such as catalase, superoxide dismutases and glutathione peroxidases. This 
increase in stress response followed the increase in expression levels of a basic leucine zipper 
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(bZip) transcription factor of yeast LEV-2. These results indicated that the Nrf2-like bZip 
transcription factor is involved in oxidative stress response in LEV-2, and are in accordance 
with the results of phylogenetic studies presented in chapters 2 and 3, which identified Nrf2 
homologs in fungi (408,510). In addition, the bZip protein Yap1 is known to play a role in the 
response to oxidative stress in the yeast Saccharomyces cerevisiae (330), and Yap1 shares a 
sequence similarity to the human Nrf2 protein (Appendix A-7). While this implies that the 
yeast LEV-2 possesses the stress response signalling similar to animal Nrf2-mediated stress 
response, no kelch-domain proteins were identified in the MudPIT analysis of LEV-2, possibly 
due to problems with protein extraction due to the large size of kelch-domain proteins and their 
association with the cytoskeleton (577). Unlike vertebrate Nrf2 and its homolog in the fly 
Drosophila melanogaster, the S. cerevisiae bZip transcription factor Yap1 has not been 
reported to be ubiquitinated and degraded by the kelch-protein associated complex (496), and 
the bioinformatics studies presented in chapters 2 and 3 suggested that fungi, in general, do not 
possess a Keap1-like inhibition of Nrf2. The protein-protein interactions of bZip proteins of 
LEV-2 are, however, currently unknown, and further research is required to determine if this 
yeast would be a suitable model for Keap1-Nrf2 interaction in vertebrates. In addition, the 
study presented in Chapter 5 utilised UV as source of oxidative stress and the UV radiation is 
also known to activate DNA-damage specific stress response pathways in animals as well as 
fungi (471). Furthermore, the discovered LEV-2 bZip transcription factor could also be 
functionally homologous to AP-1 bZip transcription factors involved specifically in UV 
response, and the sequence similarities could not be evaluated due to the lack of of genome 
sequence of yeast LEV-2. Thus the further research, possibly by exposing LEV-2 yeast to 
oxidants such as H2O2, is required to determine if bZip transcription factor discovered in yeast 
LEV-2 is involved in response to UV-induced DNA damage or specific response to oxidative 
stress. 
In summary, the MudPIT analysis of UV-stress response of the Sporobolomyces yeast LEV-2 
quantified the yeast response to UV-induced oxidative stress, led to the proposal of a stress 
response model for this UV-tolerant yeast and identified that a bZip transcription factor is 
likely involved in stress response of LEV-2. However, the validation (or refutal) of the 
hypothesis that stress-resistant yeast can provide an in vivo model of vertebrate Nrf2-based 
stress response requires further research to identify Keap1-like proteins in this yeast and to 
describe the protein-protein interactions of kelch-domain proteins and bZip transcription factors 
in LEV-2. 
 
Chapter 6: General discussion 
Page 177 of 230 
6.4 Conclusions 
This thesis examined the evolution of the Keap1-Nrf2 pathway, the role of bZip proteins 
similar to the vertebrate transcription factor Nrf2 in yeast response to UV-induced oxidative 
stress, and assessed the potential for the activation of Nrf2 regulated genes by mycosporine-like 
amino acids. Based on the studies described in chapters 2 – 5 and discussed in this chapter, the 
conclusions of this thesis are the following: 
1. The genomes of animals and certain fungi, such as UV-tolerant yeasts of the Genus 
Sporobolomyces, encode bZip transcription factors homologous to the human Nrf2 
protein. Nrf2-mediated response to oxidative stress possibly evolved under the 
selective pressures incurred by the rise in levels of atmospheric oxygen over geological 
time. 
2. The mycosporine-like amino acids, small compound natural products associated with 
taxonomically diverse marine organisms, are competitive inhibitors of human Keap1-
Nrf2 interaction in vitro. 
These conclusions provide a strategic platform for future research into the therapeutic benefits 
of microbial natural products that have evolved conjointly with the Keap1-Nrf2 antioxidant 
defence. Possible areas for future research are now described. 
6.5 Future research 
6.5.1 Phylogenetic study of animal antioxidant response elements 
The genes under transcriptional control of the cis-promotor DNA motif known as antioxidant 
response element (ARE) have been studied in multiple human and mouse cell lines, and in 
mouse animal models (117), but ARE motifs have not been extensively studied in other 
animals. The assembled and annotated genomes of a large number of animals from all major 
animal phyla are currently available in the public domain, and a detailed bioinformatics study 
of ARE sequences in these organisms presents an opportunity to examine the genes under Nrf2 
control in evolutionary distant animals, and to study the evolution of ARE motifs over 
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6.5.2 Network biology approach to evolution of Keap1-Nrf2 pathway 
Multiple microarray, ChIP-Seq and proteomics studies were conducted on mouse models,  and 
on mouse and human cell lines, to identify the genes transcriptionally activated by Nrf2 
(125,128,129,180). Yet, the genes activated by Nrf2 have been less studied in other animal 
models, such as the fly Drosophila melanogaster and the worm Caenorhabditis elegans. 
Protein-protein interactions (PPIs) have been systematically characterized in these model 
organisms, and are deposited in PPI databases such as PRIDE (591) and STRING (592). The 
analysis of cellular PPI interaction networks of the Keap1 protein and the proteins encoded by 
Nrf2 activated genes would provide a comparison of biological functions regulated by Nrf2 in 
different model organisms, and allow the reconstruction of the evolution of Nrf2 regulated 
functional networks in animals. In addition, the analysis of these PPI networks would also 
allow the prediction of PPI hubs involved in the “dark side” effects of Nrf2 activation such as 
the skin pathologies observed in mouse models over-expressing Nrf2 protein (228,229).  
6.5.3 Analysis of Keap1-Nrf2 interaction in the yeast LEV-2 
The research presented in Chapter 5 of this thesis identified the yeast LEV-2 proteins involved 
in response to oxidative stress, compared the fold change patterns of these proteins relative to 
the duration of UV-B exposure, and identified that a bZip transcription factor is likely to 
activate the stress response in this yeast. However, the Keap1-like proteins of LEV-2 were not 
detected, and the protein-protein interactions (PPIs) of LEV-2 bZip transcription factors were 
not identified. Thus, further research is required to identify if Keap1-like proteins play a part in 
the control of stress response in LEV-2. Genome sequencing of this yeast would enable 
multiple experiments to examine kelch-domain proteins. For example, a sequenced genome 
would allow identification of potential Keap1-like proteins in this yeast and allow currently 
unassigned mass spectra to be matched to LEV-2 kelch domain proteins. In addition, in-silico 
translation of LEV-2 ORFs identified from the sequenced genome would allow a calculation of 
masses of potential bZip:kelch-domain protein complexes, which would facilitate a western 
blot based examination of such complexes in LEV-2. Finally, the knowledge of DNA 
sequences encoding the kelch-domain and bZip proteins in this yeast would enable the design 
of siRNAs for knock-down of expression of bZip proteins to examine the effect of bZip 
knockdown to LEV-2 stress response. 
 
 
Chapter 6: General discussion 
Page 179 of 230 
6.5.4 Examination of Keap1-Nrf2 interaction in basal metazoans 
The Keap1-Nrf2 pathway is well described in vertebrates, the fly Drosophila melanogaster 
(435) and the nematode Caenorhabditis elegans (436). The genome of the basal metazoan 
Nematostella vectensis encodes homologs of vertebrate Nrf2 and Keap1 proteins (402,408), and 
the expression of the Nrf2 homolog of the cnidarian Hydra magnipapillata was found to be 
increased in injured hydra (593), but Keap1-Nrf2 protein-protein interaction was not studied in 
the basal metazoans. Several basal metazoan model organisms such as Hydra magnipapillata, 
Nematostella vectensis and Hydractinia echinata are suitable for cultivation in the laboratory 
(594,595) and genomes of these animals have been assembled (596–598), making them suitable 
models for study of Keap1-Nrf2 interactions. A study of PPI of Keap1-Nrf2 in a cnidarian 
model, for example by immunoprecipitation with an anti-Keap1 antibody, followed by western 
blotting with an anti-Nrf2 antibody, would elucidate if these proteins interact in cnidarian 
models. In addition, quantitative proteomics or microarray based quantification of gene 
expression in the cnidarian model subjected to Nrf2 and Keap1 knockdowns by siRNAs, and 
compared to unstressed and stressed animal controls, could be used to elucidate the genes under 
transcriptional regulation by Nrf2 in these animals. As well as describing the Nrf2 pathway in 
early animals, these studies would also identify whether nematodes such as C. elegans are an 
unusual case of Nrf2 evolution and have lost Keap1-dependant regulation, or if the Keap1-
dependant regulation evolved after the nematode divergence from the basal metazoan phylum. 
If the former is the case, and the stress response in C. elegans is an exception to stress response 
observed in all other animals, it would imply that this worm might not be a suitable model for 
studies of ageing and stress in animals. 
6.5.5 Further studies of MAA-induced activation of Nrf2-controlled genes 
Over 20 MAAs have been identified and described, but only porphyra-334 has been studied for 
Nrf2 activation in cell culture models (463), while shinorine, porphyra-334 and palythine have 
been tested for inhibition of Keap1-Nrf2 interaction in vitro (chapter 4). MAAs have similar 
biophysical properties and chemical structures, and certain MAAs, such as mycosporine-
glycine, scored highly in the in-silico model of human Keap1 antagonism (chapter 2) and are 
known to be potent in-vitro antioxidants (232,250). The mycosporine-glycine, however, was 
not tested in this project due to the difficulties in obtaining the purified compound and presents 
an opportunity for future in vitro and in vivo studies. 
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7 Appendix A 
Appendix A-1: Sequences used in Keap1 and Nrf2 distant homology search 
Appendix A-1 is included in electronic format on a supplied supplementary data files disk and 
is available online at http://www.sciencedirect.com/science/article/pii/S089158491500283X. 
Appendix A-2: Distant homology to Keap1 
DHSP (Appendix A-2) was used to search custom databases of archaeal, bacterial, fungal, plant 
and protozoan protein sequences for distant homology to Keap1. Results are shown in Table A-
2.1. 
Table A-2.1. Distant homologs of Keap1.  
Table lists the predicted number of distant homologs of Keap1 protein detected by DHSP.  






Appendix A-3: Distant homology to Nrf2  
DHSP was used to search custom databases of archaeal, bacterial, fungal, plant and protozoan 
protein sequences for distant homology to Nrf2. Results are shown in Table A-3.1. 
Table A-3.1. Distant homologs of Nrf2 
Table lists the predicted number of distant homologs of Nrf2 protein detected by DHSP. 
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The search detected no Nrf2 homology in the archaeal database and very limited homology in 
the plant and bacterial databases. No bacterial and plant taxa with homology to both Nrf2 and 
Keap1 proteins could be identified. Further analysis of the conserved domain sequences of Nrf2 
(Neh1-Neh6) detected high homology to Neh1 in fungal taxa. Results are shown in Table A-
3.2. 
Table A-3.2. Taxonomic distribution of fungal Neh1 domain homologs of human Nrf2.  
Numbers of detected homologs are listed according to appropriate taxonomical levels. 
KINGDOM matches PHYLUM matches CLASS matches 
Fungi 887 Undefined 36 Undefined 36 
  Ascomycota 658 Dothideomycetes 92 
    Eurotiomycetes 197 
    Leotiomycetes 23 
    Orbiliomycetes 7 
    Pezizomycetes 7 
    Saccharomycetes 117 
    Schizosaccharomycetes 6 
    Sordariomycetes 207 
    Taphrinomycetes 2 
  Basidiomycota 169 Agaricomycetes 98 
    Dacrymycetes 5 
    Exobasidiomycetes 3 
    Tremellomycetes 21 
    Ustilaginomycetes 17 
    Wallemiomycetes 9 
    Undefined 16 
  Chytridiomycota 6 Chytridiomycetes 6 
  Glomeromycota 8 Glomeromycetes 8 
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Appendix A-4: Human Nrf2 and Keap1 homology in Saccharomyces cerevisiae 
Saccharomyces cerevisiae human Nrf2 homologs: 
Whole length Nrf2 homology: No homology detected 
Nrf2 Neh1 domain homology 
>gi|6322153|ref|NP_012228.1|__eV{1.2e-03}Ve__ Cst6p [Saccharomyces cerevisiae 
S288c] Basic leucine zipper (bZIP) transcription factor in ATF/CREB family; 
mediates  transcriptional activation of NCE103 (encoding carbonic anhydrase) 
in response to low CO2 levels such as in the ambient air; proposed to be a 
regulator of oleate responsive genes; involved in utilization of non-optimal 
carbon sources and chromosome stability; relocalizes to the cytosol in 










>gi|398366073|ref|NP_011704.3|__eV{6.3e-03}Ve__ Bub1p [Saccharomyces 
cerevisiae S288c] 
Protein kinase involved in the cell cycle checkpoint into anaphase; in complex 
with Mad1p and Bub3p, prevents progression into anaphase in presence of 
spindle damage; Cdc28p-mediated phosphorylation at Bub1p-T566 is important for 
degradation in anaphase and adaptation of checkpoint to prolonged mitotic 
arrest; associates with centromere DNA via Skp1p; involved in Sgo1p 
relocalization in response to sister kinetochore tension; paralog MAD3 arose 















>gi|6323696|ref|NP_013767.1|__eV{3.0e-03}Ve__ Far3p [Saccharomyces cerevisiae 
S288c] hypothetical protein; involved in recovery from cell cycle arrest in 
response to pheromone, in a Far1p-independent pathway; interacts with Far7p, 
Far8p,Far9p, Far10p, and Far11p; localizes to the endoplasmic reticulum; 





Page 183 of 230 
Human Keap1 homology: 
Keap1 BTB domain homology: 




Kelch beta propeller homology: 
>gi|6321952|ref|NP_012028.1|__eV{1.6e-05}Ve__ Kel1p [Saccharomyces cerevisiae 
S288c] Protein required for proper cell fusion and cell morphology; functions 
in a complex with Kel2p to negatively regulate mitotic exit, interacts with 
Tem1p and Lte1p; localizes to regions of polarized growth; potential Cdc28p 
substrate; KEL1 has a paralog, KEL2, that arose from the whole genome 
















Whole length Keap1 homology:  
>gi|398364545|ref|NP_012265.3|__eV{2.9e-04}Ve__ hypothetical protein YIL001W 



























Alignment of human Keap1 and S. cerevisiae Skn7: 
Max Score 17.7 Total Score 67.0 Cover 11% E-value 1.6 Identity 38% 
Alignment statistics for match #1 
Score 17.7; E-value 1.6; Identities 12/32(38%); Positives 14/32 (43%); Gaps 
4/32 (12%) 
Query 378  GGRNNSPDGNTDSSALDCY--NPMTNQWSPCA  407 
            G RN  P GNT+ +       N  TN  SP   
Sbjct 317  GNRN--PTGNTNPATTTAIQSNNNTNNASPAT  346 
Alignment statistics for match #2 
Score 16.9; E-value 2.9; Identites 8/15(53%); Positives 9/15(60%); Gaps 
0/15(0%) 
Query  337  QSLSYLEAYNPSDGT  351 
            QSL+ L   NPS  T 
Sbjct  529  QSLAMLPQDNPSTTT  543 
Alignment statistics for match #3 
Score 16.9; E-value 3.0; Identities 5/8(63%); Positives 6/8(75%); Gaps 0/8(0%) 
Query  586  PDTDTWSE  593 
            PD  TW+E 
Sbjct  101  PDIVTWTE  108 
Alignment of human Keap1 and S. cerevisiae YAP1 
Alignment statistics for match #1 
Score 18.9; E-value 0.65; Identities 11/30(37%); Positives 12/30(40%); Gaps 
0/30(0%) 
Query  504  NTIRSGAGVCVLHNCIYAAGGYDGQDQLNS  533 
            NT  S   +  L N IY      G D  NS 
Sbjct  246  NTPNSSTSMDWLDNVIYTNRFVSGDDGSNS  275 
Alignment of human Nrf2 and S. cerevisiae YAP1 
Max score 24.6 Total 109 Query Cover 27% E-value 0.011 Identity 27% 
Alignment statistics for match #1 
Score 24.6; E-value 0.011; Identities 17/63(27%); Positives 32/63(50%); Gaps 
7/63(11%) 
Query  486  RRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLY  545 
            +R  +N+ A +  R+RK   + ELE+ +  L+  ++       +N+     L+ QL TL  
Sbjct  69   KRTAQNRAAQRAFRERKERKMKELEKKVQSLESIQQ-------QNEVEATFLRDQLITLV  121 
Query  546  LEV  548 
             E+ 
Sbjct  122  NEL  124 
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Alignment statistics for match #2 
Score 20.0; E-value 0.33; Identities 11/43(26%); Positives 21/43(48%); Gaps 
2/43(4%) 
Query  449  HIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKN  491 
            ++ FP +   N+ +  F+E  S+ +F+       RD  + G N 
Sbjct  469  NLAFPDDNSTNIQLQPFSESQSQNKFDYDM--FFRDSSKEGNN  509 
Alignment statistics for match #3 
Score 17.7; E-value 1.6; Identities 13/40(33%); Positives 18/40(45%); Gaps 
2/40(5%) 
Query  16   VSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFF  55 
             ++  F   + RK  ELE  KK++     Q Q E E  F  
Sbjct  76   AAQRAFRERKERKMKELE--KKVQSLESIQQQNEVEATFL  113 
Alignment of Human Nrf2 and S. cerevisiae SKN7 
Max score 16.9 Total score 49.3 Cover 11% E-value 2.6 Identity 
38% 
Alignment statistics for match #1 
Score 16.9; E-value 2.6; Identities 5/13(38%); Positives 8/13(61%); Gaps 
0/13(0%) 
Query  407  ENTPEKELPVSPG  419 
            ++ P    PV+PG 
Sbjct  536  QDNPSTTTPVTPG  548 
Alignment statistics for match #2 
Score Expect Method Identities Positives Gaps 
Score 16.5; E-value 3.5; Identities 10/37(27%); Positives 20/37(54%); Gaps 
1/37(2%) 
Query  16   VSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEK  52 
            VS++ F  + RR+  +L+K+  + K      + E +K 
Sbjct  235  VSKDAFG-NLRRRVDKLQKELDMSKMESYATKVELQK  270 
Alignment of C. elegans SKN1 and S. cerevisiae SKN7 
No significant similarity found 
Alignment of S. cerevisiae YAP1 and C. elegans SKN1 
Score 17.3 Max score 83.5 Coverage 13% E-value 2.0 Identity 33% 
Alignment statistics for match #1 
Score 17.3; E-value 2.0; Identities 5/15(33%); Positives 9/15(60%); Gaps 
0/15(0%) 
Query  132  RNDSKVLEYLARRDP  146 
            R+D +++EY     P 
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Alignment statistics for match #2 
Score 17.3; E-value 2.2; Identities 6/11(55%); Positives 8/11(72%); Gaps 
0/11(0%) 
Query  491  QNKFDYDMFFR  501 
            Q+K+DY  F R 
Sbjct  116  QSKYDYPQFNR  126 
Alignment statistics for match #3 
Score 16.9; E-value 3.0; Identities 11/34(32%); Positives 20/34(58%); Gaps 
2/34(5%) 
Query  5    TAKRSLDVVSPGSLAEFEGSKSR-HDEIENEHRR  37 
            T K  LD +SP +   +  S +R  DE+ ++H++ 
Sbjct  77   TTKHLLDNISP-TFKMYTDSNNRNFDEVNHQHQQ  109 
Appendix A-5: MAA biosynthetic pathway genes detected in fungi  
Fungal species with homology to Keap1, conserved sequences of Keap1 (Kelch1 – Kelch 6 and 
BTB domain) and with homology to Nrf2 and its conserved sequences Neh1 – Neh6 were 
analysed for genes encoding mycosporine-like amino acid (MAA) biosynthesis. Genomes were 
data-mined for pentose-phosphate and shikimate pathways of MAA biosynthesis (Fig A-5.1). 
Pentose phosphate route of MAA biosynthesis was determined via presence of homology to 
enzymes Ava_3855 (NRPS-like synthetase), Ava_3856 (ATP-grasp amino acid ligase), 
Ava_3857 (O-methyltransferase) and Ava_3858 (2-epi-5-epi-valiolone synthase) (599), and the 
shikimate pathway was determined according to presence of homology to DHQS (3-
dehydroquinate synthase) and DAHPS (3-deoxy-d-arabino-heptulosonate 7-phosphate 
synthase) (600).  
 
Fig A-5.1. Presumed pathways of MAA biosynthesis, modified from (600). 
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Table A-5.1. Fungal species with homology to Keap1, Nrf2 and biosynthesis of Mycosporine-
like amino acids (MAAs).  
Table lists fungal taxa in which homology to Nrf2, Keap1 and at least some enzymes involved in 
biosynthesis of MAAs could be detected. Nrf2 prediction scores represent the sum of numbers of 
detected homologs for Nrf2 and domain Neh1 – Neh6 conserved sequences. The Keap1 prediction 
scores represent the sum of Keap1 sequences detected and the number of conserved Kelch1 – 
Kelch6 and BTB domains. Species listed in Results (marked in blue) were selected based on Keap1 
and Nrf2 prediction scores as well as presence of homology of all tested enzymes involved in MAA 
biosynthesis. Scores marked with asterisk indicate lack of full-length homolog. 




B. bassiana 7 43 2 / 2 4 / 4 
C. gloeosporioides 8 79 2 / 2 4 / 4 
C. graminicola 15 73 2 / 2 4 / 4 
C. higginsianum 14 54 2 / 2 4 / 4 
C. militaris 8 46 2 / 2 4 / 4 
F. graminearum 10 66 2 / 2 4 / 4 
F. pseudograminearum 10 60 2 / 2 4 / 4 
M. acridum 13 38 2 / 2 4 / 4 
M. oryzae 15 79 2 / 2 4 / 4 
V. dahliae 10 40 2 / 2 4 / 4 
C. albicans 3 8 1 / 2 2 / 4 
C. apollinis 7* 21 2 / 2 4 / 4 
C. dubliniensis 10 16 1 / 2 2 / 4 
C. globosum 10* 60 1 / 2 4 / 4 
C. tenuis 5 5 1 / 2 4 / 4 
C. thermophilum 8 22 1 / 2 4 / 4 
E. lata 8* 58 1 / 2 4 / 4 
K. africana 8* 12 1 / 2 2 / 4 
L. elongisporus 6 14 1 / 2 3 / 4 
M. anisopliae 7 35 1 / 2 4 / 4 
N. crassa 11 71 1 / 2 4 / 4 
N. tetrasperma 5 35 1 / 2 4 / 4 
P. omphalodes 3* 26 2 / 2 4 / 4 
S. cerevisiae 3* 4 2 / 2 2 / 4 
S. hirsutum 2* 62 2 / 2 4 / 4 
S. macrospora 9 74 1 / 2 4 / 4 
S. schenckii 7 26 1 / 2 4 / 4 
T. blattae 6 12 1 / 2 1 / 4 
T. reesei 5* 25 1 / 2 4 / 4 
V. alfalfae 10* 66 2 / 2 2 / 4 
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Appendix A-6: Keap1 and Nrf2 homologs used for phylogenetic analysis 
Appendix A-6 is included in electronic format on a supplied supplementary data files disk and 
is available online at http://www.sciencedirect.com/science/article/pii/S089158491500283X. 
Appendix A-7: Virtual screen results 
Table A-7.1. Virtual screening results.  
Listed compounds are deemed “viable” according to their docking score, number of potential 
hydrogen bonds within the Keap1-Nrf2 binding pocket and by manual inspection of the docking 
profile. The table is sorted according to the biological function of docked ligands. 
Compound Score Structure Assignment Biological function 
ZINC49048037 0.75 AGN-PC-07CJ71 acetylcholinesterase inhibitor (361) 
ZINC15120547 -2.66 Crassinervic acid antifungal (362) 
ZINC00622123 0.77 Griseofulvin antifungal (363) 
ZINC13411177 0.02 similar to Strictifolione antifungal (364) 
ZINC14447808 1.76 AGN-PC-077JEH antifungal (365) 
ZINC40973915 -9.01 similar to Ixoside antioxidant (366) 
ZINC31157290 -2.60 Secoxyloganin antioxidant (367) 
ZINC05998957 -2.17 Lirioresinol A antioxidant (368) 
ZINC15119278 -1.04 similar to Yatein antioxidant (369) 
ZINC00898006 -0.15 Rubrofusarin antioxidant (370) 
ZINC02563652 -0.04 Alloisoimperatorin antioxidant (371) 
ZINC01580260 0.23 Cleomiscosin A antioxidant (372) 
ZINC69482380 1.63 similar to Maclurin antioxidant (373) 
ZINC06037073 -0.97 similar to Emodin cytotoxic, anti-cancer (374) 
ZINC84154280 -2.54 Geranyloxy-p-benzoic Acid farnesoid X receptor agonist (375) 
ZINC26490614 -2.69 Procyanidin B2 Nrf2 activator (376) 
ZINC30726399 -9.93 Betanidin Nrf2 activator (377) 
ZINC69482045 -6.62 similar to Ursoloic acid Nrf2 activator (378) 
ZINC69481913 -6.40 similar to Ursoloic acid Nrf2 activator (378) 
ZINC17263588 -6.17 Chlorogenic acid Nrf2 activator (379) 
ZINC84154032 -5.75 similar to Morroniside Nrf2 activator (380) 
ZINC84153764 -4.32 similar to Morroniside Nrf2 activator (380) 
ZINC04102166 -4.28 Geniposidic acid Nrf2 activator (381) 
ZINC01714287 -3.40 Piperine Nrf2 activator (382) 
ZINC03870412 -3.06 Epigallocatechin gallate 
(EGCG) 
Nrf2 activator (383) 
ZINC00073693 -2.12 Pinocembrin Nrf2 activator (384) 
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ZINC12428433 -1.84 Butein Nrf2 activator (385) 
ZINC71316232 -1.69 similar to Chlorogenic acid Nrf2 activator (379) 
ZINC01531693 -1.57 similar to Piperine Nrf2 activator (382) 
ZINC03872070 -1.52 Chrysine Nrf2 activator (386) 
ZINC00897734 -1.50 similar to Quercetin Nrf2 activator (387) 
ZINC00156701 -1.41 Naringenin Nrf2 activator (388) 
ZINC00113309 1.69 Fraxetin Nrf2 activator (389) 
ZINC01561070 -0.11 similar to Quercetin Nrf2 activator (387) 
ZINC14728348 0.14 similar to Quercetin Nrf2 activator (387) 
ZINC05733652 -1.36 Diosmetin potential Nrf2 activator, antioxidant (390) 
ZINC33832113 -1.73 similar to Phlorizin potential Nrf2 activator (391) 
ZINC69482290 -3.37 similar to Glucoerucin potential Nrf2 activator (392) 
ZINC05733537 -0.86 Ermanin, similar to  
Quercetin (Nrf2 activator) 
potential Nrf2 activator (387) 
ZINC84153966 -3.86 similar to Acetoside potential Nrf2 activator (393) 
ZINC13108875 -2.42 similar to Burchellin potential pesticide (394)  
mycosporine 
glycine-valine 
0.24 Mycosporine-like amino acid UV-protectant, antioxidant (395) 
mycosporine 
glycine 
4.21 Mycosporine-like amino acid UV-protectant, antioxidant (395) 
Porphyra 334 0.58 Mycosporine-like amino acid UV-protectant, antioxidant (395) 
ZINC15252691 -5.23 Gaudichaudianic acid trypancide (396) 
ZINC36403425 -6.02 no annotation available unknown 
ZINC69482210 -5.93 no annotation available unknown 
ZINC69482050 -5.86 no annotation available unknown 
ZINC69482369 -5.49 no annotation available unknown 
ZINC69482017 -4.92 no annotation available unknown 
ZINC69481856 -4.71 no annotation available unknown 
ZINC84153792 -4.66 no annotation available unknown 
ZINC84154198 -4.61 no annotation available unknown 
ZINC84154010 -4.16 no annotation available unknown 
ZINC84154210 -3.80 no annotation available unknown 
ZINC84154686 -3.33 no annotation available unknown 
ZINC84154382 -3.29 no annotation available unknown 
ZINC84153978 -2.93 no annotation available unknown 
ZINC69481928 -2.91 no annotation available unknown 
ZINC84153941 -2.54 no annotation available unknown 
ZINC69482062 -1.89 no annotation available unknown 
Appendix A 
Page 190 of 230 
ZINC69482080 -1.51 no annotation available unknown 
ZINC69482112 -1.48 no annotation available unknown 
ZINC84154336 -1.46 no annotation available unknown 
ZINC84154341 -1.37 no annotation available unknown 
ZINC00174016 -1.28 no annotation available unknown 
ZINC69482027 -1.07 no annotation available unknown 
ZINC84154296 -1.00 no annotation available unknown 
ZINC84154672 -0.88 no annotation available unknown 
ZINC84154479 -0.87 no annotation available unknown 
ZINC14647433 -0.31 no annotation available unknown 
ZINC19204246 0.53 no annotation available unknown 
ZINC14445187 0.77 hydroxycanthin unknown 
ZINC69481958 1.05 no annotation available unknown 
ZINC15119468 1.21 no annotation available unknown 
 
Appendix A-8: Caenorhabditis elegans Keap1 homology analysis 
Alignment of Human Keap1 and C. elegans protein SKN1 
     No significant similarity found (within BLAST e-value 100.0) 
Alignment of Human Keap1 and C. elegans Keap1-like sequence R12E2.1 (SKN1) 
 
Statistics: Score: 574 bits; Coverage: 87%; BLAST E-value: 5.0e-116 
Query  52   FSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMF  111 
             ++ + ++ K+A  +M  +R    L DV L+VK +      F AHKVVL+++SP FKAMF 
Sbjct  65   MTFCMSNYAKEALKMMYMMRSHGMLTDVVLEVKKE-----LFPAHKVVLSAASPYFKAMF  119 
Query  112  TNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRAC  171 
            T GL+E  M  V ++G+ P  M R++ F YT  I + E  V  ++  A M+Q+ +V+ AC 
Sbjct  120  TGGLKESEMSRVQLQGVCPTAMSRILYFMYTGQIRVTEVTVCQLLPAATMFQVPNVIDAC  179 
Query  172  SDFLVQQLDPSNAIGIANFAEQIGCVELHQRAREYIYMHFGEVAKQEEFFNLSHCQLVTL  231 
              FL +QLDP+NAIGIA+FAEQ GCVEL ++A  +I  +F +V ++EEF  LS  QL+ L 
Sbjct  180  CAFLERQLDPTNAIGIAHFAEQHGCVELQKKANVFIERNFTQVCQEEEFLQLSAYQLIAL  239 
Query  232  ISRDDLNVRCESEVFHACINWVKYDCEQRRFYVQALLRAVRCHSLTPNFLQMQLQKCEIL  291 
            I RD+LNV+ E EV++A + WVKYD + R   ++ +L AVRC  LTPNFL+ Q++ C++L 
Sbjct  240  IRRDELNVQEEREVYNAVLKWVKYDEDNRHCKMEHILGAVRCQFLTPNFLKEQMKNCDVL  299 
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Query  292  QSDSRCKDYLVKIFEELTLHKPTQVMPCRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGT  351 
            +    C++YL KIF++LTLHK   V   R P   R+I+ AGG+FR SL  LEAYN  D T 
Sbjct  300  RKVPACREYLAKIFKDLTLHKCPGVKE-RTPNTTRMIFVAGGFFRHSLDILEAYNVDDMT  358 
Query  352  WLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSV  411 
            W  LA+L++PRSGL    + G  YAVGGRNN+   + DS  +D Y+ +T  W PCAPMSV 
Sbjct  359  WTTLANLRIPRSGLGAAFLKGKFYAVGGRNNNIGSSYDSDWVDRYSAVTETWRPCAPMSV  418 
Query  412  PRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRL  471 
            PR+R+GV V+D  +YAVGGS G  +HN+VE Y+P+ D W LV PM  +R+GVGV V+NRL 
Sbjct  419  PRHRVGVAVMDELMYAVGGSAGMEYHNTVEYYDPDLDRWTLVQPMHAKRLGVGVVVVNRL  478 
Query  472  LYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQL  531 
            LYA+GGFDG  RL S ECY+PE NEW  +  + T RSGAGV  ++  IY  GG+DG  QL 
Sbjct  479  LYAIGGFDGNERLASVECYHPENNEWSFLPPLQTGRSGAGVAAINQYIYVVGGFDGTRQL  538 
Query  532  NSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTW  591 
             +VERYD E +TW  VAP++  RSAL +T    ++Y +GG+DG+ FL  VE YDP T+TW 
Sbjct  539  ATVERYDTENDTWDMVAPIQIARSALSLTPLDEKLYAIGGFDGNNFLSIVEVYDPRTNTW  598 
Query  592  SEVTRMTSGRSGVGVAVTMEP  612 
            +  T + SGRSG   AV  +P 
Sbjct  599  TTGTPLKSGRSGHASAVIYQP  619 
 
Alignment of Human Keap1 and C. elegans protein WDR-23 
 
Statistics: Score: 16.5; Coverage 36%; BLAST E-value: 3.8 
Query  319  CRAPKVGRLIYTAG  332 
            C A     LIY+AG 
Sbjct  318  CFADLGSNLIYSAG  331 
Query  488  EC-YYPERNE-----WRMITAMNTI---RSGAGVCVLHNCIYAAGGYDGQDQL  531 
            EC ++P  NE     W  +T + T    + G      H  I   G  D  D+L 
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Alignment of Human β-transducin repeat-containing protein (β-TrCP) and C. elegans 
protein WDR-23 
 
Statistics: Score 62.4; Coverage: 55%; BLAST e-value: 2.0e-14 
Query  339  LTGHTG----SVLCLQYDE--RVIITGSSDSTVRVWDVNTGEMLNTLIHHCE----AVLH  388 
            L G  G    +V C+++ +    I+ G+S  ++ V+DV     + T+++  E    +V   
Sbjct  260  LNGEPGRDHCAVFCVKFSDSSEQIVCGTSQYSIHVFDVEQRRRIRTIVNAHEDDVNSVCF  319 
Query  389  LRFNNGMMVTCSKDRSIAVWDMA--SPTDITLRRVLVGHRAAVNVVDF--DDKYIVSASG  444 
                + ++ +   D  + VWD    S  D+    V  GHR  V  VD   D++Y++S S  
Sbjct  320  ADLGSNLIYSAGDDGLVKVWDKRAWSDGDVEPVGVFAGHRDGVTHVDSRQDERYLLSNSK  379 
Query  445  DRTIKVW------NTSTCEFVR------------------------------TLNGH---  465 
            D+TIKVW      N S  E  R                              TL GH    
Sbjct  380  DQTIKVWDLRKFSNMSGVEATRACVQSQHWDYRWQPAPPGLCQPVAGDTSVMTLRGHSVL  439 
Query  466  ----KRGIACLQYRDRLVVSGSSDNTIRLWDIECGACLRVLEGHEELVRCIRFD--NKRI  519 
                +   +      R + +G +   + ++DI  G   R L+GH  +VR   +      I 
Sbjct  440  HTLVRANFSPESTGRRYIYTGCARGEVVVYDIMSGTVSRRLKGHTAVVRECDWHPTENEI  499 
Query  520  VSGAYDGKIKVW  531 
            VS A+DG   VW 
Sbjct  500  VSSAWDGVTTVW  511  
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8 Appendix B 
Appendix B presents a large number of protein sequences used in phylogenetic analysis and is 
unsuitable for paper-format. It is included in electronic format on a supplied supplementary 
data files disk as Appendix B.  
Appendix is also available online at http://www.nature.com/articles/srep27740#supplementary-
information. 
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9 Appendix C 
Appendix C-1: UV spectrum of twin Philips Ultraviolet-B TL 20W/12RS lamps 
The appendix C-1 presents the UV spectrum (Fig C-1.1) of lamps used to irradiate yeast 
cultures in the experiments described in the Chapter 5, and the detailed breakdown of the UV 
output of lamps, calculated for different bands of UV spectrum (Table C-1.1). 
 
Fig C-1.1: Irradiance spectrum of twin Philips Ultraviolet-B TL 20W/12RS lamps  
The figure displays a UV emission spectrum of twin Philips Ultraviolet-B TL 20W/12RS lamps 
used to irradiate yeast samples. The UV output of lamps was measured at 10 cm distance from 
the lamps, using Bentham (double grating) DM150BC spectroradiometer with 2 400 g/mm 


























UV output spectrum of twin  
Philips Ultraviolet-B TL 20W/12RS lamps  
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Table C-1.1. UV output of twin Philips Ultraviolet-B TL 20W/12RS lamps. 
Table lists the calculations of UV output of twin Philips Ultraviolet-B TL 20W/12RS lamps for different 
bands of UV spectrum. The main bands of UV spectrum (UV-A, UV-B and UV-C) are underlined for 
clarity. The output of twin lamps, corresponding wavelengths and the proportion of total UV output 
are listed for each band of UV spectrum. 
UV band Wavelength 
(nm) 
UV output  
(J/m2/s) 
Proportion 
of total UV  
UV-A 321-400 1.75 29.9% 
(UV-A > 315) 316-400 2.31 39.6% 
UV-A I 341-400 0.45 7.7% 
UV-A II 321-340 1.30 22.2% 
(UV A II > 315) 316-340 1.86 31.9% 
UV-B 281-320 4.06 69.6% 
Non-solar UV-B 281-295 0.82 14.0% 
UV-C 251-280 0.03 0.5% 
Total UV 250-400 5.84 100.0% 
 
Appendix C-2: Quantified proteome of Sporobolomyces yeast LEV-2 
Appendix C-2 presents a list of all proteins identified and quantified in MudPIT analysis of 
UV-tolerant Sporobolomyces yeast LEV-2, and is unsuitable for paper-format. It is included in 
electronic format on a supplied supplementary data files disk as Appendix C. 
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